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Abstract 
This thesis describes engineering studies with the Escherichia coli β-glucuronidase enzyme (E. 
coli β-GUS) that catalyzes the hydrolysis of D-glucuronic acids (glycone) that are conjugated 
through a β-O-glycosidic linkage to an aglycone.  The enzyme is specific for the glucuronic acid 
component and will tolerate a variety of aglycones.  A point mutation was known to convert β-
GUS into a glucuronylsynthase, that is an enzyme capable of the synthesis of glucuronide 
conjugates.  The long-term aim of the present research was to change the donor sugar 
specificity of the glucuronylsynthase from a glucuronyl donor to a glucosyl donor allowing the 
synthesis of glucosides.  The approach taken to achieve the long-term aim was to first alter the 
specificity of β-GUS and to then convert the variants to a synthase.  There were two 
approaches taken to altering the substrate specificity of β-GUS.  The first approached was to 
use site saturation mutagenesis to alter key residues that are located at the active site.  A 
more effective approach involved using directed evolution to generate variants with altered 
specificity.  A selection of these variants were converted to (putative) synthetic enzymes and 
tested for activity.  
 The structure-guided site saturation mutagenesis of 9 sites was carried out in an 
attempt to alter the substrate specificity of β-GUS.  The choice of the residues to be altered 
was made with the aid of the structure of β-GUS with a bound substrate analogue.  Nine 
codons in the β-GUS gene were randomised to create libraries that contained all possible 
amino acid of residues in and / or near the active site.  Mutants were assayed using substrates 
presenting 5 different glycones.  Of the positions randomised, most glycosyl binding residues 
were found not to tolerate amino acid substitutions, suggesting they are essential for β-GUS 
function while majority of non-glycosyl binding residues were found to tolerate amino acid 
substitutions – but not with good activity  
 One of the common dogmas of directed evolution is the idea that evolvability is 
related to stability.  We set out to test this idea while evolving substrate specificity.  Other 
workers had generated a more thermostable variant of β-GUS.  In parallel, we evolved 1) the 
native enzyme (GUS-WT) and 2) the thermostable (GUS-TR3337) variant of β-GUS.  Mutant 
libraries of both GUS-WT and GUS-TR3337 were created under identical conditions and had 
the same distributions of mutations.  After five rounds of evolution, the catalytic efficiency 
(kcat/Km) of the best mutant of the wild type parent for pNP-glucoside was increased ~307-fold 
while the best mutant of the thermophilic parent demonstrates a ~4-fold increased kcat/Km 
over the best mutant of wild type parent.  Selected mutants from both libraries were 
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characterised with regard to conformational properties and stability and these investigations, 
combined with kinetic data, provided valuable information about how thermostability 
promotes the ease of protein evolvability.   
 The initial characterisation of β-GUS variants was done with crude lysates.  It was 
observed that the GUS-WT and GUS-TR3337 variants lost their newly evolved activity after 
purification.  It was eventually determined that the BugBusterTM reagent used to lyse cells prior 
to screening, had affected the directed evolution campaign.  The n-octyl β-D-
thioglucopyranoside (OTG) presents in the BugBusterTM reagent, was very similar in structure 
to pNP-glucoside and was identified as a competitive inhibitor that suppresses glucosidase 
activity of wild-type β-GUS, indicating that it can be bound in the active site.  In response to 
the addition of OTG in the screening assay, OTG enhanced the glucosidase activity of selected 
mutants.  This observation highlights the potential pitfall in the use of commercial reagents to 
lyse cells for enzymes with glycosidase activities.  However, the evolution in the presence of 
OTG gives some insight into how an enzyme might evolve to be regulated by an effector 
molecule – OTG, in this case.  
 Finally, improved cell lysis variants were converted to glucuronylsynthase variants by 
introducing the site specific mutation.  Their glycosynthase ability was tested using a similar 
protocol developed by McLeod Group for assaying glucuronylsynthase activity.  Unfortunately, 
glycosynthase activity was not observed with α-D-glucuronyl fluoride donor and steroid 
accepters.  Time constraints did not allow other substrate to be tested. 
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Chapter 1 
Introduction 
This thesis describes engineering studies pertaining to Escherichia coli -glucuronidase (E. -
GUS) (EC 3.2.1.31) enzyme (Doyle et al. 1955).  This enzyme catalyses the hydrolysis of 
glycosidic bonds in glucuronides as shown below in Figure 1.1.  
 
Figure 1.1 General β-GUS hydrolysis reaction for glucuronide 
A glucuronide consists a glucuronyl group (blue) and an aglycone component (red). 
A brief description of the naming conventions for the glycone and aglycone groups in 
glycosides is provided in the Appendix A.  This appendix gives a description of the relevant 
nomenclature and is not intended to be a detailed description of carbohydrate chemistry.  It 
should be noted that glucuronides figure prominently in Phase II metabolism of xenobiotics 
that include drugs.  Glucuronic acid is used to tag xenobiotics that are then excreted via the 
urinary and digestive tracts.  E. coli is found in the digestive tract of humans and encounters a 
variety glucuronides being excreted as part of detoxification.  β-GUS primarily acts to de-
conjugate glucuronides to obtain glucuronic acid, that are then used as a carbon source 
(Wilson et al. 1992).  The enzyme is highly specific for the glucuronic acid, but not for the 
aglycone. 
This project was part of a research program aimed at converting -GUS into a 
synthetic enzyme capable of forming glycosides.  An explanation as to how the catalytic 
reaction is altered is given later in this chapter.  Given that the -GUS is highly specific for 
glucuronic acid and not for the aglycone, the synthase formed from it has the potential of 
producing a variety of glucuronides.  The aim of the present thesis was firstly to convert -GUS 
into a glucosidase – that is, to change its substrate specificity.  It was intended that these 
evolved glucosidases would then be converted to synthetic enzymes.  
This introductory chapter has a brief description of -GUS that includes its structure 
and mechanism.  Also described are the changes used to bring about the synthetic activity 
along within the principal target for synthesis – the glycosylation of steroids.  A brief 
β-GUS 
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introduction to the methods used to alter the substrate specificity is given.  The emphasis of 
this latter section is on directed evolution that was the main tool used to alter substrate 
specificity.   
1.1. Background 
Exogenous (xenobiotics) and endogenous (products of metabolism) compounds are eliminated 
from the body principally through excretion in urine.  Hydrophilic drug molecules can be 
excreted in urine.  However, hydrophobic compounds, such as steroids, are less likely to enter 
into the aqueous medium and will remain “stored” in the body.  These molecules require 
metabolic transformation in the liver to convert them into more hydrophilic derivatives.  An 
effective means of increasing their hydrophilicity consists in their conjugation with hydrophilic 
molecular species, like glucuronic acid.  For example, in phase II detoxification, isomers of 
glucuronosyltransferase in the lumen of the endoplasmic reticulum (ER) catalyse conjugation 
with uridine diphosphate (UDP) glucuronic acid to form hydrophilic glucuronide conjugates as 
shown schematically in Figure 1.2 (Burchell & Coughtrie 1989).  Once synthesized, those 
glucuronides are then usually excreted from the body via the bile ducts into the intestine, 
through apocrine secretions, and through the bladder into the urinary tract.   
Excreted glucuronides in the intestinal lumen may undergo de-conjugation by 
commensal microorganisms, for example, E. coli.  Most E. coli strains living in natural 
environments possess β-GUS and are able to utilize glucuronides as nutrients (Chang et al. 
1989).  The diversity of glucuronide compounds that reach the intestine has resulted in E. coli 
β-GUS evolving to cleave almost any aglycone at its β-linkage to glucuronic acid (Wilson et al. 
1995).  The released glycone can then be used as a carbon source and the apolar aglycone can 
frequently be reabsorbed by the host (Hazenberg et al. 1988).  Due to its capacity to act on a 
broad range of β-glucuronide conjugates, E. coli β-GUS has widespread application in the field 
of analytical chemistry for the de-conjugation of glucuronide metabolites.  
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Figure 1.2 Detoxification pathway 
Xenobiotic molecules may undergo phase I functionalization reactions alone or phase II 
biosynthetic conjugation reactions alone while some undergo phase I reactions followed by 
phase II reactions.  A phase I reaction introduces polar functional groups, i.e. hydroxyl or 
amino, onto lipophilic toxicant molecules.  Phase II metabolism involves the introduction of 
hydrophilic endogenous species, i.e. glucuronic acid or sulfate, to the drug molecule.  In the 
Phase II glucuronylation reaction, glucuronides are synthesized by UDP-
glucuronosyltransferase (UGT) in the lumen of the liver ER and eliminated via the kidney or 
bile.  The glucuronides excreted in the bile may be hydrolysed in the intestines by β-GUS and 
the unbound toxin can then be reabsorbed via the enterophepatic recirculation. 
1.2. β-glucuronidase enzyme 
As mentioned above, β-GUS is an exoglycosidase and is a member of the glylcosidase enzyme 
family that catalyses the hydrolysis of O-glycosidic bonds.  They exist in a range of animals, i.e. 
humans (Islam et al. 1999), dogs (Ray et al. 1998), rats (Nishimura et al. 1986); plants, i.e. rye 
(Schulz & Weissenböck 1987), rhubarb (Hodal et al. 1992), skullcap (Levvy 1954); and micro-
organisms, i.e. Escherichia coli (Jefferson et al. 1986), Clostridium (Fujisawa et al. 2001), 
Staphylococcus (Arul et al. 2008).  The β-GUS of interest in this study is from E. coli.  
E. coli β-GUS is a member of the retaining β-glycosidase family 2 (Henrissat 1991).  It 
exists as a homo-tetramer with subunits related by three perpendicular twofold axes.  The 
subunits consist of 603 amino acids that have a molecular weight of 68 kDa (Aiba et al. 1996).  
The bacterial enzyme folds into three domains: i) the N-terminal resembling a sugar-binding 
domain that consists of 180 residues, ii) an immunoglobulin-like-β-sandwich domain that 
consists of 96 residues and iii) the C-terminal domain that folds into a αβ-barrel (TIM-barrel) 
that consists of 327 residues (residues 276 to 603).  Domain I and II are important structural 
elements of the enzyme while the domain III is the catalytic domain that contains the active-
site residues E413 and E504 (Figure 1.3).  It is worthwhile mentioning that a small section of 
the loop from domain I (residues 161 to 164) also forms part of the active site. 
1 Introduction 
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Figure 1.3 Structure of E. coli β-GUS (PDB ID: 3K4D) 
Domain I is coloured red, domain II coloured blue and domain III coloured green.  Catalytic 
residues E413 and E504 are represented as sticks.  The left side of the monomer in the top 
view and the right side of the monomer in the side view.   
1.2.1. The mechanism of β-GUS  
The mechanism of action for β-GUS has been well characterised (Zechel & Withers 2000) and 
is depicted in Figure 1.4.  β-GUS catalyses the hydrolysis of glycosidic linkages by a double 
displacement mechanism with retention of the stereochemical configuration of the anomeric 
carbon (Collins et al. 2005).  Its active site consists of two strategically positioned glutamic acid 
residues: E413 and E504 that provide a general acid/base and nucleophile, respectively 
(Sinnott 1990) as shown in the figure 1.4 below. The first step in catalysis involves a 
nucleophilic attack by carboxylate anion of E504 on the anomeric carbon of the glucuronide to 
form a covalent that is broken down by the action of E413 that functions as a general acid 
(Figure 1.4) (Liang et al. 2005). 
 
Figure 1.4 β-GUS mechanism of action 
 If an alcohol is the attacking species instead of water then a β-trans-glycosylated 
product results.  This was known to occur and can be exploited to synthesize oligosaccharides.  
E504 
E504 E413 
E413 
Active site 
Domain I interacts with domain III 
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However, the trans-glycosylated product remains a substrate for hydrolysis, especially under 
aqueous conditions, so that poor yields occur unless careful substrate selection or 
perturbation of the enzymatic equilibrium occurs (i.e. with organic co-solvents) (Johansson et 
al. 1986). 
1.3. Glucuronylsynthase 
Glucuronylation activity can be acquired by mutating the nucleophilic residue of β-GUS to a 
non-nucleophilic residue as shown below in Figure 1.5.  The three glucuronylsynthase enzymes 
utilized in this project, were prepared by mutating the glutamate at position 504 (E504) to 
either an alanine (E504A), a glycine (E504G), or a serine (E504S) residue.  This renders the 
residue incapable of nucleophilic attack at the C1 position, thereby preventing degradation of 
the glucuronide product (Figure 1.5).  However, the rest of the active site remains intact and 
formation of glucuronide product can be catalysed in the presence of a synthetically-derived 
α-D-glucuronyl fluoride and an acceptor alcohol substrate.  The α-D-glucuronyl fluoride donor 
with anomeric configuration opposite to that of the original substrate (β-glucuronide), 
mimicking the enzyme-linked intermediate in the β-GUS.  The fluoride substituent at the 
anomeric carbon acts as a good leaving group for general acid-base catalysis by the E413 
residue.  The leaving group is displaced by an alcohol leading to the formation of a new 
glycosidic bond.  The reverse mechanism (fluorination) is essentially absent since the fluoride 
ion is not bound strongly to the enzyme and will be dispersed into the medium following 
glucuronide synthesis.  Additionally, the newly formed glucuronide has a poor anomeric 
leaving group and won’t be displaced by poor nucleophiles such as a fluoride ion.   
Figure 1.5 General mechanism for the E. coli β-glucuronylsynthase 
Most glycosynthases are specific for the acceptor sugar (Perugino et al. 2004, Perugino 
et al. 2003, Trincone et al. 2000).  Interestingly, after screening which aglycons would be 
susceptible to glucuronylation by the glucuronylsynthase enzyme, it was found that non-
carbohydrate acceptors such as primary, secondary and aryl alcohols were better candidates 
1 Introduction 
 
6 
 
for glucuronylation than carbohydrate-based acceptors (Wilkinson et al. 2008).  While a few 
steroid substrates were successfully used to synthesise steroid glucuronides, a screen of a 
suitably diverse steroid library was performed by Ma et al. (2014).  Out of eighteen different 
steroidal alcohols, fifteen substrates providing glucuronide conjugate in high purity and on a 
scale suitable for 1H NMR analysis.   
1.4. The glycosylation of steroids 
Among the vast array of glycol-conjugates, steroidal glycosides have drawn much attention in 
the last few decades as economically important raw materials for the pharmaceutical industry 
in the production of various steroidal hormones (Görög 2011, Fernandes et al. 2003, Hwang et 
al. 1999).  The compounds are often biologically active (Francis et al. 2002, Bedir et al. 2002, 
Yokosuka 2015) and as such are also used as ingredients for cosmetics (Kashibuchi et al. 1996). 
It should come as no surprise that there has been extensive work on the chemical syntheses of 
oligosaccharides and steroids (Ma et al. 2001, Tang et al. 2013, Fernandez-Herrera et al. 2012) 
as well as conjugates of the two compound classes.  The key to synthesising steroidal 
glycosides is the construction of the glycosidic bond between a sterol with the sugar anomeric 
carbon (Figure 1.6). 
 
 
Figure 1.6 Glycosylation of steroids  
Despite the significant advances observed in carbohydrate chemistry, the 
stereoselective formation of O-glycosidic bonds between carbohydrates and steroids remains 
time-consuming due to the requirement of multiple protection and deprotection steps that 
have relatively low yields due to the low reactivity glycosyl donor and glycosyl acceptor (such 
as the secondary alcohol functions in the steroid moiety).  The need for more efficient 
approaches has stimulated the development of enzyme-mediated glycosylation.  Such an 
approach avoids the need for stringent reaction conditions which allow synthesizing unstable 
glycosides and any protecting groups that allow one-step glycosylation (Crout & Vic 1998).  
+ 
Glycosyl donor 
X = leaving group 
Acceptor Steroidal glycoside 
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Both glycosyltransferases and glycosidases have been vigorously studied for synthetic 
purposes (Shaikh & Withers 2008, Hancock et al. 2006, Bennett & Wong 2007).  
Glycosyltransferases are the natural enzymes for catalysing the formation of glycosidic bonds 
in high yields with excellent selectivity, i.e. UGTs, were employed by Werschkun et al. (1998) 
to synthesize β-D-glucuronides from urindine UDP-α-D-glucuronic acid and a wide variety of 
endo- as well as xenobiotic aglycons.  While the inherent nature of glycosidases is to break 
glycosidic linkages in carbohydrate metabolism, there have been increasing interest in 
exploring their transglycosylation activity for making complex carbohydrates.  A β-
galactosidase from Aspergillus oryzae, showed a high transglycosylation activity and as such it 
has been involved in the enzymatic synthesis of various chemically unstable cardiac glycosides 
(Ooi et al. 1984).  Although glycosyltransferase-catalyzed reaction provides a method for mild 
and stereospecific single-step synthesis without the need for protected glycosyl donors, its 
application has been limited by two major reasons.  Firstly, glycosyltransferases require a 
sugar nucleotide as glycosylation donor and this is an unstable and expensive substrate.  
Secondly, they are substrate-specific to the acceptors, which limits the range of substrates that 
can be used as starting materials (Williams et al. 2007).  Glycosidases, on the other hand, have 
the advantage of being readily available commercial enzymes and they also use simple glycosyl 
donors and have a relaxed substrate specificity for acceptors (Trincone et al. 2003).  
Nevertheless, glycosidases are still hydrolytically active, the product of this transglycosylation 
reaction can be hydrolysed, thus reducing yields of the product obtained (McCarter & Withers 
1994). 
The drawbacks mentioned above, were circumvented by the invention of 
glycosynthases (Mackenzie et al. 1998).  As demonstrated for a range of other retaining β-
glycosidase enzymes, single point mutation of the nucleophilic residue to a non-nucleophilic 
residue disables the hydrolytic pathway (Mackenzie et al. 1998).  This concept had been 
pioneered by the McLeod group to design a feasible glucuronylsynthase from β-glucuronidase 
(β-GUS) that could be used in chemoenzymatic glucuronylation of steroid substrates (Ma et al. 
2014).  This thesis sought to extend these early investigations. 
1.5. Specific aims of the project  
To the author’s knowledge, glucuronylsynthase was the only reported glycosynthase that 
catalysed glycosidic bond formation with a wide range of alcohol and steroidal acceptors while 
most of the engineered glycosynthase catalysed the formation of oligosaccharides.  The main 
aim of this project was to convert the sugar donor specificity of E. coli glucuronylsynthase from 
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glucuronic acid to glucose.  If successful, this will open up a new path to flavonoid glycoside 
synthesis (Figure 1.7) where the new enzyme biocatalysts will grant synthetic access to 
advanced organic materials that are in high demand in the fields of pharmaceutical 
development and chemical analysis.  Moreover, a great deal about enzymes can be learnt from 
the process. For example, what type of mutation is required for changing substrate specificity? 
How do proteins evolve – are stabilizing mutations required before active site mutations are 
observed? Are mutations that affect the dynamics of the enzyme important?  These are the 
type of questions we wanted to address when mutant proteins produced in this study were 
characterised. 
(a)                                             (b)                                                 (c) 
        
Figure 1.7 flavonoid glycosides 
(a) Salicin (b) geniposide (c) gossypin. 
 To attain the stated goals of changing substrate specificity, directed evolution was 
thought to be the method of choice.  An essential requirement for the success of these 
experiments is the ability to screen large libraries for the desired property.  In the case of 
glycosynthases, the development of a screening assay is challenging, because the reaction 
products do not produce a distinct, screenable signal, such as absorbance or fluorescence.  
Directed evolution is not uncommon amongst glycosynthases.  To date, there have been two 
elegant approaches of high throughput screening applied to glycosynthases.  These include 
chemical complementation and enzyme-coupled spectrophotometry that are described briefly 
in the following paragraphs.   
 Chemical complementation was developed by the Cornish group and involves 
transcriptional modification brought about by glycosynthase activity (Lin et al. 2004).  Using a 
yeast three-hybrid system, dihydrofolate reductase (DHFR) binds to the methotrexate (MTX) 
moiety and the glucocorticoid receptor (GR) binds to the dexamethasone moiety (DEX) (Figure 
1.8).  The DHFR is fused to a DNA binding domain (DBD), which binds to a specific DNA binding 
site upstream from the LEU2 gene.  The GR is fused to a transcription activation domain which 
up-regulates the transcription of the LEU2 gene.  The formation of oligosaccharide linkage via 
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a glycosynthase reaction results in the reconstitution of a transcriptional activator that can 
promote the transcription of the LEU2 gene.  The LEU2 gene is an essential gene in the 
biosynthesis of leucine and its up-regulation allows cells to grow in leucine-deficient media.  A 
novel selection criterion is achieved by relating glycosynthase activity to cell survival.  This 
makes this assay a high throughput selection as opposed to a screen as only mutants with 
appreciable glycosynthase activity will survive.  Chemical complementation is an ingenious and 
complex model as a high throughput selection for glycosynthase activity.  Unfortunately, the 
system relies on oligosaccharide formation through the use of a small molecule disaccharide 
acceptor substrate and a small molecule disaccharide α-fluoro donor substrate, the synthesis 
of which is a multistep endeavour (Tao et al. 2006).  As a result, the glucuronylsynthase needs 
the small molecule steroid acceptor substrate to drive the glycosidic bond formation.  This 
requires the design and synthesis of the new acceptor substrate.  In addition, the small 
molecules attached both to the donor and the acceptor might be too bulky to enter the active 
sites due to the fact that β-GUS having an active site that possesses pocket topology.  This 
makes chemical complementation unsuitable for the glucuronylsynthase high throughput 
screen. 
 
Figure 1.8 Cornish’s chemical complementation model 
Formation of the glycosidic bond via glycosynthase reaction up-regulates LEU2 transcription. 
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 The second approach, enzyme-coupled spectrophotometric assay, was developed in 
the Withers group and is based on the hydrolysis of a fluorescent or colourimetric tag from the 
glycosynthase product (Kim et al. 2004).  It involves the reaction of a glycosyl fluoride donor 
with a glycoside acceptor bearing a chromophore.  An endo-glycosidase, that recognises the 
newly formed oligosaccharide, hydrolyses the glycosidic bond linking the chromophore which 
can be measured spectrophotometrically (Figure 1.9).  The hydrolysis step is usually of many 
magnitudes faster than the glycosynthase step, so the glycosynthesis is the rate-determining 
step.  The rate of fluorescence or colour formation is therefore directly related to the 
glycosynthase activity.  This assay, however, is unsuitable for the glucuronylsynthase high 
throughput screen because a new specific chromophore-containing steroid acceptor has to be 
synthesized, and an endoglycosidase that cleaves the linkage between steroids and 
chromophores, if it exists at all, should be found.   
 
Figure 1.9 An example of a glycosynthase reaction coupled with endo-cellulase to hydrolyse 
the 4-nitrophenolate chromophore in an enzyme-coupled high throughput screen 
n = 1 or 2 (Mayer et al. 2001). 
 It should be clear from the previous two paragraphs that the two major high through-
put screening assays designed for glycosynthases are not applicable for glucuronylsynthase.  
For this reason, a two-step strategy was employed in the present research.  This approach 
involves i) evolving the wild-type β-GUS to have higher glucosidase activity and ii) converting 
improved β-GUS enzymes to glucuronylsynthases by incorporating a mutation at position 504.  
The screening assay applies para-nitrophenyl-β-D-glucuronide (pNP-glucuronide) that liberates 
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para-nitrophenolate on hydrolysis which absorbs strongly in the visible light spectrum (405 
nm) and can be monitored over time by spectrophotometry (Figure 1.10).  The major 
advantage of this approach is that the substrate required for the assay pNP-glucuronide is 
commercially available and the assay is rapid and sensitive.  This two-step strategy that had 
been proposed is a unique approach and has never been reported before.  More importantly, 
it offers an alternative that circumvents the need for the development of a high-throughput 
assay for glucuronylsynthase.   
 
Figure 1.10 The hydrolysis of pNP-glucuronide by β-GUS  
1.6. A brief review on protein engineering 
To achieve the aims, protein engineering technologies will be applied.  Many of these 
techniques have been described in the literature.  This section below gives a review of the 
technologies that are available and details how they will be adopted to design suitable 
engineering approaches.  
Enzymes evolution takes place over times scales of millions years.  It is a very slow 
process for which natural selection as the sole driving force.  It has been suggested that during 
the course of this enormous length of time that the resultant enzymes should be near perfect.  
However, because enzyme evolution is driven by selection, enzymes only evolve to the point 
where they satisfy requirements of the host organism, and no more.  This state of affairs 
usually means that enzymes may not ideally suit for industrial applications.  For example, 
enzymes may often be unsuitable because of stability issues.  In many cases, there may be no 
enzyme to catalyse the target reaction and even if an enzyme is available, a great deal of work 
is often required to optimize its activity for practical applications.  Hence the need for protein 
engineering.  
 There are a number of ways to engineer or modify proteins; it can be achieved by 
chemical techniques, but the process is not specific and usually results in a considerable loss of 
protein (Means & Feeney 1990).  Direct synthesis can also be used to produce proteins, 
including proteins with modified residues, but the process is expensive and is not simple to 
execute.  Neither of the above approaches is a suitable method to produce proteins or 
modified proteins for industrial applications.  The idea that proteins could be modified in a 
β-GUS 
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specific way didn’t became a realistic proposition until the development of molecular biology – 
the ability to manipulate DNA.  Initially this tool led to studies that were aimed at 
understanding protein structure function.  Residues were mutated site specifically and 
changes in activity were monitored.  The process of engineering proteins for practical 
applications was accelerated by the discovery of the polymerase chain reaction (PCR).  This 
technology allowed large mutant libraries with a specified average error rate to be generated 
in the laboratory (Cadwell & Joyce 1994).  This technical development meant that natural 
evolution could be mimicked on a laboratory time-scale and with the intent of selecting for 
traits desired for practical applications; this became known as directed evolution.  It should be 
noted that the technology and knowledge in the field of genetic engineering has advanced 
significantly in the last few years.  In addition to the evolutionary approach (Bornscheuer & 
Pohl 2001), one can use rational design (Steiner & Schwab 2012) to enhance protein 
properties.  One often views different techniques as competitors, but this is not the case with 
the different approaches to engineering proteins as predictions made by rational methods can 
be incorporated into libraries to be screened in directed evolution.  
1.6.1. Rational design 
Rational design uses prior knowledge of the candidate protein and molecular modelling to 
predict amino acid substitutions that may yield the desired properties.  It requires a thorough 
knowledge of protein structure and function to enable computational predictions of molecular 
dynamics and behaviour (Pikkemaat et al. 2002).  Specific amino acids substitutions will then 
be introduced by site-directed mutagenesis techniques.  This was the approach used to 
convert an improved β-GUS into a glucuronylsynthase, where glutamate is replaced by 
alanine/glycine/serine specifically at position 504.   
 Although rational approaches to protein engineering have yielded some impressive 
results, it does have its limitations as only a small number of modifications can usually be 
made and there are many aspects of protein function that cannot be predicted (Ness et al. 
2000). 
1.6.2. Directed evolution 
As noted above, directed evolution or in vitro evolution is a strategy that mimics natural 
evolution on a laboratory timescale.  As with natural evolution, the process usually involves 
iteration of two steps – the generation of a genetically diverse, yet homologous population, 
and then application of an assay to screen or select for improved clones (Figure 1.11).  
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Figure 1.11 General strategies for the directed evolution of enzymes 
 Population diversity can be generated in vitro either by random mutagenesis or gene 
recombination.  However, by far the most popular in vitro mutagenesis strategy is error-prone 
PCR (ePCR), that relies on the misincorporation of nucleotides by DNA polymerase to generate 
point mutations in a gene sequence (Cadwell & Joyce 1992) (Figure 1.12a).  The accuracy of 
DNA polymerase (Taq polymerase) can be adjusted in vitro by addition of manganese ion 
(Mn2+) into the PCR reaction mixture (Zhao et al. 1999) and the mutations can be restricted to 
a specific gene or even a section of the gene – both important points for the construction of 
mutant libraries.  Gene recombination involves the fragmentation and subsequent 
recombination of multiple DNA sequences with the aim of combining beneficial mutations 
(Stemmer 1994b).  Recombination also makes it possible to remove neutral or deleterious 
mutations, which accumulate during random mutagenesis, by backcrossing progeny with 
excess parental or wild-type DNA (Stemmer 1994b).  The first gene recombination method 
that mimic genetic recombination, DNA shuffling, was introduced by Stemmer (1994a).  
Shuffling is performed on a set of naturally occurring homologous sequences using 
Deoxyribonuclease I to fragment the genes, which are then reassembled in a self-priming PCR 
reaction according to their sequence homology (Figure 1.12b).  However, this method requires 
relatively high homology between the parental genes yet crossovers tend to aggregate in 
regions of high sequence identity due to the annealing-based reassembly.  Fortunately, a 
group of homologous gene recombination methods that do not involve DNA fragmentation 
but require addition of primers were developed, and staggered extension process (StEP) was 
among them (Zhao & Zha 2006).  This technique consists of many cycles of denaturation and 
extremely short extension.  This effectively generates polynucleotide fragments that 
repeatedly switch template at every denaturation step and grow very slowly at each extension 
stage until the full-length is reached (Figure 1.12c).  To further increase the efficiency of 
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introducing homologous diversity, an elegant one-step approach that integrates ePCR and 
StEP, was developed in our group.  StEP-ePCR consists of a modification of the normal ePCR 
protocol to allow for the recombination of generated mutants during the process of mutation 
introduction as shown in the figure below (Figure 1.12c).   
(a)                                     (b)                                             (c) 
 
Figure 1.12 Common methods of library generation for directed evolution 
(a) ePCR (b) DNA shuffling by fragmentation and reassembly (c) DNA shuffling by StEP. 
The second step in directed evolution is the identification of the improved variants by 
either screening or selection.  Selection and screening are very enzyme dependent and are 
frequently the limiting steps in directed evolution.  Selection techniques are agar plate based 
and rely on a direct correlation between cell survival and the desired enzyme function.  Cells 
are transformed with an enzyme library and plated on selective media where only cells 
containing a viable variant will survive.  Selections are typically limited to antibiotic resistant 
enzymes (i.e. β-lactamases) or enzymes involved in the synthesis of nutrients essential for cell 
growth (Watson et al. 2007).  Selection methods are generally less laborious and allow larger 
libraries of the order of 105 to be evaluated.  However, it is not always possible to employ 
selection as the evaluation method, as not all enzymes can be linked to cell survival.  Also, 
selection methods may not give a good quantitative response, in which case a secondary 
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screen will be required.  A screen is more versatile than selection, involving a direct 
measurement of enzymatic activity by a high-throughput assay and can be carried out using 
bacteria growing in the wells of microtiter plates or on agar plates.  In both cases, the enzyme 
assays are carried out inside the cell and can be followed by visual inspection if the reaction 
involves the formation (or degradation) of a coloured or fluorescent substrate.  In the agar 
plate screening method, the desired biochemical activity is often tied to a phenotype.  Thus, it 
can be applied to large mutant libraries of the order of 104 – 105.  Similarly to selection 
methods, agar plate screening methods are not suitable for quantifying catalytic activities of 
individual variants in the library, making them ideal as pre-screening methods.  In contrast, 
microtiter plate screening enables quantitative activity measurements of each screened 
variant thus providing a more complete dataset for hit evaluation.  A large diversity of 
enzymatic assays can be ported to the microtiter plate format.  Correspondingly microtiter 
plate screening is significantly more labour intensive and is therefore generally limited in scope 
to the order of 104 individuals for screening (Arnold & Georgiou 2003).  Both agar and 
microtiter plate screenings were used during the course of the research described herein and 
will be described in greater detail in Chapter 2. 
For over two decades, directed evolution has proven to be an effective strategy for 
tailoring enzyme properties to the needs of industrial, research and therapeutic applications 
(Farinas et al. 2001, Reetz 2006, Toscano et al. 2007).  It allows the analysis of very large 
numbers of mutants, each containing many different sets of concerted changes all of which 
contribute to a marked enhancement in the property – often several orders of magnitude.  In 
addition, valuable insights can be obtained into the structure-function relationships of recently 
isolated and less studied enzymes (Tee & Schwaneberg 2007, Wong et al. 2006).  The main 
advantage of directed evolution, compared with rational approaches to engineering, is that it 
does not require prior knowledge of enzyme structure and mechanism.  However, several 
rounds of evolution have to be applied and a large number of variants have to be screened in 
directed evolution.  This is especially true while evolving large enzymes, i.e. β-GUS.  For a 
protein of 600 amino acids (i.e. β-GUS) with random changes in just 1, 2 or 3 amino acids in the 
whole protein, the numbers of variants screened (the library size) required to achieved 95% 
expected coverage are 1.08 x 104, 1.94 x 107 and 2.32 x 1010, respectively (the working for 
these calculations are given in Appendix A.2.).   
1.6.3. Semi-rational approaches 
To avoid some of the tedium of directed evolution, semi-rational approaches are often 
considered as they combine the advantages of rational and evolutionary methods (Chica et al. 
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2005).  An example for a semi-rational approach is site-saturation mutagenesis, that uses the 
information derived from structural data to identify amino acids in interesting regions (i.e. 
active site), which are then mutated randomly, in either an individual or combinatorial fashion.  
This method utilizes degenerate oligonucleotides as primers to create a library with all 20 
possible amino acids introduced at the residue positions of interest.  The mutagenic primers 
used for site saturation mutagenesis experiments in this thesis utilized the NNK codon (where 
N = A, C, G or T and K = G or T) representing 32 possible codons code for all 20 amino acids. 
1.7. Overview of the thesis 
The aim of the thesis is to alter the substrate specificity of β-GUS so that it can act on glucoside 
substrates.  Mutants with altered specificity will be further mutated to produce potential 
synthetic enzymes that can be tested for activity.  The remaining chapters have information as 
follows:  
Chapter 2.  Description of routine experimental procedures used in this work.  These 
procedures crop up in a number of chapters and are referred to in these chapters.  The 
procedures are routine and range from molecular biology to protein purification and 
enzymology.  These are routine procedures that reader may want to initially skip and come 
back to later when referenced in subsequent chapters.  
Chapter 3.  The substrate profile of β-GUS on various glycosides was investigated and site-
saturation experiments aimed at altering the substrate specificity were conducted. 
Chapter 4.  Directed evolution was applied to β-GUS and laboratory-evolved thermostable β-
GUS (GUS-TR3337) to produce enzyme with altered substrate specificity and test the idea that 
stability further enhances evolution of new function.   
Chapter 5.  Although directed evolution has been successfully used to improve the glycosidase 
activity of β-GUS and GUS-TR3337, the glucosidase activities obtained for purified mutants 
were significantly lower than activities measured in crude extracts.  This chapter sought to 
understand the possible reason for loss of activity in purified mutants.   
Chapter 6.  Mutations E504A/G/S were introduced into β-GUS, GUS-TR3337 and 3 improved 
variants obtained in Chapter 4, to produce the glucuronylsynthase variants.  These variants 
were tested for glycosynthase activity.   
Chapter 7.  Brief summary and concluding remarks 
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Chapter 2 
Experimental Methods 
This chapter is intended to provide details on the routine experimental procedures used 
throughout the course of this research.  Information on specific protocols developed during 
this study is given in the relevant chapters.   
There are a few general points covering basic chemicals: All chemicals were purchased 
from Sigma-Aldrich unless otherwise specified and water was purified using a Milli-Q 
purification system (Millipore).  The composition of solutions, buffers and growth media are 
given in Appendix B. 
2.1. Cell strains and expression vectors 
Throughout the course of this work, enzymes were synthesised using the cellular machinery of 
bacteria.  The requirements for cell based protein expression are a vector incorporating the 
DNA sequence for the protein of interest and a host cell (Escherichia coli).  The bacterial strains 
and plasmids are listed below. 
2.1.1. E. coli strain BW25141 
BW25141 is a strain of E. coli that does not contain the β-galactosidase and β-glucuronidase 
genes and was used to generate site-saturation libraries (Wanner 1983).  It is usually 
designated BW25141 (lacIq rrnBT14 ΔlacZWJ16 ΔphoBR580 hsdR514 ΔaraBADAH33 ΔrhaBADLD78 
galU95 endABT333 uidA(ΔMluI)∷pir
+ recA1). 
2.1.2. E. coli strain GMS407 
The E. coli strain of choice for directed evolution was the GMS407 (lacY1 tsx-29 glnX44 galK2 λ- 
manA4 uidA1 mtl-1 argE3).  This β-glucuronidase-deficient E. coli lysogenic cell line was used 
to ensure protein expression that was free of wild-type activity (Novel & Novel 1973). 
2.1.3. E. coli strain DH5α 
The E. coli strain DH5α was used for storage of plasmids.  It is a commonly used laboratory K12 
strain.  It has a high transformation efficiency, simple preparation and is easily stored.  
Detailed genotype of DH5α strain – supE44 ∆lac169 Ø80 lacZ∆M15 hsdR17 recA1 endA1 
gyrA96 thi-1 relA1.  It lacks recA, a protein responsible for recombination between 
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homologous DNA sequences, so there was minimum chance of recombination between 
homologous sequences of plasmid gene and bacteria genome.  The endA1 implies the deletion 
of the normally present non-specific endonucleases that could possibly digests the foreign 
DNA, thus avoids difficulties when preparing plasmid.  The designation hsdR17 indicates that a 
native restriction enzyme that is normally present in E. coli has been eliminated, preventing 
degradation of target plasmid transformed into the cell.   
2.1.4. Expression vector pJWL1030 
Vector pJWL1030 (par+, bla+, lacZpro, T7Ø10tir+) was derived from a high-copy number vector 
pCY76 (par+ bla+ lacZpro T7Ø10tir+) and pJJKmf (Liu et al. 2006).  The constitutive expression 
cassette was isolated from pCY76 and ligated to the backbone of pJJKmf (Kirschman & Cramer 
1988).  A leaky lac promoter allows constitutive expression of target gene cloned into 
pJWL1030.  pJWL1030 confers kanamycin resistance to the host. 
2.1.5. Expression vector pET-28a(+) 
The gus-wt and gus-tr3337 genes encoding β-glucuronidase (β-GUS) and thermostable β-GUS, 
respectively, were cloned into a Novagen® pET-28a(+) vector at the NdeI/XhoI cloning sites 
(Wilkinson et al. 2008).  The pET-28a(+) vector also carries the kanamycin resistance gene, 
T7lac promoter, and an N-terminal His6-tag extension. 
2.1.6. Expression vector pJexpress 401 
The pJexpress 401 expression vector with N-terminal His6-tag was obtained from DNA 2.0 
(Menlo Park, CA, USA).  The pJExpress 401 is an inducible protein expression system under the 
control of the Isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible T5 promoter.  It also 
contains a kanamycin resistance marker.  The gus-wt and gus-tr3337 genes were cloned into 
the multi-cloning site of pJExpress 401 using XbaI and EcoRI unique restriction sites. 
2.2. Computer software programs 
Protein sequences were analysed with the program CONSURF (http://consurf.tau.ac.il/), that 
gave the conserved and non-conserved region of a protein (Ashkenazy et al. 2010).  Structural 
diagrams presented in this thesis were generated using the PYMOL program (Delano 2002).  
Molecular docking of para-nitrophenyl-β-D-glucuronide (pNP-glucuronide) and glucuronic acid 
was performed using the pair-fit command in Pymol 1.3.  The Kolmogorov-Smirnov test, 
(http://www.physics.csbsju.edu/) was used to analyse the potential difference in two libraries.  
The null hypothesis was H0: both samples come from a population with the same distribution. 
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The H0 was rejected at the 0.05 significance level.  Protein extinction coefficient was estimated 
by PROTPARAM tool (http://web.expasy.org/protparam/).  It allowed the computation of 
various physical and chemical properties of a protein given its sequence (Gasteiger et al. 
2005).  Analysis of scanned photos was possible with IMAGEJ, a program available from the 
National Institutes of Health (USA) website (http://rsb.info.nih.gov/ij/).  SWISS-MODEL 
(http://www.swissmodel.expasy.org/) (Schwede et al. 2003) was used to generate model 
structures of GUS-WT and GUS-TR3337 mutants by using GUS-WT as template.  The solvent 
accessible surface area (SASA) for each residue in β-GUS was calculated with ASA 
(http://cib.cf.ocha.ac.jp/bitool/ASA/), using a 1.4 Å radius probe for water.  The SASA 
calculations were based on the method of Shrake & Rupley (1973). 
2.3. Molecular biology 
2.3.1. Directed evolution 
There were two primary steps in directed evolution – library generation followed by screening 
and/ or selection.  The polymerase chain reaction (PCR) was used in the first stage to introduce 
genetic diversity.  The methods used have been published and will not be described in detail 
here.  The introduction of random errors in a gene (error-prone PCR) was described by Cadwell 
& Joyce (1992) while the staggered extension process (StEP) was described by members of the 
Arnold laboratory (Zhao et al. 1998).  The combination ePCR and StEP, that is staggered 
extension process-error prone polymerase chain reaction was described by Stevenson (2006) 
who also detailed protocols for targeted [site-saturation mutagenesis or site-directed 
mutagenesis (SDM)].  The second stage is screening and/ or selection for the desired traits.  
Much of this methodology is standard molecular biology and is described briefly below.  
Detailed information is provided in the relevant chapters that follow.  
2.3.1.1. Introducing genetic diversity 
The gus-wt gene (GUS-WT) was manipulated using the construct created by cloning it into the 
pET28a(+) vector using the restriction sites NdeI and XbaI.  Five methods were used to create 
variants of gus-wt and gus-tr3337 (designated gus-wt* and gus-tr3337*, respectively) and are 
outlined below. 
2.3.1.1.1. Site-saturation mutagenesis (SSM) 
β-GUS residues E413, N412, D163, R562, Y472, N566, T509, Y469, S557 and M447 were 
subjected to randomisation with SSM (Zheng et al. 2004).  Degenerate primers containing the 
complete combination of 32 codons at the mutation points are designed to generate the SSM 
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libraries.  Sets of offset NNK mutagenic primers (Table 2.1) were used to PCR amplify the 
entire gene and plasmid sequence.  The product was digested with DpnI then purified and 
transformed into DH5α E. coli. 
Table 2.1 Mutagenic NNK primers for SSM mutagenesis 
Primer Sequence (5’ – 3’) 
GUS E413 NNK F  tat tgc caa cnn kcc gga tac ccg tc 
GUS N412 NNK F gag tat tgc cnn k ga acc gga tac cc 
GUS D163 NNK F agt taa aga ann kat gga agt aag ac 
GUS R562 NNK F aag gca tat tgn nkg ttg gcg gta ac 
GUS Y472 NNK F tta cgg atg gnn kgt cca aag cgg cg 
GUS N566 NNK F ctc gca agg cnn ktt gcg cgt tg 
GUS T509 NNK F gcg tgg atn nkt tag ccg ggc tgc a 
GUS Y469 NNK F gaa ccg tta tnn kgg atg gta tgt cca aag c 
GUS S557 NNK F ttt tgc gac cnn kca agg cat att gcg c 
GUS M447 NNK F gcg tca atg tan nkt tct gcg acg ct 
pJWL1030GUSHindIII R aag ctt ttg cca ttc tca ccg gat tc 
SSM-PCR reactions were set up with 10 ng template pJWL1030-gus, 0.2 mM dNTP, 
2.5U Pfu DNA polymerase, 1 μM forward and reverse primers, and 5 μL 10x Pfu reaction buffer 
and made up to 50 μL with deionised water.  The SSM-PCR reaction mixtures were subjected 
to single 2-stage whole-plasmid PCR: 1 cycle at 95 ˚C for 3 min, followed by 5 cycles of 95 ˚C for 
30 s, 55 ˚C for 1 min, 72 ˚C for 1 min/kb of mega-primer length, and 20 cycles of 95 ˚C for 30 s, 
68 ˚C for 1 min/kb of template length, lastly, 1 cycle at 68 ˚C for 10 min. 
2.3.1.1.2. Site-directed mutagenesis (SDM) 
gus-tr3337, wt3p24e11-E504A, wt3p24e11-E504G, wt3p24e11-E504S, wt5p26a7-E504A, 
wt5p26a7-E504G, wt5p26a7-E504S, thermo4p11f2-E504A, thermo4p11f2-E504G and 
thermo4p11f2-E504G were constructed using SDM that was performed by the overlap 
extension PCR method with gus-wt as the DNA template and the primers listed in Table 2.2 
(Xiong et al. 2004).  The mutation site was introduced into the first PCR fragments, and the 
second fragment was amplified by annealing the overlapping ends of the first fragments.  Final 
products were ligated into the pET28a(+) vector and sequenced.  The strategy for the SDM was 
shown in Figure 2.1. 
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Table 2.2 Primers used for point mutations in site-directed mutagenesis 
Primer Sequence (5’ – 3’) 
GUS Q493R F  tgg cct ggc ggg aga aac tgc atc ag 
GUS Q493R R atg cag ttt ctc ccg cca ggc cag aag ttc 
GUS T509A F ccc ggc taa cgc atc cac gcc gta tt 
GUS T509A R ggc gtg gat gcg tta gcc ggg ctg 
GUS M532T F tgg ctg gat acg tat cac cgc gtc ttt g 
GUS M532T R gac gcg gtg ata cgt atc cag cca tgc ac 
GUS N550S F cag gta tgg agt ttc gcc gat ttt gc 
GUS N550S R aaa atc ggc gaa act cca tac ctg ttc ac 
GUS G559S F gac ctc gca aag cat att gcg cgt tgg 
GUS G559S R aac gcg caa tat gct ttg cga ggt cgc aa 
GUS N566S F gtt ggc ggt agc aag aaa ggg atc ttc 
GUS N566S R gat ccc ttt ctt gct acc gcc aac gcg 
pET28aGUS F aag aag gag ata tac cat ggg cag c 
pET28aGUS R tgg tgg tgc tcg agt cat tgt ttg cc 
 
Figure 2.1 SDM from gus-wt and gus-tr3337 primers employed in this study 
Red: forward; blue: reverse. 
2.3.1.1.3. Error-prone polymerase chain reaction (ePCR) 
ePCR was based on the protocol developed by Leung et al. (1989), with reactions consisting of: 
16 ng of the parent gene, 10 μM of forward and reverse primers, 0.2 mM of dNTPs, 5 mM 
MgCl2, different concentrations of Mn
2+ ranging from 0.05 - 0,5 mM, 5 μL of 10x polymerase 
buffer without Mg2+, 2.5 U Taq DNA polymerase and made up to 50 μL with deionised water.   
Thermocycling was performed with 30 cycles of 94 ˚C for 10 s, 50 ˚C for 10 s and 2 min 
at 72 ˚C.  The ePCR products were purified with PCR purification kit and digested in one 
reaction with NdeI, XbaI and DpnI.  The latter was required to selectively digest the parent 
genes since they were synthesised in vivo and have methylated DpnI restriction sites 
(Sambrook & Russell 2001).  Finally, DNA with the correct size was isolated by gel purification 
with Promega® PCR purification kit and ligated into pET28a(+) with T4 ligase.  The constructs 
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used in verifying the error-rate by DNA sequencing were purified from randomly selected 
GMS407 transformants. 
2.3.1.1.4. Staggered extension process (StEP) 
The StEP reaction consisted of 16 ng of template, 10 μM of each forward and reverse primer, 
0.2 mM dNTP, 5 mM MgCl2 and 1 U of Phusion high fidelity polymerase.  The cycling conditions 
were 100 cycles of 94 °C for 10 s, 50 °C for 10 s and 72 ° for 2 s. 
2.3.1.1.5. StEP-ePCR 
Recombination of gene variants was simplified by the use of the StEP-ePCR.  StEP-ePCR was set 
up in 50 μL with: 16 ng of parent genes in equal proportions, 10 μM of forward and reverse 
primers, 0.2 mM of dNTPs, 5 mM MgCl2, 1.5 mM MnCl2, 5 μL of 10x polymerase buffer without 
Mg2+ and 2.5 U of Taq polymerase.  SteP-ePCR thermocylcing required 30 cycles of: 94 ˚C for 
10 s, 50 ˚C for 10 s and 72 ˚C for 10 s. 
2.3.1.2. Preparing libraries of variants for screening 
A population of gus-wt, prepared by SSM, was ligated into pJWL1030 via NdeI and XbaI 
restriction sites.  The variants of gus-wt were created and resulting in pJWL1030-guswt* 
constructs.  In contrast, the random mutagenesis libraries of gus-wt and gus-tr3337 were 
digested at XbaI and XhoI restriction sites and ligated into the pET28a(+) expression vector, 
resulting in pET28a-guswt* and pET28a-gustr3337*, respectively.  The ligation reaction 
products were isolated with a Promega® PCR purification kit and eluted in 30 μL of water.  5 
μL of the purified ligation products was transformed into 50 μL of E. coli strain GMS407 and 
recovered with 1 mL yeast extract nutrient broth (YENB) (Appendix B) at 37 ˚C.  50 μL of the 
culture was plated out on Luria-Bertani-Kanamycin (LBK) agar (Appendix B) and incubated 
overnight at 37 ˚C to estimate the cell density.  After determining the cell density, the 
transformants were diluted such that 50 μL of culture that contained about 300 viable cells.  
Library culture aliquots of 50 μL were applied to each LB-Kanamycin agar and spread out with 
sterile ball bearings (5 mm diameter, steel) to provide an even distribution of colonies.  10 
colonies were sequenced to examine the randomness of the point mutations; that is the 
average number of mutations.   
2.3.1.2.1. In vitro screening of site-directed libraries with β-glycoside substrates 
In each SSM library, 96 single colonies were picked manually from the LBK agar plates and 
grown individually in 96-well round bottom culture plates with 200 μL of LBK per well.  The 
plates were incubated at 37 ˚C overnight.  120 μL of culture from each well was transferred to 
a new sterile 96-well microplates and 20 μL of 7x BugBuster was added to each well to lyse the 
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cells.  The proteins were assayed with 200 μM para-nitrophenyl-β-D-glucuronide (pNP-
glucuronide), 3 mM pNP-glucopyranoside, 3 mM pNP-galactopyranoside, 3 mM pNP-
mannopyranoside and 3 mM pNP-xylopyranoside in 50 mM phosphate buffer, pH 7.4.  The 
release of pNP was monitored at 405 nm (A405) on a Labsystems Multiskan Ascent 96-well 
microplate ultraviolet/visible spectrometer.  The activities were compared to those of wild-
type.  Clones with enhanced, moderate and decreased activities toward five substrates were 
selected.  Plasmids were isolated with miniprep kit and sequenced. 
2.3.1.2.2. Colony screening 
E. coli expressing β-GUS can moderately cleave externally supplied 5-bromo-4-chloro-3-indolyl-
β-D-glucoside (X-glucoside) to produce glucose and an intense blue precipitate of chloro-
bromoindigo.  Another artificial chromogenic substrate, pNP-glucoside, can also be moderately 
hydrolysed by β-GUS resulting in glucose and the yellow stained pNP.   
This formed the primary screening and secondary phases.  The primary screening can 
be done on solid medium that contains X-glucoside whereas the liquid medium base for 
secondary screening contained pNP-glucoside.  The primary screening narrows hundreds of 
thousands of β-GUS versions down to less than three thousand.   
2.3.1.2.2.1. Primary screening of colonies 
The first two generation examined colonies via agar plate screening while generations 3, 4 and 
5 examined colonies via top agar screening.  An overview of this scheme is presented in the 
Figure 2.2. 
 
Figure 2.2 Screening strategies 
The two screening strategies used in directed evolution of GUS-WT and GUS-TR3337 are 
presented in a schematic form with agar plates, top agars plates and 96-well plates are 
illustrated at the top, bottom and right, respectively.   Agar plate screening is described in 
Section 2.3.1.2.2.1.1., top agar screening is described in Section 2.3.1.2.2.1.2. and culture 
screening is described in Section 2.3.1.2.2.2. 
Primary screening Secondary screening 
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2.3.1.2.2.1.1. Agar plate screening 
50 μL of library culture aliquots were applied to each agar plate.  The agar plates were 
prepared with 10 mL of LBK agar supplemented with 0.15 mM IPTG and 0.1 mM X-glucoside.  
After overnight incubation at 37 ˚C, thirty most blue colonies on each plate were picked and 
inoculated in individual 200 μL aliquots of sterile LBK into a 96-well culture plate. 
  Each screening batch, typically a 100 agar plates, resulted in about 3000 inoculants 
with additional inoculants as controls.  The negative control was E. coli GMS407 transformed 
with empty pET28a(+) and the positive control was the same strain expressing GUS-WT, GUS-
TR3337 or the best variant from each generation.   
2.3.1.2.2.1.2. Top agar screening 
15 mL of molten glucosidase activity indicator agar (Appendix A) was carefully poured onto 
each agar plate, covering all the colonies.  Colonies expressing active β-GUS would start to turn 
darker blue after 10 min with the top agar.  The two most blue and distinct colonies on each 
plate were identified within 30 min.  Each of the identified colonies was used to inoculate 
individual 200 μL aliquots of sterile LBK (Appendix B).   
2.3.1.2.2.2. Secondary screening of β-GUS activity 
After the 96-well culture plates were incubated overnight, 120 μL of each culture was 
transferred to a 96-well plate.  The cells of each sample were lysed by adding 20 μL of 7x 
BugBuster and incubating for 30 min at room temperature.  Addition of 100 μL of assay buffer 
produced a 220 μL reaction with: 50 mM phosphate buffer at pH 7.4, 800 μM of pNP-
glucoside.  The reactions were performed at room temperature (25 ˚C) and the hydrolysis of 
pNP-glucoside was measured by monitoring the rate of the release of pNP at A405 over 20 min. 
2.3.2. Protein expression 
pET28a-guswt*, pET28a-gustr3337*, pJexpress401-guswt* and pJexpress401-gustr3337* 
plasmid DNA (pDNA) samples were purified with the Qiagen Miniprep® kit as follows.  1 μL of 
the pDNA was used to transform BW25141 or GMS407 cells, that were recovered with 1 mL 
YENB medium after electroporation.  50 μL of the recovery culture was streaked onto an LBK 
agar plate that was then incubated at 37 ˚C overnight.  The following day, a single colony was 
inoculated into 20 mL 2x YT-Kanamycin broth and incubated at 37 ˚C overnight.  The culture 
was then transferred to 1 L of same medium and grown at 37 ˚C overnight.  Cells were induced 
with a final concentration of 0.5 mM IPTG when.  The culture was further incubated 
aerobically by orbital shaking for 3 hours until an OD600 of 0.8 was reached.  Cells were 
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harvested by centrifugation at 3700 g in a Sorvall SLA 3000 for 20 minutes.  The supernatant 
was removed and the cells were used immediately for lysis or stored at -80 ˚C for later use. 
2.3.3. Protein purification 
Prior to purification, the theoretical values of molecular weight (monomer), isoelectric point 
and extinction coefficient of every β-GUS protein were calculated with PROTPARAM. 
All purification steps were carried out at 4 ˚C to minimise loss due to denaturation.  
Two protocols were used to purify GUS* in this study.  All buffers and milliQ water (mQH2O) 
used in purification were filtered with vacuum driven 0.45 μm nitrocellulose membrane filters.  
AKTATM FPLC system was used to automatically control the elution in chromatography steps. 
2.3.3.1. Immobilised metal affinity chromatography (IMAC) 
The harvested cells were resuspended in 25 mL of buffer A (Appendix B).  The cells were lysed 
with a French Press and the lysate was centrifuged at 3700 g for 40 min at 4 ˚C to separate the 
cell debris.  The supernatant was loaded onto 5 mL HisTrap FF (GE Healthcare) column that 
eluted with 0-0.5 M imidazole gradient at a flow rate of 3 mL/min.  Fractions that displayed the 
highest activity were analysed by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE).  Fractions with the highest amounts of β-GUS protein were concentrated to 0.5-1 
mL for the next purification step. 
2.3.3.2. Size-exclusion chromatography (SEC) 
SEC or gel-filtration chromatography was used to separate proteins according to their 
molecular weight.  The concentrated protein solution was then loaded onto a Superdex 200 
gel filtration column.  The sizing column had a column volume of 120 mL and had been 
calibrated with protein standards.  The protein was eluted at 0.3 mL/min to ensure good 
resolution.  Fractions with the highest activity were confirmed via SDS-PAGE and pooled.  
Examples of the elution profiles and SDS-PAGE of column fractions are given below for the 
IMAC and SEC (Figure 2.3).  Fractions judged to be at least 95% pure were dialysed against 
buffer 50 mM phosphate, pH 7.4 overnight.  Purified β-GUS proteins were stored at 4 °C.  A 
description of the procedure used to calibrate the SEC columns and the determination of 
protein molecular weights with SEC are given below.  
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(a) 
 
(b) 
kDa           M      1        2        3        4        5       6        7        8       11     13      15       17   
             
β-GUS 
97.4 - 
66.2 -  
45    -  
31    - 
21.5 - 
14.4 - 
Fraction  
Number (red) 
β-GUS 
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(c) 
 
(d) 
  kDa      M   11  12   13  14   15   16  17   18   19  20  21  22   
             
Figure 2.3 Purification of GUS-WT  
(a) Elution profile using IMAC (b) SDS-PAGE gel of selected fractions from IMAC.  Fraction 
numbers are indicated above each lane (c) Elution profile using SEC. Peak 1, tetramer (279 
kDa); peak 2, dimer (139 kDa) and peak 3, monomer (69 kDa). (d) SDS-PAGE gel of selected 
fractions from SEC.  Fraction numbers are indicated above each lane. 
The size exclusion column used in this study was pre-calibrated with protein standards 
whose molecular weights ranged between 43 – 669 kilo-Daltons (kDa) (Figure 2.4).  A linear 
graph of logarithm of protein sizes in Da versus their elution volumes was plotted and its 
97.4 - 
66.2 -  
45    -  
31    - 
21.5 - 
β-GUS 
14.4 - 
Fraction number (red) 
β-GUS 
1 
2 
3 
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function is derived from linear regression (Figure 2.5).  β-GUS protein sizes were subsequently 
calculated based on the equation.   
(a)                                                                      (b) 
 
Figure 2.4 Elution profiles of molecular weight markers from Superdex 200 size exclusion 
column 
(a) Peak 1: Ferritin, 440 kDa; 2:  Conalbumin, 75 kDa; 3: Ovalbumin, 43 kDa (b)Peak 4: 
Thyroglobulin, 669 kDa; 5: Aldolase, 150 kDa. 
 
Figure 2.5 Calibration curve obtained with molecular weight markers eluted from Superdex 
200 size exclusion column 
The linear equation derived from the curve fit is given. 
2.3.4. Analysis of GUS-WT and GUS-TR3337 variants 
The GUS-WT and GUS-TR3337 variants were characterised in several ways.  The pure GUS-WT 
and GUS-TR3337 variants were subject to kinetic investigations with respect to glucuronide, 
glucoside concentrations and temperature.  Finally, an attempt was made to rationalize these 
results in terms of the β-GUS structure. 
 Each of the variants selected as progeny throughout the directed evolution of GUS-WT 
and GUS-TR3337 were named according to the generation number (1-5) and an identification 
number.  The first digit refers to the batch number (1-5), the second digit refers to the 96-well 
plate number and is followed by the well position.  For example, the variant WT1P17G2, from 
the gus-wt library, is derived from generation 1 and isolated from 96-well plate number 17 at 
well position G2. 
1 
2 
3 
4 
5 
2 Experimental Methods 
 
34 
 
2.3.4.1. Kinetic analysis 
Purified and dialyzed GUS-WT or GUS-TR3337 variants proteins were assayed for glucuronide 
and glucosidase activity with pNP-glucuronide and pNP-glucoside, respectively, as the 
substrate.  The rate of hydrolysis was monitored through the release of pNP at 405 nm 
(extinction coefficient 14730.38 M-1cm-1 and path length 0.52 cm) with Cary IE UV-Vis 
spectrophotometer (Figure 2.6).  The standard curve of pNP were constructed to determine 
the extinction coefficients of pNP by using the Beer-Lambert equation that is given in Equation 
2.1 (Grimsley & Pace 2001): 
A = ɛlc                                                                                                                                     (Equation 2.1) 
where A is the absorbance, ɛ is the molar absorption coefficient (M-1cm-1), l is the cell path 
length (cm) and c is the molar concentration (M). 
 
Figure 2.6 The standard curve used to calculate the extinction coefficient value 
The standard reaction mixture contained (in a total volume of 200 µL): 50 mM 
phosphate buffer pH 7.4, various concentration pNP-glucuronide or pNP-glucoside and 20 µL 
of diluted enzyme sample.  The two assay conditions were the standard reaction mixture and 
the standard reaction mixture with 5 mM octyl-β-D-thioglucopyranoside (OTG).  The 
production rate of pNP was monitored spectrophotometrically at A405 by various 
concentrations of pNP-glucuronide and pNP-glucoside.  pNP-glucuronide concentrations 
ranged from 2.5 µM to 20 mM while pNP-glucoside concentrations ranged from 2.5 µM to 90 
mM.   
2.3.4.1.1. Non-cooperative β-GUS enzymes 
For β-GUS enzymes that showed no cooperativity, the kinetic parameters were determined by 
fitting the data to the Michaelis-Menten Equation 2.2 using the curve-fitting software 
Kaleidagraph Version 3.5 (Synergy Software, USA). 
14.4 - 
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v = Vmax [S] / (Km + [S])          (Equation 2.2) 
where v is the initial velocity, Vmax is the maximum velocity, Km is the Michaelis constant, and 
[S] is the substrate concentration.  Kcat was calculated by dividing Vmax by the enzyme 
concentration (Vmax = kcat[E]). 
2.3.4.1.2. Negatively cooperative β-GUS enzymes 
For β-GUS enzymes that showed negative cooperativity, the Eadie-Hofstee is a linear form of 
the Michaelis-Menten equation that can be rearranged as follows: 
v = - Km (v / [S]) + Vmax           (Equation 2.3) 
In an Eadie-Hofstee plot, the velocity v is plotted against v divided by [S].  These plots were 
used to obtain the apparent values of Vmax and Km as described in Chapter 5.  Microsoft Excel 
was used for Eadie-Hofstee curve fitting. 
2.3.4.2. Thermal optima 
The catalytic rate of GUS-WT* and GUS-TR3337* was analysed in reactions at various 
temperatures, ranging from 25 to 85 °C.  The phosphate buffer, containing pNP-glucuronide or 
pNP-glucopyranoside, was pre-incubated for 20 min in the micro plate reader.  20 μL of 
enzyme was added to give a final reaction volume of 200 μL in a 96-well microplate. 
The activity was determined from the slope during 10 s to 60 s after the reaction was 
started; the first 10 s of reaction were required for thorough mixing.   
2.3.4.3. Thermal denaturation 
This trait was measured by incubating 25 μL of 20 μM GUS-WT* or GUS-TR3337* sample at 
one of several temperatures for 5 min.  Before and after incubation, the enzyme samples were 
stored on ice.  20 μL of 20 μM GUS-WT* or GUS-TR3337* sample was used in a final reaction 
volume of 200 μL.  The activity of these GUS-WT* and GUS-TR3337* samples was assayed 
using 800 μM of pNP-glucoside at 25 °C and pH 7.4.  All samples were assayed simultaneously 
using 96-well plate format to monitor the release of pNP in A405 over 1 min.  The results were 
analysed by non-linear regression (Kaleidagraph) with the following equation: 
a = a0 – a0 · T
h / (Th + T1/2
h)           (Equation 2.4) 
where the activity (a) after exposure to temperature (T) is described in terms of original 
activity (a0), the temperature at which half the GUS-WT or GUS-TR3337 mutants will be 
irreversibly inactivated after 5 min (T1/2) with a cooperativity term h.  Equation was based on 
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the assumptions that residual activity is proportional to the amount of GUS-WT or GUS-
TR3337 mutants that was not irreversibly denatured, and that irreversible denaturation is a 
cooperative process.  Cooperativity is involved because the overall integrity of a protein 
depends upon the stability of individual secondary structures, each of which depends upon the 
integrity of neighbouring structures. 
2.3.4.4. Thermal shift assay 
Overall protein unfolding was monitored using the change in fluorescence caused by binding 
of the fluorophore SYPRO Orange to hydrophobic residues exposed upon protein 
denaturation.  Fluorescence was measured at 605 – 610 nm with a 7900HT Fast Real-Time PCR 
system with the temperature increased linearly from 10 – 90 °C at the rate of 1  C min-1.  
Samples were run in triplicate, consisting of 5 μM enzyme and 5 x SYPRO orange dye with 5% 
v/v DMSO (dimethylsulfoxide) 100 mM NaCl in 50 mM phosphate buffer at pH 7.4.  Melting 
temperatures were determined by fitting the data to the Boltzmann equation (Niesen et al. 
2007) using SciDAVis version 0.2.4 where errors are the standard deviation. 
2.3.4.5. Comparison of protein solubility 
Cell growth was standardized by growing them aerobically to an optical density of 1 at 600 nm 
(OD600).  5 mL were sedimented at 3700 g for 5 min.  The pellet was resuspended in 120 μL of 
50 mM phosphate buffer (pH 7.4).  20 μL 7x Bugbuster lysis solution was added and incubated 
for 30 min at ambient temperature.  70 μL of the lysate was centrifuged.  The soluble fraction 
was aspirated and the insoluble protein was resuspended in 70 μL of 9 M urea.  Equal volumes 
of the lysate, soluble fraction and resuspended insoluble protein were analysed by SDS-PAGE.  
These SDS-PAGE gels are shown in Chapter 4 (Section 4.4.1.). 
2.3.4.6. Discontinuous native protein gel electrophoresis analysis 
The discontinuous native gel electrophoresis analysis was carried out as described by 
Niepmann & Zheng (2006).  Briefly, purified proteins were mixed with sample buffer (100 mM 
Tris-Cl pH 8, 40% glycerol, 0.05% Serva Blue G-250) and incubated for 10 min at room 
temperature.  Protein samples were loaded onto 8% native PAGE gels and separated at 4 °C in 
a cathode buffer containing 100 mM histidine (adjusted to pH 8 using Tris base) and 0.002% 
Serva Blue G-250. 
2.3.4.7. Bis(sulfosuccinimidyl)suberate (BS3) crosslinking 
To covalently cross-link GUS-WT and WT3P24E11, a water soluble BS3 was used.  Around 10 μg 
of purified protein was mixed with 0.15 mM of freshly prepared BS3, then incubated at room 
temperature for varying time points (0 min, 1 min, 5 min, 20 min).  The reactions were 
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quenched by adding 5 μL of 1 M Tris.  The protein samples were then boiled at 95 °C for 5 min, 
and separated in the 12% SDS-PAGE.  Proteins including the crosslinked proteins were 
detected by Coomassie Blue staining. 
2.3.4.8. Effects of additives 
The effects of additives were evaluated by measuring glucosidase activity in the presence of 10 
x BugBusterTM protein extraction reagent, octyl-β-D-glucoside, sodium dodecyl sulphate, octyl-
β-D-thioglucoside, Tween 20 and Triton-X-100.  The reaction mix with respective additives, but 
without enzyme, served as blank.  The reaction mix without any additives was taken as a 
control (100%). 
2.3.4.9. Determination of the modes of enzyme inhibition and the inhibitory 
constant (Ki) values 
The mode of enzyme inhibition was graphically determined from the Lineweaver-Burk double 
reciprocal plots of the reciprocal of velocity versus the reciprocal of substrate concentration.  
The inhibitory constant (Ki) value was calculated with the secondary plot representing the 
slope rate of the Lineweaver-Burk plot versus the OTG concentrations (Ramasamy et al. 2014).   
2.3.4.10. Enzyme unfolding 
The process of enzyme unfolding was monitored by assaying the initial rate of the residual 
enzyme activity and the fluorescence spectrum.  In the enzyme activity assays, GUS-WT and 
GUS-TR3337 mutants were incubated with various concentrations of urea and GdnHCl in 
phosphate buffer (50 mM, pH 7.4) at 25°C.  After 10 min, the substrate hydrolysis was 
measured by following the absorbance at 405 nm for 10 min at 6 s intervals.  The rate of 
hydrolysis in the absence of urea was taken as 100%.  In the intrinsic fluorescence 
spectroscopic experiments, the spectra were recorded in the range 300 – 380 nm after exciting 
the sample at 295 nm, at a protein concentration of 0.6 µM. 
2.3.5. Enzyme crystallisation screens 
High through-put screening for appropriate protein crystallisation conditions were performed 
using the Hampton Research  crystal screens including IndexTM, Crystal ScreenTM, PEGRxTM, 
PEG/IonTM and SaltRxTM.  Crystal screens were performed as microbatches in 96-well crystal 
plates.  WT5P26A7 was concentrated to 20 mg/mL in 20 mM HEPES, pH 7.4.  Hanging drop 
method was used for crystallisation and 1 µL of protein sample was mixed with 1 µL of each 
screen buffer.  Plates were stored at 4 °C and examined under microscope for the presence of 
crystallisation. 
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2.3.6. Steroid glycosynthase reactions 
0.4 mg/mL GUSWT-E504A, GUSWT-E504G, GUSWT-E504S, WT3P24E11-E504A, WT3P24E11-
E504G, WT3P24E11-E504S, WT5P26A7-E504A, WT5P26A7-E504G, WT5P26A7-E504S, 
GUSTR3337-E504A, GUSTR3337-E504G, GUSTR3337-E504S, THERMO4P11F2-E504A, 
THERMO4P11F2-E504G or THERMO4P11F2-E504G was added to a solution containing 2 mM 
DHEA O-(carboxymethyl)oxime (CMO-DHEA) or 5 mM testosterone, 10% v/v tert-butanol and 
4  mM α-D-glucosyl fluoride in 100 mM sodium phosphate buffer (pH 7.5).  The reaction was 
incubated at 37 °C for 2 days.  The reaction was then subjected to solid-phase extraction (SPE).  
The Oasis  WAX SPE cartridge (3 mL, Waters Co.) was pre-conditioned with 1 mL methanol, 
then 3 mL mQH2O.  The crude reaction was loaded into the cartridge and washed with 3 mL of 
2% formic acid, 3 mL mQH2O, 3 mL methanol, then ammonium hydroxide in methanol (5% v/v, 
9 mL).  The solvent from the appropriate fraction was evaporated to dryness by rotary 
evaporation.  The dried residue was resuspended in an appropriate deuterated solvent or 
mQH2O and subjected to 
1H nuclear magnetic resonance or electron-spray ionisation mass 
spectrum analysis, respectively.  This work did not constitute a large portion of the 
experimental work of this thesis and was done with the assistance of Mr. Andy Pranata of the 
McLeod lab.  The experimental details of this work have been published (Ma et al. 2014).   
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Chapter 3 
Identification of Residues Critical to 
Substrate Binding in β-GUS 
3.1. Introduction 
As noted in Chapter 1, the initial objective of this research was to alter the substrate 
specificity of β-GUS.  The possible target substrates were conjugates of monosaccharide sugars 
that were like β-glucuronic acid (Figure 3.1).  It was thought that a reasonable place to start 
was to examine the ability of native β-GUS to act on potential target substrates.  The objective 
was to identify those substrates that gave rise to low levels of activity with β-GUS as they 
would be suitable targets for future directed evolution studies.  β-GUS was known to be very 
specific for the glycone, but not the aglycone.  This meant that it was reasonable to choose an 
aglycone that was easy to detect in an enzyme assay – para-nitrophenol (pNP).  The term 
“reasonable”, was meant to imply that mutant forms of β-GUS that act on pNP derivatives 
were also likely to act on substrate with a variety of aglycones, as does the native enzyme.  The 
compounds to be tested were: pNP-glucuronide, a control and native substrate, and pNP-
glucoside, pNP-galactoside, pNP-mannoside, pNP-xyloside, the possible target substrates.  
(a)                (b)                        (c)                        (d)                        (e)                         (f) 
               
Figure 3.1 Chemical structures of the inhibitor and sugars 
(a) GDL (b) β-glucuronic acid (c) β-glucose (d) β-galactose (e)β-mannose (f) β-xylose. 
Of the possible alternative substrates, glucuronic acid was most similar glucose.  These 
two compounds were different in that carbon six of glucose is oxidized to a carboxylic acid in 
glucuronic acid (Figure 3.1b & c).  The structure had been determined of β-GUS with a bound 
inhibitor that mimics of the transition state of the native substrate during catalysis (Wallace et 
al. 2010).  This meant that residues that interacted with the C6 carboxylate could be identified 
and mutated. The question arose: could simply altering active site residues, known to interact 
with the C6 carboxylate, alter the substrate specificity of β-GUS from that of a glucuronide 
degrading enzyme to that of a glucoside degrading enzyme?  Testing this idea was relatively 
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straightforward.  As outline in Chapter 2, protocols for site-saturation mutagenesis were 
available and the substrate could be tested in a high-throughput assay.  Although it was felt 
that the probability of success was low, the resulting mutant genes could be used (along with 
that of the native enzyme) to generate libraries for directed evolution.  Active site changes 
often destabilize an enzyme, but this destabilization can be compensated for by second site 
changes, as would occur in the library generation step of directed evolution.  
Similar arguments to those presented in the previous paragraph, can be made 
regarding a few active site residues.  For example, does changing the residues that interact 
with the C4 hydroxide enhance the activity of variant β-GUS enzymes towards β-galactose 
derivative?  The choice of residues that were changed is described below.  For now, it is 
sufficient to note that the worst-case outcome for the proposed experiments was thought to 
be improved libraries for directed evolution and a better understanding of the importance of 
active site residues for catalysis; i.e. a better understanding of how β-GUS functions, 
specifically the importance of specific residues in binding substrate.  
3.2. Measurement of activities in crude cell lysates 
The β-GUS activities towards the native and related substrates are shown below in Figure 3.2 
with the assay conditions given in Table 3.1.  The assay conditions required to get a reasonable 
estimate of the activity towards non-physiological substrates were quite different to that used 
to measure the activity with the physiological substrate.  As expected, the activity towards 
non-physiological substrates was significantly weaker than that observed for the native 
substrate.  As shown in Figure 3.2, the native substrate, β-glucuronide, was rapidly hydrolysed 
by β-GUS with an observed activity of 73 mAU/min, but pNP-glucoside, pNP-galactoside, pNP-
mannoside, pNP-xyloside substrates were hydrolysed relatively poorly.  Notably, the pNP-
glucoside substrate was down from the native substrate by more than a factor of ten, but it 
was at least seven-fold better substrate than the other glycosides.  As evident from Figure 3.2, 
the concentrations used to detect activity with the non-physiological substrates were much 
higher than that used to detect activity with the physiological substrate.  The activity of β-GUS 
towards pNP-glucoside was detectable in high throughput assays, provided high substrate 
concentration was used, so that altering the substrate specificity towards glucoside derivatives 
was a realistic proposition.  Both enhanced (due to desirable changes) and diminished (due to 
detrimental changes) activities could be detected in high throughput screens.   
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Figure 3.2 Activities of native β-GUS hydrolysing pNP-glycoside substrates are presented in 
the colorimetric assay units (mAU/min) 
Error bars represent standard deviation from the mean of triplicate measurements.   
Table 3.1 Assay conditions with different substrate concentrations and assay time 
Substrate Assay time Substrate concentration (mM)  
pNP-glucuronide 10 min 0.2 
pNP-glucoside 
pNP-galactoside 
pNP-mannoside 
pNP-xyloside 
1 day 
1 day 
1 day 
1 day 
3 
3 
3 
3 
3.3. Choice of sites for site-saturation mutagenesis 
The choice of residues to be altered was initially made by examining the structure of E. 
coli β-GUS with a low-affinity inhibitor glucaro-δ-lactam (GDL) (PDB ID: 3K4D) (Wallace et al. 
2010).  The structure of this inhibitor is very similar to the glucuronic acid (Figure 3.1a & b), 
and serves as a suitable enzyme-glycosyl complex model to deduce important glycosyl binding 
sites.  pNP-glucuronide was docked into the active site by pair-fitting pNP-glucuronide with the 
inhibitor GDL.  The pair-fit root mean square deviation (RMSD) value was 0.182 (Figure 3.3).  
Since β-GUS is glycosyl-specific but not specific for the aglycone component, key binding 
residues were taken to be those that interacted with the glycosyl rings.  It was thought that by 
targeting these sites or nearby sites that changes in the binding behaviour would occur and 
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that changes in the specificity might occur.  The ten residues that were chosen for SSM are 
listed in Table 3.2.  
Table 3.2 The sites chosen for randomisation and their roles 
Sites Comments 
D163 Glycosyl C4 interaction 
R562 Glycosyl C6 interaction 
N412 Basic residue adjacent to catalytic glutamate E413 participating in general acid/base 
hydrolysis 
E413 General acid/base catalyst 
M447 Leaving group interaction 
Y469 Flipped residue creating room within the active site 
Y472 Glycosyl C6 interaction upon flipping into the active site 
T509 Important site based on literature not involved in binding 
S557 Important site based on literature not involved in binding 
  
 
Figure 3.3 Location of residues selected for SSM in β-GUS   
Key residues that are colored yellow interact with the compound.  Non-glycosyl binding 
residues are coloured green. 
 This structural study indicated that the primary contacts between the enzyme and the 
inhibitor involved D163, Y472, R562, N412 and E413.  All of these residues were found in the 
TIM-barrel domain, except D163 that was located on the loop of Domain 1 that protruded into 
the active site (see Chapter 1).  Residue D163 also forms salt-bridge interaction with R562, that 
was also implicated in glycosyl binding.  Y472 and R562 were observed to interact with the –
Active site 
S557 
T509 
R562 
Y472 
GDL 
Y469 
M447 
E413 
N412 
D163 
pNP-glucuronide 
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COOH group of the inhibitor and were within 3.5 Å of the C6-glycosyl.  Residue N412 was a 
polar residue next to the catalytic residue E413 and was capable of forming hydrogen bond 
with it.  As noted in the introduction E413 was known to be a catalytic residue that was a 
general base responsible the second step of the double displacement mechanism of the β-
GUS.  Consequentially, changing N412 was likely to alter the interaction and disturb the 
configuration in the active site.   
 Four other residues (M447, Y469, T509 and S557), that were not implicated directly in 
glycosyl binding, were also investigated as they were in locations that it was thought might 
allow them to modulate catalysis. Residue M447 forms hydrophobic interaction with the para-
nitrophenolate (pNP) leaving group (aglycone) in the model structure shown in Figure 3.3.  It 
was positioned at the mouth of the active site formed where it could facilitate departure of 
the leaving group product.  In addition, a comparison of the native and the GDL-bound crystal 
structures of β-GUS suggested that side chain of Y469 flipped away from the active site making 
room for the carboxylic functional group of the inhibitor.  This conformational change was 
thought to have consequences for substrate binding.  In addition to residues chosen on the 
basis of the β-GUS structure, two residues were selected based on literature reports. Mutants 
of these two residues, T509A and S557P were reported to have altered substrate specificity 
compared with native β-GUS (Matsumura & Ellington 2001).  
3.4. Sequence comparisons using the ConSurf program 
Apart from an inspection of relevant crystal structures, there were other methods of 
identifying residues of functional or structural significance.  Sequence comparisons were 
frequently used to identify highly conserved residues that were taken to be important for 
either structure or function.  This type of approach can be combined with known structural 
data has been incorporated into the ConSurf program.  The β-GUS amino acid sequence was 
submitted for ConSurf analysis to quantify the degree of conservation for each residue based 
on the evolutionary relatedness between the β-GUS and its homologues (Mayrose et al. 2004).   
A total of 360 homologs were collected from the SWISS-PROT database using CS-BLAST 
and 123 unique amino acid sequences were selected for analysis (Landau et al. 2005).  Out of 
these unique homologous sequences, 89 of them are β-GUS found in different species and 34 
other unique sequences are unknown proteins that have significant sequence identity 
between 35% - 95% with E. coli β-GUS.  The ConSurf analysis revealed that the catalytic residue 
(E413) and 4 key glycosyl binding residues (N412, D163, R562 and Y472) have a high 
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evolutionary conservation score of 9, which indicated a high level of conservation (Table 3.3 & 
Figure 3.4).  A high conservation score indicated the significance of the sites either for function 
or structure (Draghi et al. 2010, Soskine & Tawfik 2010, Tokuriki & Tawfik 2009).  These may 
appear through direct interaction with the substrate (i.e. N412, D163, R562 and Y472) or they 
may be spatially oriented such that they are involved in the dynamics that will affect important 
binding sites (e.g. Y469 and T509).  Therefore, one expects that highly conserved residues to 
appear less tolerant towards substitutions.  However, highly conserved sites that are involved 
in substrate binding may also hold the potential for the acquisition of a novel function.  
Despite the fact that some of the chosen sites were invariant, they were selected for 
saturation mutagenesis in hope of altering the specificity of β-GUS.  In among the chosen 
residues, M447 had a relatively low evolutionary conservation score of 5 that indicated a high 
variability of this residue. 
Table 3.3 Conservation score and residues variety of targeted residues provided by Consurf 
Amino acid residue Conservation score 
9-conserved, 1-variable 
Residues variety 
E413 9 E 
N412 9 N 
D163  9 D 
R562 9 R, L 
Y472 9 F, Y 
T509 8 S, A, T, N 
Y469 
S557 
M447 
7 
6 
5 
S, F, W, N, P, E, Y, R, L 
A, S, W, T, N, K, V, H, Q, D, I 
A, S, F, T, K, E, V, Q, M, R, G 
 
  
Figure 3.4 A ConSurf analysis for the β-GUS 
The amino acids are colored by their conservation grades using the color-coding bar, with 
turquoise-through-maroon indicating variable-through-conserved.  The run was carried out 
using PDB code 3K4D and the figure was generated using the PyMol (Sayle & Milner-White 
1995) script output by ConSurf.   
S557 
T509 
R562 
Y472 
GDL 
Y469 
M447 
E413 
N412 
D163 
Variable      Average      Conserved 
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3.5. Codon randomisation and screening 
SSM libraries for each position were made using degenerate oligonucleotides so that each 
would randomly introduce one of the twenty amino acids.  SSM has been performed with a 
variety of different protocols developed during the past two decades (Hogrefe et al. 2002).  At 
the time of writing, the most widely used protocol was the traditional protocol of whole 
plasmid amplification as implemented by Stratagene QuikChangeTM.  For the present study, 
the individual codons of interest in the β-gus gene were randomised using a single two-stage 
whole-plasmid PCR as described by Sanchis et al. (2008) and shown in Figure 3.5.  In the first 
stage of the PCR, a mutagenic primer contained a single degenerated “NNK” codon (that had 
32 triplets, encoding 20 amino acids) and an anti-primer (a non-mutagenic primer used to 
complete the complementary extension and help in uncoiling the DNA) were used for only 5 
cycles to generate a small amount of mega-primer as excess mega-primer promotes self-
annealing.  Once the mega-primer was generated, the second stage began in which the 
annealing temperature was increased to avoid the priming of oligonucleotide primers, and a 
further 20 cycles were carried out to amplify the mutated plasmid.  
                                           
Figure 3.5 Reaction scheme illustrates a single site randomisation experiment 
The gene is represented in red, the vector backbone in blue, the position randomised in green 
and the formed megaprimer in black. 
To avoid contamination with the wild-type enzyme, it was necessary to identify an E. 
coli strain that was free of endogenous glucuronidase activity, GMS407 (see Chapter 2, Section 
2.1.2.).  Each of the 9 random libraries was introduced into E. coli strain GMS407 (Datsenko & 
Wanner 2000).   
An ideal PCR protocol for performing SSM should yield i) a uniform mutational 
spectrum in terms of quality and ii) a sufficient number of colonies to achieve 95% library 
coverage, so that there was a 95% probability of observing a given variant within the pool.  To 
ensure that libraries were not biased toward a certain sequence, an average of ten random 
mutants from each library were sequenced to verify that the codon of interest had been 
randomly mutagenized.  The amino acid residues of the random mutants from each library are 
shown in Table 3.4.  In terms of achieving 95% library coverage, a library comprised of 100% 
Stage I Stage II 
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variants would require screening 96 variants (NNK = 32 codons, 32 x 3 = 96) (Patrick et al. 
2003).  To cover the theoretical library size of SSM libraries, two 96-well plates were used for 
each library to screen for one substrate (total 5 β-glycoside substrates). Each of these plates 
contained 84 library transformants and 12 positive control wells.  Triplicate sets of screens 
were performed for each library in the presence of 200 µM pNP-glucuronide, 3 mM pNP-
glucoside, 3 mM pNP-galactoside, 3 mM pNP-mannoside and 3 mM pNP-xyloside, using the 
assay method described in Section 3.2.   
Table 3.4 Summary of sequencing results for the β-GUS random libraries   
Stop codons are represented by an asterisk, the number of occurrences of the mutant among 
sequenced clones is presented by the numbers in superscript. 
Amino acid 
position 
D163 N412 E413 M447 Y469 Y472 T509 R562 S557 
Amino acids found 
among the 
random mutants 
G3 G4 E G4 G4 G3 T R G2 
E V2 G2 S R2 R G4 G7 V2 
C2 F V3 L2 C Q Q T A2 
Q D2 Y A A N S D C2 
R * W2 P V K2 A  I 
V  R D * L E  L 
*     D P   
The activity exhibited by the mutants in a SSM library was classified into four types of 
phenotype:  
(i) Inactive mutants (relative activity < 10% of the positive control) 
(ii) Partially active mutants (relative activity between 10 and 80%) 
(iii) Neutral mutants (relative activity between 80 to 120%) 
(iv) Improved mutants (relative activity > 120%).   
Since only 10 mutants from each category were sequenced, it was not expected that all 19 
canonical amino acids would be found but the screen did enable different type of mutations to 
be identified.  For the purposes of describing the results of the activity characterisation, the 
variants were divided into two categories – those that contacted the substrate and other 
residues in or near the active site. 
3.6. Glycosyl binding residues 
The glycosyl binding residues investigated were E413, Y472, D163, R562 and N412.  The results 
of these experiments are given in Table 3.5 below.  As was expected the E413 variants 
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exhibited no activity because of the key role it played in catalysis.  The residues Y472 and R562 
both interacted with the acid group at the C6 position.  No viable variants were identified for 
Y472, but active variants were found for R562.  In the presence of four non-native substrates, 
mutations at position R562 appeared to retain partial β-glycosidase activity even though they 
were not active in the presence of native substrate β-glucuronide (Table 3.5).  The residue 
D163 interacted with both R562 and the OH attached the C4 carbon.  Again no viable variants 
were identified for any substrate.  There were observations of N412 variants with low levels of 
activity towards the physiological substrate as well as some other substrates.  
Table 3.5 Mutants isolated from the SSM libraries targeting E413, Y472, D163, R562 and 
N412 residues 
The numbers indicate the relative activity of the mutant to β-GUS on 5 substrates: blue if 
below 10%, red if between 10 and 80%, green if between 80% and 120% and purple if above 
120%.  The relative activity of each clone was determined in quantitative whole cell 
glycosidase assays.  The tested substrates included pNP-glucuronide (pNP-glucu), pNP-
glucoside (pNP-gluco), pNP-galactoside (pNP-gal), pNP-mannoside (pNP-man) and pNP-
xyloside (pNP-xyl).  A stop codon is coded with an asterisk (*). 
Position Amino acid substitution 
Relative activity (%) 
pNP-glucu pNP-gluco pNP-gal pNP-man pNP-xyl 
E413 Y, R, G, W, A, V, S, D, T n.d. n.d. n.d. n.d. n.d. 
Y472 Q, D, N, K, L, R, F, G, M, * n.d. n.d. n.d. n.d. n.d. 
D163 V, E, G, Q, C, A, W, S, R, * n.d. n.d. n.d. n.d. n.d. 
R562 C, G, T, L, K, V n.d. ~ 30 - 71 ~ 22 - 58 ~ 31 - 79 ~ 22 - 30 
 T, M n.d. ~ 30, ~ 10 ~ 40, ~ 23 ~ 60, ~ 31 ~8, ~ 3 
 D, W n.d. n.d. n.d. n.d. n.d. 
N412 D ~ 15 ~ 14 ~ 13 n.d. n.d. 
 F, Y, A n.d. ~ 10 - 17 ~ 12 - 17 ~ 1 ~ 11 - 16 
 C, E, G H, I, K, L, R, S, T, V, * n.d. n.d. n.d. n.d. n.d. 
n.d.: not detected. 
 To explain the results observed in Table 3.5, at least some mutants should be 
subjected to much more detailed kinetic studies to determine kcat and Km values.  In addition, 
structural studies of at least some mutants should be carried out to determine the possible 
effects of structural change.  However, a few points can be made with the available data.  The 
retention of partial activity exhibited by some variants implies that in these variants the 
substrate binding site must be reasonably similar to that of the native protein.  Furthermore, 
these variants must form a sufficiently strong affinity for the substrates to allow catalysis to 
occur – that is the Km cannot be elevated to the point where the activity could not be observed 
with the substrate concentration used in the assay.  Residues R562 and N412 fall into this 
category.  The results observed with R562 are not surprising as this residue does not appear to 
be essential for binding non-physiological substrates.  N412, on the other hand appears to 
make a contact that would be common to all the substrates tested, except mannose.  A 
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significant drop in activity could be best explained by a small drop in affinity for the substrates, 
but with retention of the active structure.  
 Variants that show no observed activity cannot be explained as easily with the 
available data.  The Both D163 and Y472 make interactions with the native substrate and 
would be expected to make similar interactions with the other substrates.  If this were indeed 
the case, then one would expect diminished activity as was observed for N412.  Thus it 
appears that the most likely cause for the lack of activity of the D163 and Y472 variants would 
be an altered active site.  A superimposition of the E. coli β-GUS crystal structure (PDB ID: 
3K46) and the inhibitor bound crystal structure (PDB ID: 3K4D) is given below in Figure 3.6.  
From this Figure it is apparent that Y472 flips into the active site so that it can interact with the 
inhibitor/substrate.  Y469, on the other hand, would flips away from the active site.  As noted 
below, all variants of Y469 are inactive with all substrates.  It is not just “structure” that is 
important; the ability to undergo an appropriate conformational change is critical for the 
maintenance of activity.  
 
Figure 3.6 Adapted from Wallace et al. (2010) E. coli β-GUS crystal structure (PDB ID: 3K46; 
shown in blue) superimposed on the inhibitor bound crystal structure (PDB ID: 3K4D; shown 
in green) 
Y472 flipped into the active site and formed interaction with the carboxylate group at C6, and 
Y469 flipped out.  
3.7. Non-glycosyl binding residues  
The results for the experiments with non-glycosyl binding residues are given below in Table 
3.6.  Although these residues did not participate in binding the glycosyl moiety, they did have 
other interesting features.  As previously noted, M447 appeared to interact with the aglycone 
moiety (Figure 3.3).  Like Y472, Y469 was part of a section of peptide that appeared to undergo 
a conformational change on binding substrate.  Both T509A/S and S557P variants were found 
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in multiple directed evolution experiments.  While the T509 and S557 sites did not participate 
in substrate binding, the various experiments reported in the literature showed that they can 
alter the function of β-GUS (Rowe et al. 2003, Geddie & Matsumura 2004, Smith et al. 2011). 
 M447 was observed to have a low conservation score residue (conservation score of 5) 
and showed moderate activity with most β-glycoside substrates (Table 3.6).  Nevertheless, it 
did not produce any mutants that could improve the glycosidase activity.  An explanation for 
this is that its interaction with pNP leaving group was not a crucial interaction; this was 
consistent with the fact that β-GUS was not aglycone-specific.  Therefore, mutagenesis at this 
site would have been unlikely to alter its preference in accommodating the different glycosyl 
ring in β-glucoside.  
Table 3.6 Mutants isolated from the SSM libraries targeting M447, Y469, T5095 and S557 
residues 
The numbers indicate the relative activity of the mutant to β-GUS on 5 substrates: blue if 
below 10%, red if between 10% and 80%, green if between 80% and 120% and purple if above 
120%.  The relative activity of each clone was determined in quantitative whole cell 
glycosidase assays.  The tested substrates included pNP-glucuronide (pNP-glucu), pNP-
glucoside (pNP-gluco), pNP-galactoside (pNP-gal), pNP-mannoside (pNP-man) and pNP-
xyloside (pNP-xyl).  A stop codon is coded with an asterisk (*). 
Position 
Amino acid 
substitution 
Relative activity (%) 
pNP-glucu pNP-gluco pNP-gal pNP-man pNP-xyl 
M447 Q, H n.d. ~ 96, ~ 83 ~ 68, ~ 15 ~ 58, ~ 58 ~ 42, ~ 10 
 G, S ~ 33, ~ 27 ~ 9, ~ 1 ~ 12, ~ 17 ~ 81, ~ 80 n.d. 
 D, A, C, L, P, R, V, W, * n.d. n.d. n.d. n.d. n.d. 
Y469 A, R, C, V, G, * n.d. n.d. n.d. n.d. n.d. 
T509 A, S ~ 91, ~ 115 ~ 306, ~ 204 ~ 186, ~ 173 ~ 96, ~ 94 ~ 106, ~ 81 
 E, Q ~ 74, ~ 15 ~ 87, ~ 80 ~ 45, ~ 59 ~ 32, ~ 41 ~ 57, ~ 69 
 G ~ 15 ~ 107 ~ 10 ~ 34 ~ 23 
 L ~ 19 ~ 6.6 ~ 76 ~ 16 ~ 85 
 P n.d. ~ 9.4 ~ 88 ~ 70 ~ 68 
 C, V, W ~ 22 - 69 ~ 27 - 74 ~ 23 - 34 ~ 25 - 49 ~ 22 - 52 
S557 P ~ 75 ~ 119 ~ 131 ~ 63 ~ 30 
 V, A, I ~ 27 - 68 ~ 83 - 115 ~ 81 -103 ~ 35 - 77 ~ 11 - 79 
 C, L ~ 41, ~ 44 ~ 70, ~ 79 ~ 10, ~ 11 ~ 51, ~ 55 ~ 30, ~ 33 
 G, W n.d. n.d. n.d. n.d. n.d. 
n.d.: not detected. 
The residue Y469 showed moderate conservation score of 7 but its variants were 
completely inactivated.  As noted above, this observation suggests that the flip of Y469 was 
important for catalytic activity and that altering Y469 may have significant impact on the 
dynamics of Y472 and the subsequent interactions of Y472.   
Even though residue T509 exhibited a high conservation score of 8 (Table 3.3), it was 
moderately tolerant and yielded several clones with increased β-glucosidase and β-
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galactosidase activities.  The sequences of the improved clones were determined to be T509A 
and T509S.  The T509A variant had 3 and 2 times higher β-glucosidase and β-galactosidase 
activities compared to wild-type while the β-glucosidase and β-galactosidase activities of 
T509S variant are 2 and 1.7 times greater.  Even though this residue does not interact with the 
substrate or with substrate binding residues, it may modulate the flexibility of the loop that 
contains the catalytic nucleophile E504, thereby enabling the accommodation of the non-
native β-glucoside substrate.   
Mutation at S557 also gave variants with moderate glycosidase activity.  The S557P 
variant identified by Matsumura et al. (2001), showed 1.3 times higher than the wild-type with 
β-galactoside as substrate.  It was proposed that the S557P mutations might destabilize the 
active-site loop, thereby decreasing the specificity of the binding pocket.   
3.8. Concluding remarks 
The experiments described in this chapter have the potential of providing information relating 
to the structure and function of β-GUS.  The inability to find viable mutants of Y469 was 
unexpected as it was not a highly conserved residue.  The low levels of activity exhibited by 
variants of N412 were surprising as it was adjacent to a key catalytic residue that figures 
prominently in catalysis.  Although the activities of these variants were very low, it would be 
interesting and informative to examine the structures of these variants and to determine their 
kinetic properties; was there a small structural change that caused weaker binding (as 
manifested by a higher Km) or did the structural change make the location of the nucleophile 
suboptimal so that a decrease kcat resulted.  These questions are left for future investigators.   
The principal aim of this work was to alter the substrate specificity.  The approach 
taken in this chapter was to observe the effects of changes to active site residues – those that 
appear to interact with the substrate and those that sit of the periphery of the active site.  
Based on the results of site-saturation mutagenesis experiments, the chosen sites can be 
classified into four groups:  
(i) Critical, only the wild-type amino acid had activity towards substrates 
(ii) Restrictive, substitutions had 10% to 80% activity towards substrates 
(iii) Partially tolerant, 1 - 3 substitutions had at least 80% activity towards substrates 
(iv) Tolerant, 3 - 6 substitutions had at least 80% activity towards substrates.   
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The critical set of residues included the catalytic residue (E413), 2 glycosyl binding residues 
(Y472 and D163) and a non-glycosyl binding residue (Y469).  Another 2 main glycosyl binding 
residues (R562 and N412) were restrictive sites.  Only 2 amino acid types were consistent with 
wild-type levels of hydrolysis at position M447.  Finally, variants with changes at positions 509 
and 557 showed consistent activity with a broad range of substrates; some with significantly 
more activity than the wild-type enzyme.  Notably, variants with the following changes, 
T509A/S, showed about 3- and 2-fold higher β-glucosidase activity than that of the wild-type β-
GUS, respectively.  T509A and T509S were also exhibiting an average of 0.6 and 0.4-fold 
improvement, respectively, in galactosidase activity.  Hence, this implied that position T509 
may affect the substrate specificity of the enzyme.  It is also important to highlight that even 
though assays were performed with triplicate culture of each mutant, β-galactosidase, β-
mannosidase and β-xylosidase activities in crude lysates were too low to be measured 
accurately.  Therefore, unless a mutant exhibits a significant higher glycosidase activity than of 
wild-type β-GUS, it is thought to be unworthy of further investigation. 
 In total, 6 of the 9 mutated residue positions are highly conserved positions and 
important for glycosidase activities (E413, Y472, Y469, D163, R562 and N412).  Five of this set 
of essential residue were thought to be important for the binding and positioning of substrate.  
The highly variable positions are S557 and T509, which are slightly further away from the 
inhibitor.  T509 obtained a high conservation score of 8 but 2 different mutants were found to 
have increased activity against substrates with β-glucoside and β-galactoside while most of the 
isolated mutants are active against the β-glycoside.  Single site mutants T509A, T509S and 
S557P were found to have enhanced glucosidase and galactosidase activities.  The effect of 
T509A and S557P mutation on the glucosidase activity will also be discussed in Chapter 4 along 
with a description of experiments to more effectively alter substrate specificity.  
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Chapter 4 
Stability and the Evolution of New 
Substrate Specificity 
4.1. Introduction 
One of the key aims of this thesis was to alter the substrate specificity of GUS.  In the previous 
chapter, site-saturation mutagenesis was used to probe the role and importance of active site 
residues.  At the time this seemed like a reasonable place to start a study to alter the substrate 
specificity, but it soon became apparent that simply changing one residue did not provide 
sufficiently useful insights into how the enzyme could be rationally engineered to achieve the 
project aims.  Furthermore, it was suspected that directed evolution was a far more useful 
approach.  However, the choice of a starting point for such a study was not clear.  One could 
use the gene for the native protein or one could use the gene for a mutated form of the 
protein that had been evolved with selection for enhanced stability (Xiong et al. 2007).  
It should be noted that the choice of whether to choose the native or the more stable 
form of β-GUS was not straightforward.  The native protein was more active, but there were 
precedents in the literature that suggested the stable form of the protein was the better 
choice.  Enhancement of β-glucosidase activity in β-GUS could be achieved through 
introduction of changes at key positions.  However, changes that modulate enzyme function 
frequently hamper interactions that ensure the stability of the protein.  For example, Tokuriki 
et al. (2008) observed that changes that confer new functions give rise to a large stability 
burden and were found to be more destabilizing than neutral mutations.  Hence, as changes 
accumulate, protein fitness declines.  To compensate for the destabilizing effect of the crucial 
function-altering changes, proteins often accommodate changes that exert stabilizing effects 
so that the protein stability can be restored.  In other word, there appears to be a relationship 
between stability and evolvability as noted by Bloom et al. (2006) that enhanced stability 
allows a protein to withstand the destabilizing effect of functionally beneficial changes and 
thereby increasing its ability to adopt new functions.  This makes the more stable protein an 
attractive starting point for the proposed study.   
After some consideration, it was decided to evolve both the native and stabilized 
forms of GUS in parallel.  This would test the idea that stability promotes evolvability and allow 
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the effects of evolution to be monitored for both the native and the stable forms of GUS.  For 
example, would the stable form of the protein remain stable or would its stability drop in 
response to selection for altered substrate specificity? Similarly, would the native form of the 
protein gain or lose stability to accommodate altered substrate specificity? 
In the remainder of this chapter, there is a description of the thermostable enzyme, as 
well as a general description of the methods used in directed evolution.  This section places 
emphasis on the special needs of the present work; that is the need to evolve the native and 
stable enzymes in an essentially identical manner.  Following this there is a description of the 
course of the evolution that includes a comparison of the results of the two sets of 
experiments.  These evolution experiments must, by necessity, be carried out by monitoring 
the activities of proteins as found in crude lysates.  However, crude lysates can conceal a great 
deal of useful information, and a more thorough investigation of multiple factors was required 
to gain an understanding of the evolutionary process.  The chapter concludes with a 
description of the experiments to characterise the possible effects of evolution; these include 
changes in the expression and solubility as well as changes in the stability and kinetic 
properties.  
4.2. Thermostable GUS 
The thermostable mutant, GUS-TR3337, was chosen as the stable form of GUS.  This variant 
was evolved in the laboratory by Xiong et al. (2007) and found to have six changes that gave 
rise to increased thermostability.  As shown towards the end of this chapter, the GUS-TR3337 
protein was significantly more stable that the wild-type protein, but displays less activity 
towards glucuronide substrates when compared with the native protein.  Both the native and 
GUS-TR3337 proteins have extremely high levels of activity towards glucuronide substrates, 
and low (but detectable) levels of activity towards glucoside substrates.  The afore-mentioned 
facts make the test of “stability enhances evolvability” a reasonable objective.  
The effects of the mutations that give rise to the enhanced stability of the GUS-TR3337 
are not concentrated in one area of the protein.  One of the residues that was changed was 
S559 that lies at the tetramer interface.  Other residues that were changed were R493 and 
T532 that lie in the TIM-barrel domain near the tetramer surface.  Finally, the residue of T509, 
N566 and S550 were found near the active site of GUS as shown in Figure 4.1.  The gus-tr3337 
gene was obtained using site-directed mutagenesis of the gus-wt via an overlap extension 
polymerase chain reaction (PCR) method as described in Chapter 2 (Section 2.3.1.1.2.). 
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Figure 4.1 The positions of the six amino acid residues Q493, T509, M532, N550, G559 and 
N566 in the WT-GUS 
The labelled residues are shown as colour balls. 
4.3. Directed evolution for glucosidase activity 
A schematic depiction of the steps involved in directed experiments is given in Figure 4.2.  To 
reasonably compare the evolvability of GUS-WT and GUS-TR3337, it was important to ensure 
that both sets of mutant libraries were generated under identical conditions with two 
checkpoints: 
1. An error rate that was sufficiently high for changes to be made, but low enough to retain 
functionality in most of the variant population.  In effect, this required library sizes that 
had a reasonable number of active mutants yet manageable with respect to the screening 
effort.  
2. A distribution of mutations that was random, since all residues in GUS-WT and GUS-
TR3337 have potential to influence the protein’s properties. 
Q493 
M532 
N550 
N566 
GDL 
T509 
G559 
G559 
N566 
T509 
M53
2 
Q493 
N550 
GDL 
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Figure 4.2 Screening strategies 
The screening strategy used in directed evolution of GUS-WT and GUS-TR3337 is presented in 
a schematic form with agar plates and 96-well plates illustrated.  
4.3.1. Error rate 
The error-rate used to create libraries for directed evolution must maintain a balance between 
diversity and function.  Other workers have investigated this balance and it usually involves a 
low mutation rate of between 1 to 2 mutations per gene (Moore & Arnold 1996).  Part of the 
rationale for this strategy is that a high mutation rate usually results in the incorporation of 
detrimental changes, so that very large libraries are required to find the few variants that only 
have positive or neutral mutations. 
To measure the mutation rate, GUS-WT libraries were prepared with different MnCl2 
concentrations.  For each MnCl2 concentration, 20 clones were randomly selected for 
sequencing.  Varying concentration of MnCl2 from 0.05 to 0.3 mM yielded mutation 
frequencies between 0.4 to 4.5 amino acid substitutions within a region of the gene that 
consisted of 165 residues (Figure 4.3).  To reduce screening efforts, in the first two rounds, 
only 165 residues that coded for the domain that had the active site were subjected to random 
mutagenesis.  Justification for this strategy has been provided by workers who demonstrated 
that active site substitutions can rapidly alter substrate specificity (Geddie & Matsumura 2004, 
4 Stability and the Evolution of New Substrate Specificity 
 
58 
 
Chica et al. 2005, Parikh & Matsumura 2005).  A MnCl2 concentration of 0.1 mM was chosen to 
create both libraries as it generated a library containing approximately 2 amino acid 
substitutions per gene. 
 
Figure 4.3 Landscape for four mutant libraries using different MnCl2 concentration 
As noted previously, the GUS-WT and GUS-TR3337 libraries were generated under 
identical conditions.  The p-values from the Kolmogorov-Smirnov test (Sachs 1982) suggest 
that these two libraries had the similar mutation rates. Figure 4.4a, b and c show that the 
mutational distributions obtained from each library were statistically indistinguishable (P = 
0.98), the mutational distribution of combined libraries is Poisson distributed (P = 0.98) and 
the mutations are uniformly distributed along the gene (P = 0.98), respectively. 
(a)                                                              (b) 
  
 (c) 
 
Figure 4.4 Distribution of mutations in the two GUS libraries 
(a) The distribution of mutations among 20 randomly chosen GUS-WT mutants and 20 
randomly chosen GUS-TR3337 mutants (b) The distribution of mutations (histogram) among all 
the 40 distribution of sequenced mutants along with a theoretical Poisson distribution (solid 
line) (c) The cumulative fraction of mutations that occur at that of position in the gene – this 
demonstrates that the mutations are uniformly distributed along genes.   
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4.3.2. Generations of GUS-WT and GUS-TR3337 in directed evolution 
The directed evolution of GUS-WT and GUS-TR3337 occurred over six generations.  Each 
generation began with the preparation of a variant library followed primary and secondary 
screens.  From the results of the secondary screens, the ten best variants were identified and 
used to generate the progeny for the next round of evolution.  Table 4.1 gives a summary of 
the experimental details.  In all, six rounds of evolution were carried out with GUS-WT and 
GUS-TR3337; the objective being to isolate variants with improved glucosidase activity.   
In generations 1 and 2, the yield of supercoiled plasmid DNA (pDNA) was the limiting 
factor in determining the library sizes.  The diversity available in the library was estimated by 
the number of GMS407 transformants created during library preparation.  However, from the 
third generation onwards, the low-copy-number pET28a(+) was substituted by a high-copy-
number pJexpress 401 that produced sufficient supercoiled pDNA to give about 100,000 
GMS407 transformants.  Estimates of the number of genotypes examined in each generation 
are presented in Table 4.1.  
Table 4.1 Summary of generation in GUS-WT and GUS-TR3337 directed evolution 
The genetic diversity for each generation was provided by ePCR, StEP-ePCR or DNA shuffling.  
Each generation was obtained through primary screening (colony) and secondary screening 
(culture) methods.  10 unique genes were used as parents in each generation. 
Generation  Diversity  Selection  Randomised 
region  
Genotypes examined  
 GUS-WT  GUS-TR3337  
1 ePCR Colony T438-Q603 10000 10000 
  Culture  3000 3000 
2 StEP-ePCR Colony T438-Q603 32000 32000 
  Culture  3000 3000 
3 
 
StEP-ePCR 
 
Colony 
Culture 
F293-Q603 
 
65000 
3000 
63000 
3000 
4 
 
StEP-ePCR 
 
Colony 
Culture 
M1-Q603 
 
78000 
3000 
80000 
3000 
5 StEP-ePCR Colony 
Culture 
M1-Q603 90000 
3000 
90000 
3000 
6 DNA shuffling Culture M1-Q603 3000 3000 
In generation 1, about 10,000 cultures were analysed for the primary selection and 
3,000 progenies for the secondary selection in both GUS-WT and GUS-TR3337 libraries.  
Generation 2 began with StEP-ePCR to recombine the changes present in the 10 parents and 
introduce more random mutations into the libraries.  Almost ten times as many colonies were 
examined in the primary selection before 3,000 cultures were assessed in the secondary 
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screen.  All the selected variants from the second round (i.e. the parents for the next round) 
were unique. 
A major change in the primary screen was necessary for round three of the evolution.  
The agar plate primary screen (Chapter 2 Section 2.3.1.2.2.1.1.), used in round one and two, 
could no longer identify improved variants.  Evolution had progressed and as a result, as most 
of the colonies now turned uniformly blue after overnight incubation.  In response, top agar 
screening was used in generations 3, 4 and 5 (Chapter 2 Section 2.3.1.2.2.1.2.).  The X-
glucoside was applied as a top agar layer after the colonies had grown.  The colonies 
responsible for colour production could then be identified within 30 min. 
To increase the probability of finding a beneficial mutation, the length of the 
mutagenized region of the gene was increased so that in generations 4 and 5 the entire gene 
was mutated.  Along with increasing the length of gene that was mutated, the library size was 
also increased from generations 3 through 5. 
4.3.2.1. GUS-WT and GUS-TR3337 sequence pedigree 
For convenience, all variants of gus-wt and gus-tr3337 produced by mutagenesis will be 
designated gus-wt* and gus-tr3337*, respectively.  During the directed evolution process, 
selected gus-wt* and gus-tr3337* were sequenced to ensure that they were unique.  A 
summary of the observed changes in the 10 variants from each generation is presented in 
Table 4.2 while a full list of all changes present in the 50 variants from each library is presented 
in Table 4.3.  The sequences are grouped according their generation so that it is easy to 
observe the evolutionary process.  The variants 1P17G2 implies that it is a first generation (1P) 
and was found in tray 17 and well G2.  In any generation, some new changes appear – a few 
maybe functional, but most are likely not to be beneficial, but simply occur in the gene in 
addition to a beneficial mutation (Table 4.3).  Changes that enhance activity to a significant 
(i.e. detectable) degree are retailed while the DNA shuffling tends to result in the elimination 
of neutral mutation.  DNA shuffling also accelerated the accumulation of positive mutations.  
Thus, in generation 5, a number of positive changes were found in all variants – that is, the 
evolutionary process has converged for these mutations.  This extensive analysis of the 
sequences has provided an interesting example of the progression of directed evolution. 
In GUS-WT library, only one of the eight changes that arose in the first generation was 
maintained in the variant population through to generation 5.  This mutation, T509A, reached 
saturation by generation 3.  Another mutation that reached saturation in the finalist 
population is from generation 2, K568Q.  K568Q must be highly beneficial for activity in the 
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selection conditions since it became saturating within one generation whereas T509A required 
two generations to achieve saturation. 
Similarly, in the GUS-TR3337 library, only one of the eight mutations, S550N, appeared 
in the first generation and was maintained through to generation 5.  Another three mutations 
that reached saturation in a final population were Q498, S566N and K568E that all appeared in 
generation 2.  Among these four mutations, positions 550 and 566 were reversions to wild-
type residues.  The reason S550N took three generations to achieve saturation was probably 
due to the competition between this change and the combination of F551L, S566N and K568E 
changes.  The S550N and F551L arose from changes that were relatively close in the nucleotide 
sequence so that a recombination event to bring them together would be rare.  
Table 4.2 Comparison of GUS-WT and GUS-TR3337 variants over 5 generations  
The 10 selected parents from each generation are summarized with the mutations in primary 
sequence indicated.  The asterisks (*) indicate residues that were mutated back to their native 
residues.  The hash (#) symbol is associated to mutated residues that were found in both 
libraries.  Residues that confer enhanced thermostability are bordered in black.  Shading has 
been used to highlight the significant differences.  The number of occurrences of the mutation 
is presented by the numbers in superscript. 
                                                                                                                            *                              * 
                                                    #                              #                #       #                       #                             # 
  
Generation 6
4
 
2
7
9
 
3
5
0
 
4
6
9
 
4
7
4
 
4
8
0
 
4
9
3
 
4
9
8
 
5
0
9
 
5
1
6
 
5
3
2
 
5
5
0
 
5
5
7
 
5
5
9
 
5
6
1
 
5
6
6
 
5
6
8
 
5
9
7
 
GUS-WT A E D Y Q T Q Q T M M N S G L N K P 
WT1 A E D Y Q T Q Q A
6
 M M N P
2
 G L N K Q 
WT2 A E D Y Q T Q L
2
 A
7
 M K
2
/ V N S G L N Q
2
 Q
3
/ L 
WT3 A E D Y Q T Q Q A
10
 V
2
 K N P
3
 G L N Q
10
 Q
8
 
WT4 A E D N Q T Q Q A
10
 V
5
 M N P
3
 G L N Q
10
 Q
6
 
WT5 E
3
 D
3
 G
5
 N
6
 Q T Q Q A
10
 M M N P
6
 G L N Q
10
 Q
9
 
                   
GUS-TR3337 A E D Y Q T R Q A M T S S S L S K P 
THERMO1 A E D Y K M R Q A R T G/ N
2
 P
4
 S L N K P 
THERMO2 A E D H
3
 K
3
 A R K A M M N
3
 P
5
 S S N
2
 E
2
 P 
THERMO3 A E D H
2
 H M R K A M M
2
 N
5
 P
3
 S S N
7
 E
7
 P 
THERMO4 A E D Y Q M
8
 R K
10
 A M T N
10
 S S L N
10
 E
10 
 P 
THERMO5 A E D Y Q M
8
 R K
10
 A M T N
10
 S S L N
10
 E
10
 P 
Reversion Reversion 
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Table 4.3 Changes in GUS-WT and GUS-TR3337 sequences over 5 generations   
Residues that are different to the native amino acid are shaded grey and bordered in black at 
the point where they first appeared.  Only the unique variants selected to be parents for 
future generation are presented.  The asterisks (*) indicate residues that were mutated back 
to their native residues.  The hash (#) symbol is associated to mutated residues that were 
found in both libraries.  A schematic representation of the protein domains of β-GUS is 
illustrated below the table.  Domain I, II, III comprising amino acid residue 1-180, 181-274, 275-
603 correspond to sugar-binding domain, immunoglobulin domain and TIM barrel, 
respectively.  A schematic representation of the actual domain size is presented at the bottom.  
The scale bar corresponds to the length in amino acids of β-GUS.  (a) GUS-WT library (b) GUS-
TR3337 library 
(a) 
                                                          #               #     #             #            # #     # # #                 # # 
 
I II III 
1                        100                    200                     300                     400                    500                      600 
      
 
I II III 
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(b) 
                                                                                                  *            *                      * 
                                       #     #        #               #        #            #                       # #            #        # # 
 
I II III 
1                        100                    200                     300                     400                    500                      600 
      
 
I II III 
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4.3.2.2. Improvement in GUS-WT and GUS-TR3337 over five generations 
Activity of GUS-WT and GUS-TR337 improved in each generation under the selection 
conditions with the greatest improvements occurring in the first and third generation where 
new screening method was applied (Table 4.4).  The improvement in the activity of GUS-
TR3337 was much better than that of the wild-type protein (Table 4.4b).  Further improvement 
was not observed in the final generation, suggesting that GUS-TR3337 variants had reached 
optimal activity under the selection conditions.  GUS-TR3337 library also had fewer changes 
and mutational saturation occurred in generation 4 compared to GUS-WT where mutational 
saturation occurred in generation 5. 
There were two distinct phases in the evolution project: the first phase was completed 
with the agar plate screening method.  This method was replaced by the top agar screening 
method in the second phase, from generation 3 onwards, however, the selection conditions 
remained identical to those in generations 1 & 2.  That is selection essentially involved 
observation of increased activity.  However, it appeared that the screen used in the second 
phase was much more sensitive than that used in the first phase.  This was supported by the 
observation that variants from generation 3 in both libraries had the greatest increment in 
glucosidase activity compared to variants from other generations, as shown in Table 4.4.  
Table 4.4 Optimal GUS-WT and GUS-TR3337 versions for each generation   
The data have been abbreviated to show only the best variant for each of the five generations. 
The first number in the variant name refers to the generation.  The relative activity refers to 
the activity of a variant divided by the activity of best variant from the previous generation.  
Activity was determined with the crude cell lysates and 1 mM pNP-glucoside buffered at pH 
7.4.  (a) GUS-WT (b) GUS-TR3337 
(a) 
Variant 
6
4
 
2
7
9
 
3
5
0
 
4
5
1
 
4
6
9
 
4
9
8
 
5
0
9
 
5
1
6
 
5
3
2
 
5
5
7
 
5
6
8
 
5
9
7
 Relative 
activity 
Compared 
to: 
GUS-WT A E D A Y Q T M M S K P 1.0 - 
WT1P17G2 A E D A Y Q A M M S K P 5.5 Native 
WT2P14E7 A E D P Y L T M K S Q Q 2.6 WT1P17G2 
WT3P24E11 A E D A Y Q A M M S Q Q 6.4 WT2P14E7 
WT4P26F8 A E D A Y Q A V M S Q Q 1.7 WT3P24E11 
WT5P26A7 E D G A N Q A M M P Q Q 1.6 WT4P26F8 
(b) 
Variant 
4
7
4
 
4
8
0
 
4
9
8
 
5
5
0
 
5
5
7
 
5
6
1
 
5
6
6
 
5
6
8
 Relative  
activity 
Compared 
to: 
GUS-TR3337 Q T Q S S L S K 1.0 - 
THERMO1P6B9 Q T Q S P L S K 5.8 Native 
THERMO2P23C4 K T Q S P S S K 3.5 THERMO2P23C4 
THERMO3P24F7 Q T Q N S L N E 6.8 THERMO3P24F7 
THERMO4P11F2 Q M K N S L N E 5.7 THERMO4P11F2 
THERMO5P16H6 Q M K N S L N E 1.0 THERMO5P16H6 
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4.3.2.3. Shuffling of best mutants from each generation 
To identify a “best” combination of changes, a final shuffling experiment was performed.  
Three shuffled libraries were generated by using StEP (Zhao & Zha 2006).  Unique mutants 
from GUS-WT library, GUS-TR3337 library and both libraries, were used as parents in shuffled 
GUS-WT, GUS-TR3337 and combination libraries, respectively (Table 4.5).  Including the wild-
type variant in the shuffling procedure would allow us to use it as a control for the screening 
process – the confidence in the screen was higher if none of the selected variants returns as 
wild-type even though it is included in the parent mix.  This objective of the shuffling process 
was to find the best combination of mutations.  20 clones from each of the three libraries, that 
were examined for cross-over events.  The shuffled GUS-WT, GUS-TR3337 and combination 
libraries gave an average of 2.5, 2.1 and 2.4 cross-overs per gene.  The shuffled mutants were 
screened like the method used previously for library screening – for further enhancement in 
glucosidase activity.  However, after screening 3,000 mutants from each library, no variant was 
identified with better activity than WT5P26A7 and THERMO4P11F2, suggesting that, for the 
screening conditions, the evolution had converged.   
Table 4.5 Parental sequences used for shuffled GUS-WT, GUS-TR3337 and combination 
libraries 
Library Parental genes 
Shuffled GUS-WT gus-wt, wt2p14e7, wt4p26f8 and wt5p26a7 
Shuffled GUS-TR3337 gus-tr3337, thermo2p23c4, thermo3p24f7 and thermo4p11f2 
Shuffled combination gus-wt, wt2p14e7, wt4p26f8, wt5p26a7, gus-tr3337, thermo2p23c4, 
thermo3p24f7 and thermo4p11f2 
4.3.2.4. Analysis of mutation type 
For generation 1, ePCR was used to produce libraries with an average of 4.3 and 4.2 nucleotide 
base substitutions per gus-wt and gus-tr3337 gene, respectively.  In GUS-WT and GUS-TR3337 
libraries, transitions (purine to purine or pyrimidine to pyrimidine mutations) accounted for 
62% and 67% of all mutations whereas transversions (purine mutated to pyrimidine or vice 
versa) accounted for the remaining 38% and 33%, respectively (Figure 4.5).  In both libraries, 
up until generation 4, the mutation density of progeny was increased gradually due to the use 
of StEP-ePCR where this method generates new mutations and propagates existing mutations 
in new combinations.  The escalation of mutation density in generation 3 and 4 was also due 
to more changes present in the parent genes while the mutagenized region was expanded. 
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Figure 4.5 Mutation density in progeny from each generation in GUS-WT and GUS-TR3337 
libraries   
The average number of mutations per gus-wt and gus-tr3337 is presented for the unique 
progeny of each generation.  The chart columns are divided into regions indicating particular 
types of base substitutions.  Blue: GUS-WT library; red: GUS-TR3337 library. 
4.3.2.5. Distribution of mutations in the gene and the protein 
This project was based on the assumption that beneficial changes could occur at any point in 
GUS-WT and GUS-TR3337.  For this reason, it was necessary for mutations to occur randomly 
througout the gus-wt and gus-tr3337 gene.  Although the number of mutations was reduced 
by the selection for active GUS-WT and GUS-TR3337, the location of silent mutations was not 
affected by selection.  Silent mutations, therefore, represent the distribution of mutations in 
the libraries used for directed evolution.  Since the silent mutations observed over the last 2 
generations (generation 4 and 5) were evenly distributed along the gus-wt and gus-tr3337 
gene (Figure 4.6), it was concluded that the mutagenesis methods did not influenece where 
mutations would occur.  The random mutagenesis targeted the entire gus-wt and gus-tr3337 
genes in generations 4 and 5, therefore, only the silent mutations in the progeny from these 2 
generations were analysed for this purpose.   
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(a)                                                                               (b) 
 
Figure 4.6 Distribution of all mutations points over gus-wt and gus-tr3337 
The positions of silent mutations are plotted as squares and the missense mutations as 
triangles with respect to the cumulative number of mutations from the start codon.  The 
horizontal axis is divided into regions to indicate each of the three domains in GUS.  (a) gus-wt 
(the r2 value is 0.969 for silent mutations and 0.9778 for missense mutations) (b) gus-tr3337 
(the r2 value is 0.9931 for silent mutations and 0.9923 for missense mutations). 
In contrast to silent mutations, missense mutations (resulting in a change in an amino 
acid) were not randomly distributed in the GUS-WT or GUS-TR3337 progeny: missense 
mutations were more likely to occur within the domains rather than at the linker regions.  As 
the mutagenesis process was not responsible for biasing mutation location, it was concluded 
that the selection for active GUS-WT and GUS-TR3337 was biasing mutations towards regions 
that can accommodate change and give rise to enhanced activity.  Regional bias of missense 
mutations was observed in one of the first examples of enzyme directed evolution (Moore et 
al. 1996).  There were two regions in both GUS-WT and GUS-TR3337 that were susceptible to 
change.  One region corresponded to the end of the sugar-binding domain and the beginning 
of the immunoglobulin domain (residues 159-190) while the other corresponded to the 
beginning of the TIM barrel domain (residues 288-331).  The location of these two regions 
within the structure of β-GUS (Figure 4.7) influenced the interaction of the TIM domain with 
the sugar binding and immunoglobulin domains.  In addition, most parts of both regions were 
buried, and buried residues were known to be  less commonly mutated than surface residues 
(Espinosa et al. 2014).   
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Figure 4.7 GUS-WT regions 159 to 190 and 288 to 331 
The dimer of GUS-WT solved by Wallace et al. (2010) is illustrated with the established low-
affinity inhibitor, glucaro-δ-lactam (GDL) (Niwa et al. 1972) molecule in red.  The majority of 
the protein is illustrated as ribbon, whereas the two regions that are vulnerable to missense 
changes are presented as cartoons.  The right monomer is coloured in blue and the left 
monomer has the three domains labelled and the two vulnerable regions are coloured in 
purple and orange with the end residues labelled. 
The sugar-binding and TIM barrel domains not only tolerated mutations but also 
allowed changes to improve the performance of GUS-WT and GUS-TR3337 under the selection 
conditions.  Of the eight missense mutations present in the best variant of the WT5P26A7 and 
five missense mutations present in the best variant of the THERMO5P16H6, one occurred in 
the sugar-binding domain and the rest occurred in the TIM barrel domain.  Both the number 
and location of beneficial changes in the TIM barrel domain suggested that this domain was 
robust and that it was a suitable target to alter the substrate specificity.   
Overall, GUS-WT was less tolerant of mutations than GUS-TR3337, particularly in the 
immunoglobulin domain.  Mutational analysis of both libraries revealed that GUS-TR3337 had 
a higher compromised resistance and carried a higher fraction of missense mutations (55%) 
S159 
Sugar-binding 
domain Immunoglobulin 
domain 
TIM 
barrel 
V190 
Y331 
F288 
GDL 
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than GUS-WT library (45%) (Table 4.6).  This suggested that the stabilized variant, GUS-TR3337, 
showed increased tolerance to missense mutations.  The property of resilience to mutations 
was known to be important to protein engineers as it allowed a larger number of beneficial 
mutations to be introduced and screened (Elena & Sanjuan 2008). 
Table 4.6 Mutational analyses of nucleotide changes 
DNA library GUS-WT GUS-TR3337 
Average number of mutations per clone in generation 4* 
Average number of mutations per clone in generation 5* 
7.28 
7.29 
7.12 
7.12 
Silent mutations (%) 54.79 45 
Missense mutations (%) 45.21 55 
* Mutations identified in clones sequenced from each library (20 clones per library) 
4.4. Characterisation of GUS-WT and GUS-TR3337 variants  
Directed evolution resulted in GUS-WT and GUS-TR3337 variants that could be expressed in E. 
coli with improved activity toward 1 mM pNP-glucoside at pH 7.4.  The analysis of bacterial 
lysate during the directed evolution process indicated that the best variant for pNP-glucoside 
hydrolysis from GUS-WT library was WT5P26A7 and GUS-TR3337 library was THERMO4P11F2.  
Both variants were selected for a more thorough characterisation alongside parents GUS-WT 
and GUS-TR3337.  Another six variants from GUS-WT and GUS-TR3337 libraries were selected 
on the basis that they could help elucidate the effect of mutations at residues 480, 498, 509, 
516, 550, 557, 566, 568 and 597.  These mutants were: WT1P17G2, WT3P24E11, WT4P26F8, 
THERMO1P6B9, THERMO2P23C4 and THERMO3P24F7.  The final preparations of GUS-WT and 
GUS-TR3337 variants were dialysed into 50 mM phosphate buffer at pH 7.4 with 1 mM DTT. 
4.4.1. Expression and solubility of GUS-WT and GUS-TR3337 variants 
The primary goal of this directed evolution was to improve the glucosidase activity of β-GUS.  
However, that activity was determined with the protein in crude lysates.  The level of activity 
in crude lysates depends upon more than the kinetic properties of the enzyme; it will also be 
increased by enhanced expression, solubility and stability of the protein.  Each of these factors 
was investigated to determine the observed increase in activity.  
To determine changes in the level of expression and solubility due to evolution, GUS-
WT and GUS-TR3337 along with a selection of variants were grown under identical conditions 
in 5 mL test tubes and the results analysed with SDS-PAGE. The overall production, soluble and 
insoluble forms of GUS-WT and GUS-TR3337 variants, were calculated as the proportion of 
density attributed to them out of the entire protein density in both the supernatant and pellet 
analyses (Chapter 2 Section 2.2.).  This software quantifies the production and expression level 
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for each of the GUS-WT and GUS-TR3337 along with their variants.  As indicated in Table 4.7, 
there were no significant improvement in solubility from the GUS-TW and GUS-TR3337 
variants, except for WT4P26F8 displayed ~ 7% increase in protein solubility.  These results 
suggest that some of the changes, such as M516V, improved the solubility of β-GUS during 
expression in E. coli.  However, the improvement was small.  Since the error associated with 
estimating the expression level was difficult to estimate, it is very likely that they were the 
same as the differences observed for expression.  An inspection of the gels shown in Figure 
4.8, gave little indication of changes due to increased expression of the variant proteins.   
Overall, the changes in the expression and solubility of GUS-WT and GUS-TR3337 
variants were minimal and certainly not enough to account for the differences observed 
changes in the levels of activity.  Analysis of the kinetic properties and stability of these 
purified variants revealed the more significant effects from this collection of mutations.   
Table 4.7 Expression of GUS-WT and GUS-TR3337 variants   
Each variant is presented with the residues that vary between them: mutated residues are 
shaded.  The solubility refers to the proportion of GUS-WT and GUS-TR3337 variants that 
remains in the soluble fraction of cell lysate and was determined by densitometry of the 
images in Figure 4.11. (a) GUS-WT variants (b) GUS-TR3337 variants 
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GUS-WT A E D Y T M S K P 62 
WT1P17G2 A E D Y A M S K P 65 
WT3P24E11 A E D Y A M S Q Q 67 
WT4P26F8 A E D Y A V S Q Q 69 
WT5P26A7 E D G N A M P Q Q 67 
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Solubility (%) 
GUS-TR3337 Q T Q S S L S K 69 
THERMO1P6B9 Q T Q S P L S K 68 
THERMO2P23C4 K T Q S P S S K 66 
THERMO3P24F7 Q T Q N S L N E 66 
THERMO4P11F2 Q M K N S L N E 66 
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(a) 
GUS-WT variants  GUS-TR3337 variants 
                            1           2         3         4          5      M        6           7        8          9        10 
 
(b) 
GUS-WT variants  GUS-TR3337 variants 
                         1          2         3          4         5        M        6         7          8          9         10 
 
Figure 4.8 SDS-PAGE analysis of GUS-WT and GUS-TR3337 variants expression   
During the preparation of GUS-WT and GUS-TR3337 variants, samples were taken of the cell 
lysate, supernatant and pellet and analysed by SDS-PAGE.  The samples were analysed on 
three 12% gels run simultaneously.  The prominent band in supernatant and pellet proteins is 
GUS (labeled on the right side of gel images).  Lane 1: GUS-WT; 2: WT1P17G2; 3: WT3P24E11; 
4: WT4P26F8; 5: WT5P26A7; M: Protein marker; 6: GUS-TR3337; 7: THERMO1P6B9; 8: 
THERMO2P23C4; 9: THERMO3P24F7; 10: THERMO4P11F2 (a) Results for supernatant samples. 
(b) Results for pellet samples. 
4.4.2. Kinetics characterisation of GUS-WT and GUS-TR3337 variants 
GUS-WT and GUS-TR3337 variants were characterised against pNP-glucuronide and pNP-
glucoside and the kinetic parameters can be found in Table 4.8.  A casual inspection of Table 
4.8 reveals a few trends.  The glucuronidase activity of both sets of mutants decreases during 
the evolution.  The change is principally caused by a drop in the kcat of the enzymes while there 
is little change in the Km.  All the variants had higher activities towards pNP-glucoside when 
compared with their parent enzymes.  The increases in activities were evident in the kcat/Km 
values that ranged from 7 to 1299-fold, and were primarily due to reductions in Km values.  It 
was expected that improved variants would show lower Km values as the screening was 
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performed at a significantly lower substrate concentration, 1 mM, than the observed Km of 
GUS-WT (44 mM) and GUS-TR3337 (40 mM).  As observed in nature, the Km of the variant 
enzymes evolved to the point where the Km was close to the substrate concentration in their 
environment.  In addition to decreases in Km value, the variants showed modest enhancement 
in kcat but GUS-TR3337 variants had greater kcat values than GUS-WT mutants when compared 
to their respective parent enzymes.   
Table 4.8 Kinetic parameters for the hydrolysis of pNP-glucuronide and pNP-glucoside by 
selected mutants 
Substrate Variant kcat (s
-1
) Km (mM) kcat/Km (M
-1
s
-1
) Relative kcat/Km 
pNP-glucuronide GUS-WT 93.09 ± 4.0900 0.17 ± 0.0018 540256.69 1.0000 
 WT1P17G2 70.14 ± 1.1824 0.15 ± 0.0134 465439.85 0.9000 
 WT3P24E11 1.29 ± 0.0256 0.19 ± 0.0166 7203.20 0.0130 
 WT4P26F8 0.53 ± 0.0071  0.59 ± 0.0405 897.94 0.0017 
 WT5P26A7 0.39 ± 0.0060 0.14 ± 0.0101 2852.49 0.0053 
 
 GUS-TR3337 14.25 ± 0.1798 0.81 ± 0.0402 17608.21 1.0000 
 THERMO2P23C4 17.63 ± 0.3465 1.77 ± 0.1131 9968.59 0.5661 
 THERMO3P24F7 1.06 ± 0.0402 0.90 ± 0.1293 1170.91 0.0665 
 THERMO4P11F2 0.22 ± 0.0062 0.30 ± 0.0734 373.78 0.0212 
 
pNP-glucoside GUS-WT 0.136 ± 0.0040 43.52 ± 2.3900 3.14 1.0000 
 WT1P17G2 0.177 ± 0.0030 40.69 ± 2.5100 4.35 1.3853 
 WT3P24E11 0.183 ± 0.0020 0.33 ± 0.0230 547.90 174.8000 
 WT4P26F8 0.453 ± 0.0140 0.96 ± 0.0210 470.96 150.2000 
 WT5P26A7 0.751 ± 0.0070 0.78 ± 0.0430 962.61 307.1000 
 
 GUS-TR3337 0.049 ± 0.0008 40.38 ± 1.2700 1.22 1.0000 
 THERMO1P6B9 0.39 ± 0.0090 48.53 ± 1.9600 8.04 6.6000 
 THERMO2P23C4 0.724 ± 0.0100 24.74 ± 0.7600 29.27 24.1000 
 THERMO3P24F7 0.314 ± 0.0060 0.43 ± 0.0620 723.88 595.3000 
 THERMO4P11F2 0.89 ± 0.0100 0.56 ± 0.0430 1579.38 1298.8000 
It should be noted that the kinetic constants for glucosidase activity were assayed in 
the present of 5 mM octyl-β-D-thioglucoside (this will be discussed in further detail in Chapter 
5).  The K568Q and P597P mutations in WT3P24E11 further increased affinity to the pNP-
glucoside substrate, judging from the lower Km value; but accounted for the significantly 
reduced kcat  of pNP-glucuronide substrate.  The kcat value of S557P in THERMO1P6B9 increased 
6.6-fold, suggesting the significant influence of this mutation on the enzyme activity in 
substrate binding and product release.  The M516V mutation in WT4P26F8 caused a slight 
decrease in glucosidase activity.  This reflects the increased catalytic activity in the isolated 
clone during the screening process is mainly due to increased protein solubility and that the 
enzymatic properties of WT4P26F8 were not significantly altered. 
Overall, the best variant, THERMO4P11F2, was obtained from GUS-TR3337 library and 
exhibited 1.6-fold greater kcat/Km than WT5P26A7, which was the best variant from the GUS-
WT library (Figure 4.9).   
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Figure 4.9 Glucosidase specificity constant of GUS-WT and GUS-TR3337 variants through the 
progress of directed evolution 
4.4.3. Optimal catalytic temperature 
The temperature optima extracted for GUS-WT and GUS-TR3337 variants are displayed 
graphically in Figure 4.10c.  This figure showed the optimal activities for the starting enzymes 
and those of the variants with the greatest change from each generation.  The trend in the 
changes in the optimal temperatures is easily seen in Figure 4.10.  A more complete display of 
all the variants is given in Appendix C.1.  The results from assays with 800 μM pNP-glucoside at 
pH 7.4 from 25˚C to 85 ˚C revealed that the optimal temperatures of glucosidase activity were 
different, being 45 ˚C and 60 ˚C for GUS-WT and GUS-TR3337, respectively.  In GUS-WT library, 
the variants from generation 1-4 have an optimal temperature of 45 ˚C and 50 ˚C but the 
variant from generation 5, WT5P26A7, has increased optima at 55 ˚C.  In GUS-TR3337 library, 
compared to the thermophilic parent, a shift of the optimal temperature for the variant from 
generation 4, from 60 ˚C to 40 ˚C, was observed.  The directed evolution was carried out at 25 
˚C and therefore variants isolated from the screening process tend to perform better at a 
lower temperature.  Furthermore, the optimal temperature range gradually becomes wider 
with later generation of directed evolution (Figure 4.10a & b).  The variant from generation 4 
(THERMOP11F4) displays a wide optimal temperature range between 35 ˚C to 55 ˚C.  The 
mutations T480M and Q498K seem to be important residues that enhance glucosidase activity 
at lower temperatures and thus sustain a wider operating temperate range.  
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(a)                                                                                  (b) 
 
(c) 
 
Figure 4.10 Optimal temperature with 800 μM pNP-glucoside 
The relative activity for each version of GUS in the presence of 800 μM at pH 7.4 was 
determined for each GUS variant at a series of temperatures.  (a) GUS-WT and WT5P26A7 (b) 
GUS-TR3337 and THERMO4P11F2 (c) GUS-WT and GUS-TR3337 variants 
It was widely accepted that thermostable enzymes tend to display greater 
conformational rigidity (Vieille & Zeikus 2001).  However, protein function depends on both 
structure and dynamics; making a protein more stable by rigidifying it does not necessarily 
lead to enhanced functionality as proteins require optimized flexibility to perform their 
biological roles (Teilum et al. 2011).  This explains why thermostable enzymes generally 
function optimally at a higher temperature.  At that temperature, the enzymes have increased 
thermal motion so that they are flexible enough to show full activity.  Even though it has been 
proposed that both proteins exhibit the same flexibility when compared at their respective 
optimal working temperature (Wolf-Watz et al. 2004), the glucuronidase activity of GUS-WT at 
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its optimum temperature (45 °C) was 1.6-fold higher than the activity of GUS-TR3337 at 60 °C 
(Figure 4.11a).  In contrast, GUS-TR3337 has a higher glucuronidase activity at its optimal 
temperature compare to GUS-WT which might be mainly due to the presence of T509A 
mutations that conferred the glucosidase activity (Figure 4.11b).  At the screening temperature 
(25 °C), GUS-WT displayed 8% higher glucosidase activity relative to GUS-TR3337.  Even so, the 
fourth generation variant derived from thermophilic parent, THERMO4P11F2, showed higher 
glucosidase activity compared to that of fifth generation variant, WT5P26A7, that was derived 
from the wild-type library.  Furthermore, it was evident from figure 4.11b that 
THERMO4P11F2 was active at the broad temperature range of 35 – 55 °C compared to 
WT5P26A7 that was active at 45 – 55 °C.  Kinetic parameters in Table 4.8 were carried out at 
25 °C.  Therefore, higher improvement rates can be expected when the kinetic analysis was 
carried out at their respective optimum temperature. 
(a)                                                                              (b)          
 
Figre 4.11 Temperature dependence of enzymatic activity  
(a) Glucuronidase activities were expressed as relative to that of the highest activity in GUS-
WT (b) Glucosidase activities of GUS-TR3337 and THERMO4P11F2 were expressed as relative 
to that of the highest activity in GUS-WT (right y-axis) and WT5P26A7 (left y-axis), respectively.  
4.4.4. Thermal and chemical stability 
The measurement of protein stability involves disrupting the protein stucture by either 
physical or chemical means.  Temperature is one of the most widely used physical 
denaturation tools while urea and guanidine hydrochloride (GdnHCl) are the two most 
common chemical denaturants (Privalov & Khechinashvili 1974). 
4.4.4.1. Thermal denaturation 
Thermal stability was determined in two ways. The first involved monitoring the deterioration 
of the activity by measuring residual activity after heat treatment while the second involved 
the use of the fluorophore SYPRO orange to monitor the overall unfolding of the enzymes.  In 
the first set of experiments, the loss of residual activity reflects a deterioration of the active 
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site whereas the second set of experiments gives a picture of overall changes in the protein 
structures. The experimental details for these experiments can be found in Chapter 2 (Section 
2.3.4.3. and 2.3.4.4.) and the results are given below in Figure 4.12.  The inflection points in 
the curves for the residues activity as a function of temperature were 45.2 ± 0.02 °C and 74.7 ± 
1.2 °C for the GUS-WT and GUS-TR3337 enzymes, respectively.  In the GUS-WT directed 
evolution, variants with the mutations at 509 had an increase in T1/2 of 14 ˚C.  However, in 
GUS-TR3337 library the variant from generation 2 had a decrease in T1/2 of 4 ˚C, whereas 
variants from generation 3 and 4 had an additional decline of 11-12 ˚C.  The total decrease in 
T1/2 for the variant from generation 4, compared to the thermophilic parent, was 16 ˚C.  Even 
though this variant had a lower optimal temperature (40 ˚C) compared to the variant from 
generation 3 (50 ˚C), the presence of the two mutations at 480 and 498 did not decrease its 
T1/2.   
When measured using the increase in fluorescence caused by binding of SYPRO orange 
to expose hydrophobic upon protein denaturation, similar trends were observed in both 
libraries.  The melting temperatures of the same sample differed since the two methods used 
to determine stability measured slightly different unfolding events.  The SPYRO orange method 
gave slightly higher melting temperatures, as it monitors the overall structural stabilities 
during 1 minute of unfolding; while the residual activities gave lower melting temperatures, as 
it monitors the conformational stability of the active site during 5 minute of elevated 
temperatures.   
The melting temperature of GUS-TR3337* decreases from the first generation to the 
fifth generation, however, the melting temperature of THERMO4P11F2 as determined by the 
individual residual activity plot was 2.4°C higher than WT5P26A7 while the value obtained with 
fluorescence monitored thermal denaturation was 5.4 °C higher than WT5P26A7. 
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(a)                                                                                 (b) 
 
(c)                                                                                  (d) 
 
(e)                                                                                  
 
Figure 4.12 Thermal denaturation 
(a) Residual activity plot of GUS-WT variants (b) Residual activity plot of GUS-TR3337 variants 
(c) Change in SYPRO orange fluorescence in GUS-WT variants (d) Change in SYPRO orange 
fluorescence in GUS-TR3337 (e) Corresponding melting temperatures of GUS-WT and GUS-
TR4447 variants, extracted from the residual activity and SYPRO orange fluorescence data. 
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4.4.4.2. Chemical induced denaturation 
The effects of chemical denaturants on GUS-WT, GUS-TR3337 and their variants were also 
measured.  The chemical denaturants were those typically used to study denaturation; they 
were urea and guanidinium hydrochloride (GdnHCl).  The residual activity in the presence of 
denaturants was used to determine if the active site was intact.  In addition, intrinsic 
fluorescence emission spectra were used; this technique gave information about the 
environment of the tryptophan (Trp) residues that gave rise to the intrinsic fluorescence.  
Spectra were recorded from 300 to 380 nm; the red shift of the intrinsic Trp fluorescence 
emission maximum (λmax) was monitored as a function of urea and GdnHCl concentrations. 
The experimental details for these experiments can be found in Chapter 2 (Section 2.3.4.10.).  
A sample of the results a given in the Figure 4.13 and 4.14 below.  It was difficult to discern a 
trend when the data of GUS-WT and its variants were superimposed, so only GUS-WT and the 
relevant variant are shown in the figures below; similar plots are given with all the sets in 
Appendix C.2. and C.3.  Similar comments apply to the measurements with GUS-TR3337 and its 
variants.   
(a)                                                                                   (b) 
 
(c)                                                                                 (d) 
  
Figure 4.13 Chemical induced unfolding is shown by changes in λmax 
(a) Urea induced unfolding in GUS-WT* (b) Urea induced unfolding in GUS-TR3337* (c) GdnHCl 
induced in GUS-WT* (d) GdnHCl induced in GUS-TR3337. 
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(a)                                                                                  (b) 
 
(c)                                                                                    (d) 
 
Figure 4.14 Impact of the presence of different concentrations of urea and GdnHCl on the 
glucosidase activity of β-GUS variants 
 With 4 M urea and 1 M GdnHCl, the λmax of GUS-WT was shifted to 348 nm and 341 
nm, respectively, indicating the complete unfolding of the protein (Figure 4.13a & c).  In 
contrast, the fluorescence emission spectra of GUS-TR3337 showed no significant change in 
λmax up to 4.5 M urea and 1.75 M GdnHCl, implying that urea concentrations as high as 4.5 M 
and GdnHCl concentrations as high as 1.75 M do not significantly unfold GUS-TR3337 (Figure 
4.13b & d).  These observations are well supported by the effect of urea upon the catalytic 
activity of GUS-WT and GUS-TR3337.  As presented in Figure 4.14, glucosidase activity of GUS-
WT was completely lost in 3.5 M urea and 1.25 M GdnHCl while GUS-TR3337 was only 50% 
inactivated under the same conditions. 
With increasing urea and GdnHCl concentrations the λmax of GUS-WT variants and 
GUS-TR3337 variants were red-shifted and their glucosidase activities were observed to be 
decreased gradually.  GUS-WT variants had a similar intrinsic fluorescence emission spectrum 
and behaviour in the presence of chemical denaturants, compared to GUS-WT.  Notably, the 
variant WT1P17G2 showed the highest tolerance to GdnHCl and urea, suggesting the T509A 
increased stability toward chemical denaturation (Figure 4.14a & c).  The stability of the 
enzyme was first increased, creating the capacity to accept the functionally necessary 
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destabilizing mutations in later generations.  In GUS-TR3337 library, the gradual increase in 
glucosidase activity with each generation was accompanied by decreases in stability.  This was 
expected as stability was not included as a fitness parameter in the screening assay.  Another 
explanation for this trade-off was that during evolution, enzymes adjust the strength and 
number of stabilizing interactions to optimize the balance between rigidity for stability and 
flexibility for activity at the selection temperature (Fontana et al. 1998).  The K474Q and S561L 
mutations in THERMO2P23C4 reduce the stability.  This observation was consistent with the 
observation that the λmax of THERMO2P23C4 red-shifted to 352 nm as the urea concentration 
was increased to 5.5 M, indicating exposure of Trp residues upon complete unfolding 
(Subbarao & MacDonald 1994), while at the same urea concentration the λmax of GUS-TR3337 
and THERMO1P6B9 only appeared at 334 nm suggesting only a slight relaxation of enzyme 
structure.  In addition, the THERMO2P23C4 mutant lost only 85% of its initial activity in the 
presence of 3.5 M urea (Figure 4.14b) while the GUS-TR3337 retained approximately 43% 
activity in the same concentration of urea. 
 Overall, GUS-TR3337 variants were more stable than GUS-WT variants.  The λmax of 
WT5P26A7 was red-shifted to 350 nm at 2 M GdnHCl and 5 M urea whereas λmax of 
THERMO4P11F2 red-shifted to 350 nm at 2.5 M GdnHCl and 5.5 M urea (Figure 4.15a).  In 
addition, THERMO4P11F2 had a relative activity that was 10% higher than WT5P26A7 at 0.5 M 
GdnHCl and urea concentration ranging from 1.0 to 2.5 M (Figure 4.15b).  
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(a) 
 
(b) 
 
Figure 4.15 Intrinsic fluorescence spectra (line, left y-axis) and relative glucosidase activities 
(histogram, right y-axis) of GUS-WT, WT5P26A7, GUS-TR3337 and THERMO4P11F2 in the 
presence of different concentrations of chemical denaturants 
(a) GdnHCl (b) Urea. 
4.4.5. Summary of observations 
The variants obtained with directed evolution were studied to monitor the changes 
responsible for increased activity and to determine the changes in kinetic parameters that 
gave rise to increased activity.  The results of these experiments are summarized in the Table 
4.9 below.  The level of expression and the solubility of variant proteins was found to be close 
to that of the starting proteins; these factors did not have an effect on activity, as observed in 
crude lysates.  This investigation also looked at the kinetic parameters and stability; two 
factors that are often linked for proteins.  The kinetic properties were as expected; drops in 
the Km values were observed.  There were clear trends in the experiments in which stability 
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was measured as a function of temperature.  The variants that evolved from GUS-WT showed 
small increases in stabilities as the evolution proceeded. The opposite trend was observed 
with variants that were evolved from the GUS-TR3337 protein.  However, the magnitudes of 
the changes in the melting temperatures were far greater for the variants that evolved from 
GUS-TR3337 compared with those that evolved from GUS-WT.  The result obtained with the 
chemical denaturants followed a similar trend to those obtained with variations in 
temperature.   
Table 4.9 Comparison of GUS-WT and GUS-TR3337 variants over all traits 
The eight versions of GUS-WT and GUS-TR3337 are presented with the mutations in primary 
sequence indicated.  The GUS-WT and GUS-TR3337 versions have been ranked for each trait, 
with the best denoted as 1.  Shading has been used to highlight the significant differences. 
ND – Not determined 
4.5. Mutation location and effect 
At the time of writing the structure of GUS-WT had been reported (Wallace et al. 2010).  
Attempts to reproduce the GUS-WT crystals were made without success.  In addition, crystal 
screens were employed to identify new crystal forms – again without success.  The inability to 
reproduce published crystallisation procedures has been encountered in the Ollis laboratory 
on previous occasions and has been attributed to a lack of detail in the published experimental 
conditions.  A few mutant forms of both the GUS-WT and GUS-TR3337 were tested with 
commercial crystallisation screens – again without success.  Details of these experiments will 
be given in Chapter 5 Section 5.4.    
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WT5P26A7 E D G N Q T Q Q A M M N P G L N Q Q 2852 963 57 25 
GUS-TR3337 A E D Y Q T R Q A M T S S S L S K P 17608 1 75 76 
THERMO1P6B9 A E D Y Q T R Q A M T S P S L N K P ND 8 ND 57 
THERMO2P23C4 A E D Y K T R Q A M T S P S S S K P 9969 29 71 41 
THERMO3P24F7 A E D Y Q T R Q A M T N S S L N E P 1171 724 61 36 
THERMO4P11F2 A E D Y Q M R K A M T N S S L N E P 374 1579 59 34 
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The effects of mutations have been interpreted in terms of the native β-GUS structure.  
The effects of changes in sequence on the structure were not known.  In other studies, the 
effects of changes produce by directed evolution have been found to be relatively modest 
(Porter et al. 2015, Hawwa et al. 2009).  However, the possibility that structural change may 
occur must be considered when interpreting the effects of sequence changes.  The initial 
location of a mutated residue can be found in the native structure and in many cases this can 
reveal useful information and provide a basis for speculation of possible structural changes.  
However, given the scattered distribution of mutations throughout the protein, the specific 
role of every mutation cannot be assessed absolute confidence.  Only the location of 
important mutations within the best mutants isolated from GUS-WT (WT5P26A7) and GUS-
TR3337 (THERMO4P11F2) libraries, will be discussed in the following section.  This preliminary 
analysis has led to several hypotheses relating to residues responsible for the activity and 
stability. 
4.5.1. WT5P26A7 variant 
An attempt was made to understand the effects of changes on the activity of the variant 
proteins.  Apart from the location of the changes in the native structure, it was thought that 
some insight could be obtained from the calculated values of the solvent accessible surface 
area (SASA).  Figure 4.16 shows the SASA calculated for the residues in the GUS-WT structure.  
The residues that were changed in the five rounds of directed evolution are shown on this 
figure.  The SASA values for the changed residues are also given in Table 4.10 as in the % of the 
SASA found for that type of residue in a Gly-X-Gly tripeptide (Miller et al. 1987, Lee & Richards 
1971). 
 
 
                                                                                                
 
Figure 4.16 Predicted relative SASA of mutation sites in WT5P26A7 
Out of 8 mutations in WT5P26A7, 4 residues (E279, Y469, S557 and Q597 – as in the 
native sequence) are partially exposed to solvent and 4 residues (A64, D350, T509 and K568) 
   Domain I                      Domain II                                          Domain III 
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are buried (Table 4.10).  Of these, T509A, S557P and K568Q are in the active site (Figure 4.17) 
and were found in the early round of evolution while A64E, E279D, D350G and Y469N changes 
were found in the fourth or fifth generation variants.  The change at position 597 did not occur 
in isolation (it only occurs with other changes) so that its effects are difficult to predict. 
Table 4.10 Predicted SASA and their relative values of mutation sites in WT5P26A7 
Residue SASA (Å2) Relative (%) 
A64 11.44 9.5 
E279 43.93 23.3 
D350 0.00 0.0 
Y469 67.93 28.1 
T509 0.46 0.3 
S557 27.17 21.2 
K568 1.29 0.6 
Q597 20.31 13.1 
(a) 
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(b) 
 
Figure 4.17 Mutation locations of WT5P26A7 
The crystal structure of the GUS tetramer (Wallace et al. 2010) is illustrated at the top.  One 
monomer is drawn (a) with each mutation site labelled: 1; A64, 2; E279, 3; D350, 4; Y469, 5; 
T509, 6; S557, 7; K568, 8; P597.  The GDL molecule is shown in red.  This diagram is also shown 
viewed from the right side (b). 
Y469 is one of three tyrosine residues (Y472 and Y468) that occluded the entrance of 
the active site pocket (Wallace et al. 2010). The change brought about by the Y469N mutation 
could widen the substrate entrance and facilitate easier access to the active site (Figure 4.18).   
(a)                                                                                    (b) 
 
Figure 4.18 Surface model of the active sites of GUS-WT and WT5P26A7 
The surface of WT5P26A7 was calculated using Swiss PDB viewer.  The GDL is overlaid in both 
structures to show the entrance of the active site.  The residue Y469 and N469 are labelled. (a) 
GUS-WT (b) WT5P26A7. 
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In the GDL (an established low-affinity inhibitor)-bound wild-type crystal structure, the 
negatively charged C-6 carboxylate group of GDL was shown to interact with the positively 
charged residue K568, suggesting that K568 was involved in substrate recognition and binding 
(Matsumura & Ellington 2001).  This is consistent with the results obtained in the present 
study since K568Q change gave a kcat/Km for pNP-glucoside that was increased 223-fold while 
activity with pNP-glucuronide was reduced 65-fold.  The replacement of lysine 568 with an 
uncharged with a polar amino acid glutamine, allowing glucose to be better accommodated in 
the active site (Figure 4.19b).  In addition, this lysine was also thought to be important for the 
quaternary structure of the protein (Matsumura et al. 1999).  Mutations to the residue 568 
have already been shown in experiments by Matsumura et al. (2001) to be deleterious to 
enzyme function in isolation.  As a result, this change was only found in variants with the 
T509A mutation, whereby T509A introduced stability into the protein to compensate for loss 
of stability brought about by changes at position 568.  The T1/2 of WT1P17G2 was 14 °C higher 
compared with the parent.  In addition, WT1P17G2 retained 27% of its activity in 3 M urea 
while all selected variants from the GUS-WT library lost virtually all of their activities when 
measured under the same conditions.  These observations can explain why the change of 
residue 568 was found in GUS-TR3337.  It was suggested that alanine residues are the best 
helix-forming residues (Argos et al. 1979).  Facchiano et al. (1999) observed that helices of 
thermophilic proteins were generally more stable than those of mesophilic proteins.  In our 
studies, the T509A mutation occurred in the first round of directed evolution while K568Q 
mutation was only identified later in the third round.  Apart from providing higher stability, 
T509A was also the key residue involved in enhanced glucosidase activity.  The two mobile 
loops (green and blue in Figure 4.19) above the active site, are connected through hydrogen 
bonds between T509, Q526, K567, K568 and K578.  However, the hydrogen-bonding 
interactions between the hydroxyl group of T509 and residues K567, K578 and Q526 were lost 
upon T509A mutation, thus adding to the mobility of the active-site loops.   
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(a)                                                                              (b) 
 
Figure 4.19 Connectivity between the loop (blue) bearing residues 557, 567, 568 and 578; 
and loop bearing residues 509 and 526 in WT5P26A7 and wild-type β-GUS 
GDL is presented in red.  The two loops (green and blue) are interconnected via T509.  Atoms 
capable of hydrogen bonding are connected by yellow dash lines and intermolecular bonding 
distances are all less than 3 Å.  (a) The environment around active-site loops is displayed from 
the crystal structure by Wallace et al. (2010) (b) The mutations were modelled with SWISS-
MODEL using GUS-WT (PDB ID: 3K4D) as template. 
The S557P change of a serine to a proline is unusual.  Proline is unique amongst the 
amino acids in being cyclic.  As a result, this amino acid can change the direction of the 
backbone.  The introduction of the cyclic structure of proline forces a directional change to the 
loop.  This change affects the local shape of the binding pocket and changes the hydrogen 
bonding ability.  This change is most likely to affect the binding of the new substrate. 
4.5.2. THERMO4P11F2 variant 
This variant had five amino acid substitutions.  S550, S566 and K568 were at least partially 
solvent accessible and two sites – T480 and Q498 – had less than 10% relative SASA (Figure 
4.20) (Table 4.11).  These were plotted onto the crystal structure of GUS to determine their 
position relative to the active site and other mutation sites (Figure 4.21).   
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Figure 4.20 Relative SASA of mutation sites in THERMO4P11F2 
Table 4.11 Predicted SASA and their relative values of mutation sites in THERMO4P11F2 
Residue SASA (Å2) Relative (%) 
T480 48.38 34.9 
Q498 21.23 11.4 
N550 1.69 0.01 
N566 2.44 0.02 
K568 1.29 0.01 
 
Figure 4.21 Mutation locations of THERMO4P11F2 
The mutated residues have been colored blue to highlight their position relative to other 
mutations.  Each mutation site labelled: 1; T480, 2; Q498, 3; N550, 4; N566, 5; K568.  GDL is 
presented in red.   
The two mutations on the THERMO4P11F2 surface (Q498K and T480M), displayed 
about a 2-fold higher kcat/Km as compared to THERMO3P24F7, which does not include these 
4 
1 
2 
3 5 
GDL 
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two mutations.  T480 was at the interface with another monomer – well removed from the 
active site.  However, substituting it with methionine could involve in stabilizing the 
quaternary structure of the enzyme by independently increasing the affinity between the 
subunits.  
Two key amino acids (S550 and S566) that conferred thermostability in GUS-TR3337 
had reverted to wild type amino acids (N550 and N566).  These two reversions accompany a 
significant decrease in T1/2 of ~10 °C.  N566 was known to be essential for the substrate 
binding due to the hydrogen bond with the C4 OH of GDL (Figure 4.22).  In the predicted GUS-
TR3337 structure, the hydroxyl side chain of S550 is hydrogen-bonded to the backbone of 
F551 and the hydrogen of G294, the backbone of S550 is hydrogen-bonded to the backbones 
of I570 and K568 (Figure 4.23a).  The hydrogen bonds of G294, F551 and K567 with S550 are 
eradicated upon mutation of S550 to asparagine, resulting in a significant increase in mobility 
of the residues adjacent to 568 (Figure 4.23b).  As discuss earlier, K568 was thought to be 
important for the substrate specificity as its positive charge resulted in an interaction with the 
negatively charged C6 carboxylate of pNP-glucuronide when bound to the enzyme.  As a result, 
point mutations of K568 either by a change to glutamine as in WT5P26A7 or to a glutamic acid 
as in THERMO4P11F2 leads to an enzyme with higher glucosidase activity. 
 
Figure 4.22 Residue 566 and GDL 
S566 in GUS-TR3337, N566 in THERMO4P11F2 and the environment around these residues are 
shown in green, blue and magenta, respectively.  They were modelled with SWISS-MODEL 
using GUS-WT as template.  The GDL is presented in red.  Atoms capable of hydrogen bonding 
are connected by yellow dashes. 
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(a)                                                                       (b) 
    
Figure 4.23 Hydrogen bonding network of residue 550 
(a) The hydroxyl functionality of K568 in the predicted GUS-TR3337 structure is hydrogen 
bonded to the side chain of G294 and the backbone of F551, the backbone of S550 is hydrogen 
bonded to the backbone of I570 and K568  (b) Upon S550N mutation, the hydrogen bonding 
network illustrated in (a), except the hydrogen bond between S550 and I570, is eradicated.  
This results in increasing the flexibility of the loop where residue E568 resides. 
4.6. Summary 
Directed evolution was used to explore in some detail the relationship between evolvability 
and stability.  This technique was applied to a native as well as a previously stabilized variant of 
GUS.  It was found that evolution of the native protein towards a non-physiological substrate 
(i.e. increased glucosidase activity) resulted in changes that increase stability as well as 
activity.  That is, increased stability was most easily achieved by mutations stabilized the 
overall protein structure so that destabilizing active site mutations could be made to increase 
activity.  Conversely, the same experimental conditions resulted in a drop in the overall 
stability of the variant that initially had been evolved to increase stability.  These results are 
consistent with those obtained by other workers who worked with different proteins.  To the 
author’s knowledge the present study is unique in that it monitored the evolution of similar 
proteins with different stabilities.  
It should be noted that the activity of GUS-WT and GUS-TR3337 towards the 
glucosides had a very elevated Km values – that is, substrate binding was poor in both cases.  
Evolution was carried out by monitoring changes in activity at concentrations well below these 
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F551 I570 I570 
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Km values.  As expected, most of the shift in the activity of the variant enzymes was achieved 
by decreases in the Km values of the enzymes.  These brought about significant increases in 
activity as reflected in greatly increased values in kcat/Km, i.e. WT3P24E11 and THERMO3P24F7.  
Had more cycles of evolution been carried out, an increase in kcat would be expected. As 
expected and as has been noted by others (Smith et al. 2011, Rowe et al. 2003, Geddie et al. 
2004), the activity of GUS towards its physiological substrate decreased as activity towards the 
non-physiological substrate increased.  
The best variant derived from the GUS-WT library was the WT5P26A7 variant that 
encompassed eight mutations – A64E, D279E, D350G, Y469N, T509A, S557P, K568Q and 
P597Q whereas the best variant derived from the GUS-TR3337 library was the THERMO4P11F2 
variant that encompassed five mutations - T480M, Q498K, S550N, S566N and K568E.  
WT5P26A7 and THERMO4P11F2 had 307-fold and 1300-fold catalytic efficiency (kcat/Km) 
improvement towards β-glucoside, respectively.  The fourth-generation mutant from the GUS-
TR3337 library, THERMO4P11F2, displayed about 1.6-fold greater kcat/Km than the fifth 
generation mutant from the GUS-WT library, WTP26A7.  Furthermore, GUS-TR3337 also 
showed greater tolerance for amino acid substitution than GUS-WT as mutants from the GUS-
TR3337 library exhibited 10% more missense mutations.  A higher level of mutational 
tolerance could afford a higher error-rate in libraries.  It could also increase the chance of 
finding synergistic beneficial mutations that would not be identified individually.   
 Apart from significant changes to glucosidase activity, GUS-TR3337 variants were 
found to exhibit higher stabilities both thermally and chemically compared to WT5P26A7: a 2 
°C increase in melting temperature was observed while the difference in denaturing urea 
concentration was 0.5 M in favour of THERMO4P11F2.  In addition, the range of temperatures 
at which THERMO4P11F2 was active was broader than those of WT5P26A7; THERMO4P11F2 
retained over 80% of relative activity in the range from 35 – 55 °C as opposed to the range 
from 45 – 55 °C for WT5P26A7.   
 Although the directed evolution approach was successfully used to enhance the 
glucosidase activity of GUS, the activity levels of purified proteins were significantly lower than 
those of cell lysate.  The following chapter presents a series of experiments to investigate the 
factor behind their loss of enzyme activity.  The kinetic parameters of glucosidase activities 
presented in this chapter, are described in more detail in Chapter 5. 
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Chapter 5 
Kinetic Analysis of GUS-WT and GUS-
TR3337 Variants in Directed Evolution 
5.1. Introduction 
The previous chapter described directed evolution experiments that resulted in β-GUS variants 
that had enhanced glucosidase activity.  However, the “enhanced activity” was obtained with 
crude lysates of cells expressing β-GUS and was not observed with purified enzymes.  In fact, 
the activity of later generation variants was like that of the native protein.  It appeared that 
the changes brought about by evolution did not increase the catalytic properties of the 
purified enzymes.   
Initially, it was thought that that the disparity between results obtained with crude 
lysates and purified protein was due to incorrect variants being selected.  That is the variants 
assayed in crude lysate were not those used to produce purified protein.  The variants genes 
were sequenced (again) to verify that the correct mutants had been selected – they were 
correct.   
Another possibility for the differences between the results obtained with crude lysate 
and purified protein was due to differences in protein concentration.  In other words, the 
protein evolved so that variants were expressed at higher concentrations.  That is, the 
enhanced activity of the variants was simply due to a more of the variant proteins being 
expressed.  As noted in the previous chapter, the expression of native and variant proteins was 
very similar and it could not account for the different levels of catalytic activity.  The results of 
these experiments can be found in Section 4.4.1. 
The effects of temperature were considered as a possible explanation for the above 
anomalies.  This was not thought likely, but it was also thought prudent to check.  It was found 
that the optimal activities of the eight selected variants and parent strains were above 40 °C 
(Chapter 4, Section 4.4.3.) while the activities were measured at 25 °C.  Thus, the assays were 
repeated at 45 °C (Figure 5.1b).  At this temperature, all the purified variants exhibited 
increased activities, but the increases were small compared with the increased activities 
obtained with crude lysates. 
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Some insight into the puzzling observations that are described above, was gained 
when it was realized that β-GUS had been evolved in the presence of a factor in the crude 
lysates: BugBusterTM, the reagent used to break open the cells to give the crude lysates.  This 
reagent was not used in the purification protocol.  It should be noted that the manufacturer of 
BugBusterTM reagent would not disclose the ingredients of the product and attempts to 
identify the chemical composition by mass spectrometry were not initially successful.  The 
reagent had an unknown composition.  It was a proprietary mixture of non-ionic detergents 
that the manufacturer said was “capable of cell wall perforation without denaturing soluble 
protein”.  Non-ionic detergents contain uncharged, hydrophilic head groups that consist of 
either polyoxyethylene moieties as in Tween, Triton, and the Brij series or glycosidic groups, 
i.e. octyl glucoside and dodecyl maltoside.  
This chapter describes early experiments in which purified forms of evolved GUS were 
compared with the similarly purified native enzyme.  The experiments showed that the 
BugBusterTM reagent was the cause of the anomalies in the directed evolution.  The 
identification of the probable component of BugBusterTM reagent, octyl-β-D-thioglucoside 
(OTG), that interacts with β-GUS is also described along with the characterisation of the native 
and mutant enzymes, in the presence and absence of this factor.  The chapter concludes with 
the implications of the directed evolution in the presence of OTG – that is the evolution of an 
activating factor.  
5.2. Loss of enzyme activity on purification 
A selection of mutants of GUS-WT and GUS-TR3337 were chosen for purification.  Mutants 
were chosen from the earlier rounds as well as the final round.  By choosing variants from 
each round some idea of the progress made with evolution could be obtained.  In most cases 
these variants had the highest activity for their generation.  These variants along with GUS-WT 
and GUS-TR3337 were expressed and crude lysates used to measure their activities (Figure 
5.1a).  The results were as expected in that the activities increased as evolution proceeded.  
These native and variant proteins were then purified, as described in Chapter 2 (section 
2.3.3.1.) and their activities measured again (Figure 5.1b).  However, most of the GUS-WT and 
GUS-TR3337 variants displayed a dramatic loss of activities after purification, especially those 
in the later rounds of directed evolution (Figure 5.1b).  The trend in the loss of activity was 
particularly disturbing – later generations appeared to have less activity than earlier 
generations.  However, the expected trend in activity with the progress of evolution was 
obtained by the addition of BugBusterTM reagent to the purified protein (Figure 5.1c).   
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(a) 
 
(b) 
 
(c) 
 
Figure 5.1 Activity data of variants with 0.8 mM pNP-glucoside substrate under the default 
assay conditions of 50 mM phosphate buffer pH 7.4 at different temperatures 
(a) Activity of 100 μL GUS-WT* and GUS-TR3337* crude lysates at 25 °C (b) Activity of 60 nM 
purified GUS-WT* and GUS-TR3337* at 25 °C and 45 °C (c) Activity of 60 nM purified GUS-WT* 
and GUS-TR3337* in the presence of 0.05 X BugBusterTM reagent at 25 °C. 
5.3. Effects of 10 X BugBusterTM protein extraction reagent  
It appeared that anomalous behaviour of variant enzymes was due to the presence of 
BugBusterTM reagent.  In the screening procedure, the lysate was prepared with 1 X 
Crude lysate 
Purified protein 
Purified protein with BugBusterTM reagent 
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BugBusterTM reagent and assayed for hydrolysis of pNP-glucoside; a non-physiological 
substrate.  The question arose as to whether the enhanced activity stimulated by BugBusterTM 
reagent would also be observed with a glucuronide substrate, a physiological substrate?   
The influence of BugBusterTM reagent upon glucuronidase and glucosidase activities 
was monitored by assaying GUS-WT and WT3P24E11 in the presence of 1 X BugBusterTM 
reagent.  The results of these experiments are shown in Figure 5.2.  As can be seen in this 
figure, glucosidase activity of GUS-WT was inhibited by BugBusterTM reagent while that of 
WT3P24E11 was stimulated by a factor of about 10.  However, the glucuronide activities of 
GUS-WT and WT3P24E11 were inhibited.  At this point it seemed that directed evolution for 
increased glucosidase activity had resulted in variants with increased activity in the presence 
of BugBusterTM reagent.  It was clear that the presence of this reagent greatly affected the 
course of the evolution.  
 
Figure 5.2 Effect of BugBusterTM reagent on glucuronidase and glucosidase activity of GUS-
WT and WT3P24E11 
Activity was calculated as relative (%) considering control as 100%.  All assays were performed 
in triplicate.  The data points and error bars indicate the average values and standard errors. 
BugbusterTM is not the only reagent on the market that is used to break open cells.  It 
was thought that other commercial reagents probably contain similar ingredients.  A test was 
made of the B-PER  reagent with the results presented below in Figure 5.3.  It should be clear 
from this Figure that B-PER  reagent has a very similar effect to BugBusterTM reagent.  
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Figure 5.3 Effect of 0.5 X B-PER  and 0.5 X BugBusterTM reagentson glucosidase activity of 
GUS-WT and GUS-TR3337 variants 
The BugBusterTM reagent probably exerted its effect in the evolution experiments by 
binding to GUS-WT and GUS-TR3337.  If this were the case, then the activities of all the 
proteins would depend upon the concentration of BugBusterTM reagent.  To confirm that this 
was the case, the glucosidase activity of GUS-WT, evolved variants along with GUS-TR3337 and 
its evolved variants were measured with increasing concentrations of BugBusterTM reagent.  In 
these experiments the rate of hydrolysis of pNP-glucoside was used as the substrate.  For GUS-
WT variants, WT1P17G2, WT3P24E11, WT4P26F8 and WT5P26A7 were chosen; while for GUS-
TR3337 variants, THERMO1P6B9, THERMO2P23C4 THERMO3P24F7 and THERMO4P11F2 were 
chosen, these being either the best or close to the best within their generation.  The 
BugBusterTM reagent was titrated into the assay solution over the concentration range 0.005 
to 0.5 X.  The results of these experiments are shown below in Figures 5.4 & 5.5. 
An inspection of Figure 5.4 reveals that GUS-WT and the first generation variant are 
inhibited by the BugBusterTM reagent.  At the end of the titration, activity is only slightly above 
the error level of the assay.  The later generations (3, 4 and 5) of GUS-WT all show enhanced 
activity that saturates at quite low concentrations of the BugBusterTM reagent.  A similar trend 
is observed with GUS-TR3337 and its variants, except that this series of reactions includes a 
member of generation 2 – this enzyme appears to show very little effect due to BugBusterTM 
reagent (Figure 5.5).  Overall, the evolution firstly abolishes inhibition and then evolves so that 
the BugBusterTM reagent appears to enhance activity.  This way of describing these 
experiments is a little misleading.  The BugBusterTM reagent is not “enhancing” the activity of 
variants, rather evolution results in the enhancement of β-GUS-BugBuster complex activity.   
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(a)                                                                          (b) 
    
(c)                                                                                  (d) 
  
(e) 
  
Figure 5.4 Effect of BugBusterTM reagent on glucosidase activity of GUS-WT mutants 
Control activity refers to the activity of the individual enzyme in the absence of added 
BugBusterTM reagent (a) GUS-WT (b) WT1P17G2 (c) WT3P24E11 (d) WT4P26F8 (e) WT5P26A7. 
GUS-WT WT1P17G2 
WT3P24E11 WT4P26F8 
WT5P26A7 
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(a)                                                                          (b) 
   
(c)                                                                                   (d) 
   
(e) 
 
Figure 5.5 Effect of BugBusterTM reagent on glucosidase activity of GUS-TR3337 mutants 
Control activity refers to the activity of the individual enzyme in the absence of added 
BugBusterTM reagent (a) GUS-TR3337 (b) THERMO1P6B9 (c) THERMO2P23C4 (d) 
THERMO3P24F7 (e) THERMO4P11F2. 
To determine which components affect the glucosidase activity of β-GUS variants, it 
was decided that the effect of octyl-β-D-glucoside (OG), octyl-β-D-thioglucoside (OTG), Triton-
X-100 (TX100) and Tween 20 would be investigated.  Since the glucosidase activities of GUS-
WT and its variants as well those of GUS-TR3337 and its variants were completely inhibited by 
0.05% Tween 20 and 0.05% TX100 (data not shown), the effects of these two surfactants were 
not investigated further.  In addition to OG and OTG, it was also thought useful to examine the 
GUS-TR3337 THERMO1P6B9 
THERMO2P23C4 
THERMO3P24F7 
THERMO4P11F2 
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effects of sodium dodecyl sulphate (SDS) on the enzymes as it has some structure similarity to 
non-ionic detergents (Figure 5.6). 
(a)                                            (b)                                                  (c) 
   
Figure 5.6 Chemical structures 
(a) OG (b) OTG (c) SDS. 
5.3.1. Effect of SDS 
The results of the experiment with SDS are shown below in Figure 5.7.  Like BugBusterTM, SDS 
reagent inhibits the starting enzymes and early generation variants, but stimulates the activity 
of later generation variants.  These later generation variants showed approximately 3- to 4-
fold increased activity with 17.34 mM (0.5%) SDS but lost activity as the concentration was 
increased to 34.68 mM (1%) SDS.  However, the enhanced glucosidase activity of mutants in 
the presence of SDS, while significant, was much smaller than observed with BugBusterTM.   
 
Figure 5.7 Effect of SDS concentrations on the glucosidase activity of the GUS-WT and GUS-
TR3337 variants 
5.3.2. Effect of OG 
OG is one of the common examples of non-ionic detergents that is used for cell lysis.  The 
influence of OG upon the glucosidase activity was monitored by assaying the enzyme in the 
presence of increasing concentrations of OG as shown in Figure 5.8.  This Figure showed that 
1.2 mM OG inhibited the activity of WT-GUS, WT1P17G2, GUS-TR3337 as well as 
THERMO1P6B9 by about 50%.  In a similar manner to BugBusterTM reagent, the addition of OG 
up to a concentration of 5 mM resulted in increased glucosidase activity for WT3P24E11, 
[SDS] 
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WT4P26F8, WT5P26A7, THERMO3P24F7 and THERMO4P11F2.  Of these, the glucosidase 
activities of GUS-WT variants were greater than those of GUS-TR3337 variants.  Furthermore, 
these improvements in activities of variant enzymes due to OG were relatively modest 
compared with those observed with BugBusterTM. 
 
Figure 5.8 Glucosidase activity of GUS-WT and GUS-TR3337 mutants as a function of OG 
concentrations 
The activity was assayed in the presence of various OG concentrations.  The whole procedure 
was carried out at 25 °C. 
It should be noted that it is probable that OG is a potential substrate of GUS and that 
the inhibition of starting and early generation mutants may just be due to competitive 
inhibition.   
5.3.3. Effect of OTG 
The effects of OTG on glucosidase activity was tested and the results shown below in Figure 
5.9.  A similar activity pattern was observed with OG, 0.5 mM OTG inhibited glycosidase 
activity of GUS-WT, WT1P17G2 and GUS-TR3337 by about 70%.  However, maximum activity 
of WT3P24E11, WT4P26F8, WT5P26A7 and THERMO4P11F2 was achieved with the addition of 
at least 5 mM OTG.  These improvements in the glucosidase activities are very similar to the 
increases observed by the addition of BugBusterTM to later generation variants.  Therefore, it 
was concluded that OTG was a reasonable candidate for the component of BugBusterTM 
reagent that caused the major increase in glucosidase activity of later generation variants of 
GUS-WT and GUS-TR3337.  The presence of OTG in the BugBusterTM reagent was later 
confirmed by nuclear magnetic resonance spectroscopy and mass spectrometry (Appendix 
D.1.). 
[OG] 
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Figure 5.9 Effects of different OTG concentrations on GUS-WT and GUS-TR3337 mutants 
5.3.3.1. Inhibitory and activating effects of OTG 
At this stage it was clear that OTG bound to GUS-WT and GUS-TR3337 and inhibited the 
activity of these enzymes.  However, the nature of the inhibition was uncertain.  Given the 
structural similarity of OTG and pNP-glucoside, it was possible that OTG was a competitive 
inhibitor.  Consequently, OTG was tested for its mode of inhibition.  The inhibition constant (Ki) 
is the concentration of inhibitor required to reduce the rate to half of the uninhibited value.  
The higher the Ki value the weaker the inhibitor binds to the enzyme and vice versa.  The Ki 
variable is similar in concept to Km and gives an indication of the binding constant for the 
substrate binding to the enzyme.   
The Ki value was evaluated by using Microsoft Excel® (Chapter 2.3.4.10.).  The 
graphical analysis with the Lineweaver-Bulk and the consequent secondary plots are given 
below in Figures 5.10.  The figures 5.10b & f indicated that OTG binds to GUS-WT and GUS-
TR3337 and gives rise to competitive inhibition with a Ki value that could be described as weak 
(1 mM).  Competitive inhibition of OTG implies that OTG competes with a substrate (pNP-
glucoside used in this study) to bind to the active site of β-GUS.  The observed high Km values 
given in Chapter 4 (Section 4.4.2, Table 4.7) for GUS-WT, WT1P17G2, GUS-TR3337 and 
THERMO1P6B9 were determined in the presence of 5 mM OTG while their true Km values (i.e. 
with no OTG) are given in Table 5.1.  In the case of the WT1P17G2 variant; it was also inhibited 
by OTG, but it was with a Ki of 1.5 mM (Figure 5.10d).  It appears that the evolution has 
decreased the affinity between the enzyme and OTG – at least, as determined by completion 
studies with a simple substrate.  It was possible that OTG still bound to the variant enzymes via 
the long aliphatic chain and that this could give rise to the enhanced activity in later 
generation variants.  
[OTG] 
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(a) 
 
(b) 
  
(c)                                                                                  (d) 
  
(e)                                                                                   (f) 
 
Figure 5.10 OTG inhibition of GUS-WT, WT1P17G2 and GUS-TR3337 
(a) Double reciprocal Lineweaver-Burk plots of the GUS-WT kinetic assays for hydrolysis 
reaction of pNP-glucoside in the presence of different fixed concentrations of inhibitor 
compounds (b) the secondary plots with an abscissa intercept of -Ki (c) Lineweaver-Burk plots 
for WT1P17G2 (d) Secondary plots for WT1P17G2 (e) Lineweaver-Burk plots for GUS-TR3337 
(f) Secondary plots for GUS-TR3337. 
-Ki 
-Ki 
-Ki 
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By way of contrast with the plots shown above, the Michaelis-Menten plots for 
WT3P24E11, WT5P26A7 and THERMO4P11F2, shown below in Figure 5.11, indicate that there 
was no inhibition with OTG, but rather OTG acts as an activator.  While WT3P24E11 was 
maximally activated at above 10 mM OTG, lower concentrations of WT5P26A7 and 
THERMO4P11F2 achieved maximum activation of glucosidase activity at OTG concentrations 
of 6mM (Figure 5.11).  The kinetics data obtained for glucoside activity given in Chapter 4 
(Section 4.4.2., Table 4.7), were measured in the presence of 5 mM OTG.  A description is 
given in the next section of a more detailed investigation of the reaction kinetics of GUS-WT 
and its variants as well as of GUS-TR3337 and it variants.  
(a)                                                                        (b) 
 
(c) 
 
Figure 5.11 Michaelis-Menten plots for the activation of glucosidase activity by OTG as the 
variable substrate  
(a) 2.33 µM of WT3P24E11 (b) 1.47 µM WT5P26A7 (c) 0.7 µM THERMO4P11F2. 
5.3.3.2. Kinetic analysis of GUS-WT and GUS-TR3337 variants 
To better show the differences between the purified native enzymes (GUS-WT and GUS-
TR3337) and later generation variants (WT5P26A7 and THERMO4P11F2), the enzymes were 
subjected to kinetic analysis with both pNP-glucuronide and pNP-glucoside substrates at pH 
7.4 and 25 ˚C.  The points to be made can be adequately illustrated with plots for the above 
enzymes, but a more complete collection of variant data sets can be found in Appendix D.2., 
D.3., D.4., D.5., D.6. & D.7.  Figure 5.12 showed Michaelis-Menten plots for GUS-WT and 
WT3P24E11 WT5P26A7 
THERMO4P11F2 
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WT5P26A7 with the corresponding Eadie-Hofstee plots given in Figure 5.13.  The 
corresponding plots for GUS-TR3337 and THERMO4P11F2 are given in Figure 5.14 & 5.15. 
(a)                                                                                  (b) 
    
(c) 
    
(d) 
 
Figure 5.12 Michaelis-Menten plots of GUS-WT and WT5P26A7 
The points show the measured values with their standard deviation. (a) Hydrolysis of pNP-
glucuronide by GUS-WT (b) Hydrolysis of pNP-glucoside by GUS-WT (c) Hydrolysis of pNP-
glucoside by WT5P26A7 (d) Hydrolysis of pNP-glucoside by WT5P26A7 in the presence of 5 
mM OTG. 
GUS-WT without BugBusterTM GUS-WT without BugBuster
TM 
WT5P26A7 without BugBusterTM 
WT5P26A7 with BugBusterTM 
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(a)                                                               
    
(b) 
 
(c)                                                                          
    
(d) 
 
Figure 5.13 Eadie-Hofstee plots of GUS-WT and WT5P26A7 
Each plot is the mean of triplicates. (a) Hydrolysis of pNP-glucuronide by GUS-WT (b) 
Hydrolysis of pNP-glucoside by GUS-WT (c) Hydrolysis of pNP-glucoside by WT5P26A7 (d) 
Hydrolysis of pNP-glucoside by WT5P26A7 in the presence of 5 mM OTG. 
GUS-WT without BugBusterTM 
GUS-WT without BugBusterTM 
WT5P26A7 without BugBusterTM 
WT5P26A7 with BugBusterTM 
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(a)                                                                                  (b) 
    
(c) 
    
(d) 
 
Figure 5.14 Michaelis-Menten plots of GUS-TR3337 and THERMO4P11F2 
The points show the measured values with their standard deviation. (a) Hydrolysis of pNP-
glucuronide by GUS-TR3337 (b) Hydrolysis of pNP-glucoside by GUS-TR3337 (c) Hydrolysis of 
pNP-glucoside by THERMO4P11F2 (d) Hydrolysis of pNP-glucoside by THERMO4P11F2 in the 
presence of 5 mM OTG. 
  
GUS-TR3337 without BugBusterTM GUS-TR33374 without BugBuster
TM 
THERMO4P11F2 with BugBusterTM 
THERMO4P11F2 without BugBusterTM 
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(a)                                                                                  (b) 
    
(c)                                                                                 (d) 
    
Figure 5.15 Eadie-Hofstee plots of GUS-TR3337 and THERMO4P11F2 
Each plot is the mean of triplicates. (a) Hydrolysis of pNP-glucuronide by GUS-TR3337 (b) 
Hydrolysis of pNP-glucoside by GUS-TR3337 (c) Hydrolysis of pNP-glucoside by 
THERMO4P11F2 (d) Hydrolysis of pNP-glucoside by THERMO4P11F2 in the presence of 5 mM 
OTG. 
In Figures 5.12 and 5.14, the (a) and (b) Michaelis-Menten plots show the native 
enzymes with glucuronide and glucoside substrates, respectively.  The hyperbolic natures of 
Michaelis-Menten plots are confirmed by the linear Eadie-Hofstee plots given in the (b) and (d) 
of Figures 5.13 for wild-type enzyme and its variants; and along with the (b) and (d) of Figures 
5.15 for the thermostable enzyme and its variants.  These are quite different to the Michaelis-
Menten plots for the later generation mutants given in part (c) of Figure 5.12 and 5.14.  These 
plots appear to be biphasic and this is confirmed by the Eadie-Hofstee plots given in Figures 
5.13c & 5.15c.  These plots can be used to calculate kinetic parameters for the low and high 
affinity substrate ranges (Martin-Nieto et al. 1992).  Table 5.1 contained the kinetic 
parameters obtained with Eadie-Hofstee plots for native enzymes (GUS-WT and GUS-TR3337) 
and representative variant enzymes from each round of evolution.  The validity of values 
found for variants exhibiting biphasic kinetics can be questioned since in neither the low or 
high substrate ranges is it possible to see a saturation of the binding event.  However, from 
these calculations it was evident that the kinetic parameters obtained at high substrate differ 
GUS-TR3337 without BugBusterTM 
GUS-TR3337 without BugBusterTM 
THERMO4P11F2 without BugBusterTM 
THERMO4P11F2 with BugBusterTM 
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dramatically from those obtained at low substrate concentrations suggesting that substrate 
binding brings about a change in the enzyme in the later generation variants.  The addition of 
saturating concentrations of OTG to later generation variants gives rise to a Michaelis-Menten 
curves (Figure 5.12d & 5.14d) that appear to be hyperbolic and Eadie-Hofstee plots that are 
straight lines (Figure 5.13d & 5.15d).  In the presence of OTG, substrate concentration has little 
effect on the nature of catalysis of the variant enzymes – as is the case for a typical non-
cooperative enzyme.  
In the previous section (5.4.2.1.) it was found that OTG was a competitive inhibitor for 
the native enzymes; that is the hyperbolic shape of the Michaelis-Menten curves did not 
change with increasing concentrations of OTG. This is in sharp contrast to the variant enzymes 
that show a change in their response to substrate as the substrate concentration increases.  
Furthermore, OTG decreases the velocity of the native enzymes, it effectively increases the 
catalytic rate of variants at the same substrate concentration.  
Table 5.1 Apparent values of kcat, Km and kcat/Km of GUS-WT* and GUS-TR3337* with pNP-
glucoside at different temperatures 
(a) 25 °C (b) 45 °C. 
(a) 
Enzyme Activity App.* kcat 
(s
-1
) 
App.* Km 
(mM) 
App.* kcat/Km 
(M
-1
s
-1
) 
WT-GUS  0.200 ± 0.0260   7.600 ± 0.492 26.28 
WT1P17G2  0.590 ± 0.0610   4.486 ± 0.084 109.75 
WT3P24E11 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
0.409 
 
0.018 
96.6 
 
   0.007 
4.23 
 
2503.34 
WT4P26F8 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
0.072 
 
0.0036 
  78.2 
 
  0.03 
0.92 
 
120.34 
WT5P26A7 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
0.33 
 
0.017 
42.1 
 
  0.01 
7.95 
 
1673.64 
GUS-TR3337 
THERMO1P6B9 
 
 
0.083 ± 0.0079 
0.400 ± 0.031 
  4.400 ± 0.016 
  8.300 ± 0.200 
18.71 
47.59 
THERMO2P23C4 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
0.62 
 
0.0062 
10.5 
 
  0.05 
58.90 
 
123.69 
THERMO3P24F7 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
0.16 
 
0.0092 
 
47.7 
 
  0.01 
3.36 
 
917.01 
THERMO4P11F2 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
0.88 
 
0.075 
48.7 
 
  0.01 
18.00 
 
7517.20 
App. – apparent 
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(b) 
Enzyme Activity App.* kcat 
 (s
-1
) 
App.* Km 
 (mM) 
App.* kcat/Km 
(M
-1
s
-1
) 
WT-GUS  0.33 ± 0.0041   9.79 ± 0.38 33.56 
WT1P17G2  1.74 ± 0.0480 11.80 ± 0.00098 147.10 
WT3P24E11 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
0.44 
 
0.02 
 
37.3 
 
  0.005 
 
11.89 
 
3992.90 
WT4P26F8 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
0.14 
 
0.01 
13.1 
 
  0.02 
10.53 
 
517.42 
WT5P26A7 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
1 
 
0.025 
54 
 
  0.005 
18.62 
 
5027.65 
GUS-TR3337  0.51 ± 0.0054   8.00 ± 0.28 64.38 
THERMO2P23C4 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
2.33 
 
0.0058 
  8.5 
 
  0.01 
274.28 
 
582.85 
THERMO3P24F7 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
1.6 
 
0.048 
93.2 
 
  0.04 
17.17 
 
1200.00 
THERMO4P11F2 High activity, low affinity 
(At high substrate concentrations) 
Low activity, high affinity 
(At low substrate concentrations) 
4.79 
 
0.32 
58.5 
 
  0.04 
81.92 
 
7987.22 
App. – apparent 
5.3.3.2.1. Assessing negative cooperativity in evolved variants using the Hill equation 
The biphasic kinetics obtained with the variant enzymes were clearly not indicative of 
Michaelis-Menten enzymes.  However, not all enzymes obey Michaelis-Menten kinetics – the 
most common deviation is due to cooperativity that can usually be described with Hill 
equation; a modification of the Michaelis-Menten equation, as shown below: 
v = (Vmax [S]
n)/(K0.5
n + [S]n)                                                                                                    (Equation 5.2) 
Where v is initial velocity; Vmax, maximum velocity; n, Hill coefficient; [S], substrate 
concentration and K0.5 is the substrate concentration at half-maximal velocity.  When n = 1, 
Equation 5.2 is exactly the same as the Michaelis-Menten equation and K0.5 = Km. 
The Hill equation can be used to describe cooperative binding of ligands to 
macromolecules was proposed by Hill (1910), based on his observation of the oxygen binding 
nature to haemoglobin.  Cooperativity in proteins and enzymes is often due to interactions 
between subunits or subsites so that binding of the first ligand molecule increases (positive 
cooperativity) or decreases (negative cooperativity) the binding affinity of the other(s) (Atkins 
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2005).  In the aforementioned case, cooperativity involves multiple subunits so that each 
molecule has multiple substrate binding sites.  Cooperativity also gives rise to a non-Michaelis-
Menten kinetic response in certain enzymes that consist of a single subunit with a single 
substrate-binding site (Rose et al. 1993, Ferdinand 1966, Rabin 1967).  
For the Hill equation, if n = 1, there is no cooperativity, n < 1 indicates negative 
cooperativity while n > 1 indicates positive cooperativity (Cornish-Bowden 2004).  A cursory 
glace at the plots in Figures 5.11C & 5.13C are clearly not indicative of positive cooperativity, 
but are suggestive of negative cooperativity.  Proving negative cooperativity using the Hill 
equation can be a rather ambiguous process (Goodrich & Kugel 2007).  The Hill equation is 
more easily applied to ligand binding studies in receptors and cytochrome P450, where the 
binding capacity, which is equivalent to Vmax is known (Sakai 1994).  The Hill coefficients were 
determined by using KaleidaGraph software to perform a non-linear least-squares fit of all the 
data points to the Hill equation (Equation 5.2).  The Hill plots for all the data sets are given in 
Appendix D.3. & D.4. while the Hill constants (n values) for the data sets are given below in 
Table 5.2.  The calculated values of n demonstrate the non-cooperativity (n = 1) of both 
parents and first generation mutants; and suggest negative cooperativity (n < 1) of mutants in 
later generations in the absence of OTG.  Hill coefficients of 1 indicate that there was no 
cooperativity in pNP-glucoside hydrolysis after treating the mutants with 0.5 mM OTG.  Even 
though fitting the data to the a Hill equation yields values for n and parameters corresponding 
to Vmax and Km, the errors associated with the parameters were high for the mutants, making 
the computation of the Hill coefficient meaningless (Appendix D.3.).  The latter generation 
enzymes cannot be said to exhibit negative cooperativity in the absence of OTG.  
Table 5.2 Values of the Hill constant (n) of wild-type and evolved variants as derived from 
the plots in Appendix D.3. & D.4. and their corresponding correlation coefficient (R2) values 
Enzyme 
In the absence of 5 mM OTG In the presence of 5 mM OTG 
n R2 n R2 
GUS-WT 1.00 1.00 1.01 1.00 
WT1P17G2 1.03 1.00 1.00 1.00 
WT3P24E11 0.65 0.99 1.00 1.00 
WT4P26F8 0.51 1.00 1.01 1.00 
WT5P26A7 0.90 1.00 1.00 1.00 
GUS-TR3337 1.01 1.00 1.00 1.00 
THERMO1P6B9 1.01 1.00 1.00 1.00 
THERMO2P23C4 0.74 1.00 1.00 1.00 
THERMO3P24F7 0.52 1.00 1.00 1.00 
THERMO4P11F2 0.59 0.99 1.00 1.00 
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The kinetics curves of WT5P26A7 and THERMO4P11F2 were dissected into 2 regions 
(one operating at low and another at high pNP-glucoside concentrations).  Data were fitted to 
the Hill equation, one for concentrations up to 0.8 mM and another one using only 
concentrations above 3.2 mM.  Dissection of the kinetic data reveals that at substrate 
concentrations below 0.8 mM, glucosidase activity conforms to Michaelis-Menten kinetics 
with the Hill coefficient equal to 1 (Figure 5.16a & c); at elevated substrate concentration (<0.8 
mM) both mutants exhibited greater activity but a decrease in cooperativity (Figure 5.16b & 
d).  Random addition of OTG abolished cooperativity at higher substrate concentrations, as 
evidenced by the hyperbolic curve (Figure 5.17).   
(5) (b) 
    
(5) ©(d) 
    
Figure 5.16 Velocity-substrate curves of improved variants at low (micromolar range) and 
high (millimolar range) substrate concentrations 
(5) Plots of WT5P26A7 at the substrate concentration range of 2.5 – 800 µM  (b) Plots of 
WT5P26A7 at the substrate concentration range of 0.8 – 90 mM (c) Plots of 
THERMO4P11F2 at the substrate concentration range of 2.5 – 2400 µM  (d) Plots of 
THERMO4P11F2 at the substrate concentration range of 2.4 – 90 mM.   
WT5P26A7 WT5P26A7 
THERMO4P11F2 
THERMO4P11F2 
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Figure 5.17 Comparison of substrate saturation curves for 0.6 µm WT6P26A7 and 
THERMO4P11F2 in the presence and absence of 0.5 mM OTG 
The initial turnover at 25 °C in pH 7.4 solutions with several concentrations of pNP-glucoside 
up to 30 mM.  Data collection and curve fitting are described in Chapter 2 (Section 2.3.4.1. & 
2.3.4.1.1.). 
Since the kinetics of variants starts with a hyperbolic-like pattern followed by a near 
linear portion at later stage, the biphasic curves represent data also fitted to a double 
Michaelis-Menten curve: 
v = Vmax1 [S] / (Km1 + [S]) + Vmax2 [S] / (Km2 + [S])                                                                (Equation 5.3) 
in which v is the initial velocity, Vmax is the maximum velocity, Km is the Michaelis-Menten 
constant and [S] is the substrate concentration.  This model assumes Vmax2 > Vmax1 and Km2 > 
Km1.  Although this equation provides good fit to the experimental data, the values of the 
constants estimated from the equations can vary dramatically when [S] approaches Km2.  In 
this study, the apparent Vmax2 was unable to be accurately predicted and thus apparent Km2 in 
which saturation is unobtainable up to 0.1 M pNP-glucoside (Appendix D.8.).  The value of 
apparent Km and Vmax returned from the fit were different from the values calculated from 
Eadie-Hofstee transformation (Hofstee 1959) (Table 5.3).  It is apparent that the double 
Michealis-Menten equation gives a much more precise estimation of Km and Vmax as indicated 
by a higher R2 as compared to Eadie-Hofstee transformation.  
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Table 5.3 Km values obtained from the linear fittings of Eadie-Hofstee transformation and 
double Michealis-Menten equation 
Goodness of fit was evaluated from R2. 
Enzyme 
Eadie-Hofstee Double Michealis-Menten 
Km1 (mM) R
2
 Km2 (mM) R
2
 Km1 (mM) Km2 (mM) R
2
 
WT3P24E11 0.007 0.99 96.6 0.98 0.0045 ± 0.0012 150.26 ±   8.35 1 
WT4P26F8 0.030 0.91 78.2 0.90 0.1249 ± 0.0442 128.48 ± 23.52 1 
WT5P26A7 0.010 0.97 42.1 0.97 0.0038 ± 0.0033   66.12 ±   4.08 1 
THERMO2P23C4 0.050 0.92 10.5 0.91 2.4276 ± 1.5005   60.43 ± 20.55 1 
THERMO3P24F7 0.010 0.99 47.7 0.93 0.0186 ± 0.0072   70.99 ±    7.83 1 
THERMO4P11F2 0.010 0.95 48.7 0.94 0.0057 ± 0.0019 114.08 ±    9.61 1 
5.4. Structure – Implications of mutations  
Structures often provide a basis for understanding complex biological phenomena and for this 
reason some effort was made to obtain some structural information.  Cooperativity is often 
associated with inter-subunit interactions where the binding of a ligand to one subunit may 
affect ligand binding to other subunits (Koshland et al. 1966).  The enhanced activity in the 
presence of OTG was first observed for WT3P24E11 (T509A, K568Q, P597Q) and 
THERMO3P24F7 (S550N, S566N and K568E).  Given T509A has no significant effect on the 
activation of WT1P17G2 and P597Q is located far away from the active site, it was likely that 
K568Q was responsible for the activation.  This agrees well with the similar mutations 
observed in THERMO3P24F7 where the serine at position 550 and 566, were both converted 
back to asparagine, the original residues in GUS-WT; and the fact that K568E affects activation 
directly.  Furthermore, it has been noted in other studies that evolution has resulted in 
changes at the interface of subunit boundaries and that this could account for enhanced 
stability of the variant enzymes.  For these reasons, it was thought useful to obtain some 
indication of the oligomeric structure of the native and variant enzymes.  Size exclusion 
chromatography and discontinuous native protein gel electrophoresis analysis were 
performed to monitor the different oligomeric forms of the native and variant enzymes.  The 
data are presented in the Appendix D.9.1. & D.9.2., respectively.  These are not approaches 
that could lead to the identification of minor changes in the oligomeric state of the proteins.  
In fact, the elution and native gel profiles of the selected variants and parents look very similar 
leading to the conclusion that there are no significant differences between the natives and 
their variant forms.  However, neither physical technique could detect small differences in the 
equilibrium between the different oligomeric forms and that there were small differences in 
this equilibrium.  Our results also ruled out the possibilities that it might be caused by: i) 
differences in the ratio of dimer/tetramer that gave rise to different performance; ii) protein 
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concentrations and iii) end-product inhibition and activation.  The results and discussions of 
these experiments are found in Appendix D.9.3. 
A more definitive approach to structure involves the use of X-ray crystallography.  
Although this is a very powerful tool, it requires the production of crystals for diffraction 
experiments.  The crystal structures of E. coli β-GUS alone and in combination with a low-
affinity inhibitor have been solved (Wallace et al. 2010).  An attempt to grow a crystal of 
WT5P26A7 was performed using the published conditions (2 mg/mL protein in 17% 
polyethylene glycol 3350, 250 mM magnesium acetate, and 0.02% sodium azide at 16°C) with 
varying polyethylene glycol (PEG) 3350 concentration from 14% to 19% versus magnesium 
acetate concentration from 150 mM to 300 mM.  Unfortunately, no crystals were observed.  
Second attempt was performed with a library of known crystallising conditions.  A series of 
microbatch crystallisations in 96-well plates were performed using Hampton Research 
Crystallisation kits including IndexTM, Crystal ScreenTM, PEGRxTM, PEG/IonTM and SaltRxTM.  Out 
of 480 crystallising conditions trialled, only six conditions displayed possible crystal formation 
(Figure 5.18). 
The growth of crystals large enough for x-ray diffraction was attempted using the 
hanging-drop method in 24-well plates.  The crystallisation conditions were optimized by 
varying the pH values and PEG concentrations.  No crystals were observed from any of the 
scaled up crystallisations.  Repeating the conditions using batch crystallisation (as used in the 
screens) might be more successful.  However, the appropriate crystallisation conditions to 
grow sizable crystals for x-ray crystal analysis are still under investigation.  
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(a)                                                                   (b) 
    
(c)                                                                    (d) 
    
(e)                                                                    (f) 
    
Figure 5.18 WT5P26A7 crystals grown under different conditions  
(a) 0.2 M ammonium tartrate dibasic, 20% w/v PEG 3350, pH 6.6 (b) 0.2 M ammonium tartrate 
dibasic (pH 7), 20% w/v PEG 3350 (c) 0.2 M ammonium sulfate (pH 6), 20% w/v PEG 3350 (d) 
0.1 M sodium citrate tribasic dehydrate (pH 5.5), 22% w/v PEG 3350, 0.1% w/v OG (e) 0.1 M 
sodium citrate tribasic dehydrate (pH 5.5), 18% w/v PEG 3350 (f) 1.8 M ammonium sulfate, 0.1 
M BIS-TRIS (pH6.5) 2% v/v PEG monomethyl ether 550. 
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5.5. Conclusions 
The contents of this chapter were, for the most part, not anticipated in the initial stages of the 
project.  The work came about as a result of the use of the BugBusterTM reagent.  As noted at 
the start of this chapter, the manufacturer advertises that the reagent disrupts membranes 
but does not interfere with the cellular proteins.  In addition, the manufacturer did not specify 
what was in the BugBusterTM reagent so that it was difficult for the investigator to determine if 
the reagent was likely to affect a protein of interest without resorting to experimental tests.  
BugBusterTM did not completely obliterate the activity of β-GUS and the treatment devised for 
the assays gave rise to low levels of activity so that it appeared that this was an ideal protocol 
to detect the increased activity of variants.  It now apparent that a test of alternative methods 
of lysis, such as lysozyme (and not some other surfactant), should have been carried out.  
Despite the problems introduced by the BugBusterTM reagent, this work serves as an 
example of how enzyme evolves to increase new activity in response to a competitive 
inhibitor.  This study also reveals the presence of OTG in most of the commercial non-ionic 
detergents making them not an ideal choice for cell lysis in directed evolution where the aim is 
to enhance glucosidase activity.  Consequently, the directed evolution of GUS-WT and GUS-
TR3337 has confirmed that “you can’t always get what you want”, but you do “get what you 
select for” (Jagger & Richards 1969, Giver & Arnold 1998) – that is, variants that have 
enhanced activity in the presence of a component of BugBusterTM.  
The early experiments (Section 5.3) of this chapter identify the BugBusterTM reagent as 
the cause of the anomalies in the directed evolution.  The evidence presented was clear-cut.  
However, the process by which OTG effects β-GUS, was not so clear-cut.  The BugBusterTM 
reagent is a mixture of compounds and analysis by chemical means was not straightforward.  
Given the time constraints of an Australian PhD, it seemed that testing likely components of 
the BugBusterTM reagent was a more realistic option.  OTG mimics the effects of BugbusterTM 
reagent on purified proteins, but it was possible that the BugBusterTM reagent contains more 
than one compound that affects β-GUS.  If there was more than one compound or if there 
were different compounds in the BugbusterTM reagent that was (or were) responsible for the 
effects on β-GUS, then it was very likely that it was (or they were) very similar to OTG.  
Structurally, OG was a glycoside derived from glucose and octanol (Figure 5.6a).  
Because it was less stable and can be hydrolysed by β-glucosidase, Saito & Tsuchiya (1984) had 
first synthesized OTG to offer an alternative to OG.  The presence of the thioether linkage 
made OTG resistant to degradation by β-glucosidase (Figure 5.6b).  Given the structures of OG 
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and OTG it was not a surprise they inhibited the glucosidase activities of wild-type and the 
variants generated in the first 2 rounds of directed evolution.  Similar behaviour was observed 
with SDS suggests that the aliphatic chain of OTG was in large part responsible for the affects 
observed in the experiments described in this chapter.  
The fact that OTG was a competitive inhibitor of GUS-WT and GUS-Tr3337 was 
consistent with the idea that it binds in the active site.  This is also consistent with the 
observation that OTG has a sugar component that is similar to the physiological substrate and 
the substrate being selected for in the directed evolution experiments.  One would expect that 
the glycosyl group of OTG caused it to bind in the active site and this gave rise to the observed 
competitive inhibition.  The Ki obtained in these experiments indicates that it binds with very 
low affinity.  Variants have evolved such that OTG activates glucosidase activity, in a 
concentration dependent manner, is surprising and has important implications.  
Activation by OTG of later generation variants was surprising (at least to the 
candidature) because evolution could simply have produced variants that did not bind OTG.  
Clearly, the glycosyl group of OTG did not interfere with the activity of the later generation 
variants suggesting that mutations prevented the glycosyl group of OTG from binding in the 
sugar binding site, but how did this happen? Perhaps, mutations were introduced that 
prevented the glycosyl group from binding in the active site, but which allowed retention of 
binding via the aliphatic group.  This suggestion was speculative and further proof is needed if 
it is to be regarded as factual.  However, the facts were that 1) OTG enhances the activity and 
2) it did so in a concentration dependent manner.  This second fact strongly suggests that OTG 
acts on the later generation variants by binding to them.  Experiments to verify and quantitate 
OTG binding to GUS are best done with an isothermal titration calorimetric study, however, a 
suitable instrument could not be accessed in the time needed to complete the experiment.  It 
is intended that this experiment be done in the future. 
Further evidence that OTG binds to and causes significant changes to β-GUS is 
provided by a comparison of the kinetics of the β-GUS and β-GUS in the presence of OTG.  OTG 
causes β-GUS to take on Michaelic-Menten kinetics while the activity profile of the enzyme in 
the absence of OTG is clearly not Michaelis-Menten.  The saturation curves of OTG free 
enzyme variants are best fit with a double Michealis-Menten model but obey Michaelis-
Menten kinetics upon addition of OTG.  This suggests that a structural change is involved and 
that the structural change is brought about by OTG.  This change may be due to OTG having a 
direct effect on the active site or it may cause an alteration in the subunit interactions that 
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then causes a change in the active site.  This later case was explored by trying to use negative 
cooperativity to explain the reaction profile.  However, the error associated with the 
calculated Km is significant indicated a poor fitting model.  A more definitive technique was 
required to settle this issue; ideally x-ray crystallography could have been used to clarify this 
issue if suitable crystals had been obtained. 
The use of BugbusterTM cost the PhD candidature a great deal of time and effort, but 
its use also gave some insight into how enzymes might evolve in nature.  At this stage some 
speculation is in order.  A component of BugbusterTM (OTG) binds to β-GUS and it seems likely 
that it induces a structural change in the protein.  Variants were selected based on the activity 
of the enzyme / OTG complex.  In the absence of OTG, these same variants displayed much 
less activity suggesting that OTG also binds to the variants, but not in the same manner as the 
occurs in native β-GUS (and thermostable GUS-TR3337).  In the absence of OTG, the structure 
of the variant enzymes is not optimal for activity; hence the appearance of OTG activates the 
variant forms of β-GUS.  In the experiments described in this chapter, OTG is an experimental 
artefact.  However, in the cell, it is possible that there is selective advantage in turning on (or 
activating) an enzyme response to the presence of a non-substrate reagent (call it factor X).  
Under these circumstances, there will be some tendency for the enzyme to evolve in such a 
way that later generation variants bind X and require it for activity.  This seems to be what has 
occurred in the evolution of β-GUS with OTG.   
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Chapter 6 
Synthesis of steroidal glucosides using 
glucuronylsynthase 
6.1. Introduction 
One of the aims of the present study was to convert the evolved β-GUS variants with 
glucosidase activity into enzymes that could catalyse the synthesis of steroid glucosides, 
enzymes that were denoted glucosynthases.  Similar experiments had been carried out with β-
GUS mutants; denoted as glucuronylsynthases.  Background for this work was given in Chapter 
1.  The main impediment to the experiments described in this chapter was time. The 
experiments to evolve GUS variants with altered substrate specificity had taken most of the 
time allowed for an Australian PhD and there was only a short interval of time available to 
make the necessary changes that might bring about synthetic activity. Very little time was left 
to optimize experimental conditions for the synthesis reaction.   
6.2. Glycosylation reaction of glucuronylsynthase 
In late 2005, three glucuronylsynthases (E504A, E504G, and E504S mutants of GUS-WT) were 
successfully expressed and isolated at the University of Sydney (Wilkinson et al. 2008).  From 
McLeod group’s small scale glucuronylation reactions, it was found that the glycine variant 
(E504G) was more active.  This observation was thought to be due to the absence of a side 
chain on G504.  Similar experimental trials were carried out with some of the best variants 
described in Chapter 4.  That is, the nucleophilic glutamate residue (E504) was also replaced by 
either an alanine (E504A), glycine (E504G), or serine (E504S) residue, substitutions known to 
be effective in other glycosynthases (Williams & Withers 2002).  Both GUS-WT and GUS-
TR3337 along with evolved mutants (WT3P24E11, WT5P26A7 and THERMO4P11F2) were 
subjected to mutagenesis at position 504. The mutants are shown in Table 6.1 below. 
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Table 6.1 The glucuronylsynthase enzymes prepared through the site-directed mutagenesis 
of the native E. coli gus 
Hydrolase 
Glucuronylsynthase 
E504A E504G E504S 
GUS-WT GUSWT-E504A GUSWT-E504G GUSWT-E504S 
WT3P24E11 WT3P24E11-E504A WT3P24E11-E504G WT3P24E11-E504S 
WT5P26A7 WT5P26A7-E504A WT5P26A7-E504G WT5P26A7-E504S 
GUS-TR3337 GUSTR3337-E504A GUSTR3337-E504G GUSTR3337-E504S 
THERMO4P11F2 THERMO4P11F2-E504A THERMO4P11F2-E504G THERMO4P11F2-E504S 
The present work follows protocols developed in the study of glucuronylsynthases so 
that a brief description of that work will be given here.  The first steroid glucuronide isolated 
from the glucuronylsynthase reaction was derived from dehydroepiandrosterone (DHEA) 
(Figure 6.1a) (Wilkinson et al. 2008).  DHEA was glucuronylated in a low yield of 26%, largely 
caused by the very hydrophobic nature of the DHEA (Wilkinson et al. 2008).  The low aqueous 
solubility of the DHEA was overcome by the synthesis of DHEA O–(carboxymethyl)oxime 
(CMO-DHEA) (Figure 6.1b) (Wilkinson et al. 2008).  The carboxylic acid attached to the end of 
this oxime has a pKa of ~2-3 meaning the carboxylate anion would and provide prevail 
enhanced water solubility in the glucuronylsynthase reactions performed at pH 7.5.  The 
higher aqueous solubility afforded an impressive 76% yield of CMO-DHEA β-glucuronide from 
the glucuronylsynthase reaction (Wilkinson et al. 2008).  Of particular interest, the 
glucuronylation of testosterone afforded the desired glucuronide in 48 – 50% yield (Ma et al. 
2014).  Since CMO-DHEA and testosterone were two examples used to demonstrate the 
successful glucuronylsynthasis of steroidal glucuronides, these two steroids were used as 
steroidal acceptors to test the glycosylation capability of the glucuronylsynthase. 
(a)                               (b)                                                          (c) 
       
Figure 6.1 Chemical structures of steroids 
(a) DHEA (b) CMO-DHEA (c) Testosterone. 
 The glucuronylation protocol developed had three main components: the 
glucuronylsynthase enzyme, the synthetically derived α-D-glucuronyl fluoride donor and a 
suitable acceptor alcohol (Figure 6.2) (Wilkinson et al. 2011).  In this study, the 
glucuronylsynthase enzymes are given in Table 6.1.  The donor and acceptor substrates were 
α-D-glucosyl fluoride and steroids (CMO-DHEA and testosterone), respectively.  They were 
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prepared by Mr. Andy Pranata from the McLeod research group (ANU).  Similarly, the 
glycosylation reactions were carried out in a mixed 10% v/v tert-butanol-sodium phosphate 
buffer at pH 7.5 and 37 °C for 2 days.  The addition of tert-butanol aids the solubility of 
hydrophobic steroids and enhances the reaction rate for glucuronylsynthesis (Wilkinson et al. 
2011).   
 
Figure 6.2 The glucuronylsynthase protocol 
6.3. Extraction for glucuronides from the reaction mix 
The solid-phase extraction (SPE) cartridges were used to separate the components of the 
glycosylation reactions.  The SPE cartridges elute one or more components from a small 
amount of sorbent using different types of mobile phases.  The sorbent can be normal-phase, 
reverse-phase, ion-exchange or a combination of each media.  The protocol developed by the 
McLeod group for SPE purification employed Oasis  WAX (weak anion exchange) branded SPE 
cartridges containing polar and weak anion exchange residues (Figure 6.3).  The carboxylic acid 
function of the glucuronide conjugates, allow02 isolation of these conjugates using mixed 
phase anionic SPE cartridges.  Figure 6.4 gives an example of how SPE works; it illustrates the 
extraction of testosterone β-D-glucuronide directly from a reaction mixture by the use of an 
Oasis  WAX cartridge.  The reaction mixture contains the parent steroid (testosterone), α-D-
glucuronyl fluoride, the glucuronide product (testosterone β-D-glucuronide) and the 
glucuronylsynthase enzyme.  
Figure 6.3 Schematic diagram of the procedure used for WAX SPE cartridges 
+   OH-Steroid 
E. coli glucuronylsynthase, 
10% tert-butanol,  
50 mM sodium phosphate buffer, pH 7.5,  
37 °C, 2 days 
1           2% formic acid 
2                   mQH2O 
3                methanol 
4       5% NH4OH in MeOH 
Hydrophilic compounds: α-D-glucosyl fluoride 
Salts: phosphate 
Neutral lipophilic compounds: steroids 
Lipophilic acidic compounds: steroid glucuronides 
Fraction   Reaction mixture 
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Figure 6.4 The interactions of the components from the testosterone glucuronylsynthase 
reaction with the Waters Oasis  WAX sorbent 
Lipophilic residues are coloured green, hydrophilic residues are red and ionic residues are 
coloured blue. 
 There were three key components present in the sorbent of the cartridge: i) the 
polymeric hydrocarbon functionality (green) provided the lipophilic interaction with the 
similarly lipophilic backbone of the steroid; ii) the hydrophilic functionality (red) of γ-lactam 
provided the polar interactions with the hydroxyl groups of the sugar and iii) the ionic 
functionality (blue) of piperazine provided the weak anion exchange.   
 The first mobile phase is 2 % v/v aqueous formic acid, that serves to elute the sugars.  
Then water was passed through the cartridge to protonate piperazine (blue) and ionize the 
carboxylate on the glucuronide at about pH 6-7.  Elution with methanol was then performed.  
The unconjugated testosterone was readily soluble in methanol and eluted while the 
glucuronide remained bound to the resin through the charged interaction between the 
carboxylate anion and the piperazinium cation.  The final elution step was performed with 5 % 
v/v ammonium hydroxide in methanol where ammonium hydroxide deprotonates the 
piperazinium cations, removing the charged interaction and allowing the glucuronide to 
dissolve into methanol and elute from the SPE cartridge in the form of an ammonium salt. 
6.4. The glycosylation reaction 
In this study, the target glucoside conjugate was purified by SPE using the same protocol.  
Unlike glucuronide conjugates, steroidal glucosides were isolated based on the chemical 
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properties of steroids.  Thus, steroidal glucosides will be eluted with steroid in the same 
fraction.  For example, CMO-DHEA β-glucosides produced in the glycosynthase reactions 
would co-elute with CMO-DHEA in fraction 4 (5 % NH4OH in MeOH) due to the carboxylic acid 
of the oxime and glucoside; testosterone β-D-glucuronides would co-elute with testosterone in 
fraction 3 (methanol).  The resulting fractions 3 and 4 from each glycosylation reaction were 
subjected to the analysis by 1H NMR and electron-spray ionization mass spectrum (MS-ESI) 
analyses. 
6.5. Detection of steroidal glucosides from the glycosylation 
reaction 
After a 2 day incubation of 6 reactions containing CMO-DHEA, α-D-glucuronyl fluoride and six 
synthetic enzymes (GUSWT-E504A, GUSWT-E504G, GUSWT-E504S, GUSTR3337-E504A, 
GUSTR3337-E504G and GUSTR3337-E504S), the crude reactions were loaded onto Oasis  WAX 
SPE cartridges.  The 1H NMR spectrum of fraction 4 from the reactions with CMO-DHEA, gave 
evidence for only the CMO-DHEA – no product.  Among these reactions, visible precipitation 
was observed in the fraction 4 of the reaction catalyzed by GUSWT-E504G.  The solids were 
isolated and evaporated to dryness by rotary evaporation.  The dried residue was suspended 
in approximately 600 µL deuterated water (D2O) prior to
 1H-NMR analysis.  The 1H-NMR 
spectrum showed some evidence for the presence of the CMO-DHEA β-glucoside (data not 
shown).  Unfortunately the result could not be further confirmed by MS-ESI as the sample was 
accidentally discarded. 
 Following the failure to detect the glucoside compounds from the glycosylation 
reaction using wild-type synthases, the reactions were tested against CMO-DHEA and 
testosterone using mutant enzymes listed in Table 6.1.  From the experience gained in 
previous reactions, fractions 3 and 4 from each extraction of the reactions, were dried and 
dissolved in D2O for 
1H- NMR analysis and subsequent MS-ESI.  However, no glucoside 
products were detected in all of the 18 glucuronylsynthase reactions. 
 Since octyl-β-D-thioglucoside (OTG) was found to have a positive effect on the 
glucosidase activity of improved mutants, it was added into a new set of synthetic reactions 
using mutant listed in Table 6.1, in the hope of providing similar effects on the glycosylation 
activity.  OTG was eluted in fraction 3 and identified by 1H-NMR and MS-ESI.  Other than OTG, 
no glucoside products were detected in all reactions. 
Synthesis of steroidal glucosides using glucuronylsynthase 6 
 
127 
 
6.6. Concluding remarks 
The GUS-WT and GUS-TR3337 and their variants were successfully converted to the 
corresponding synthases.  The methods, which involved glucuronylsynthase reaction and 
subsequent SPE purification of the products (steroidal glucoside), were adopted from Ma et al. 
(2014).  No activity was detected with the substrates used to produce steroidal glucuronides.  
There was insufficient time to optimize the protocols for the synthesis and purification of 
steroidal glucosides.  Furthermore, although no activity was detected with steroids, it is 
possible that the enzymes could have worked with other substrates.  Again, there was not 
time to test this hypothesis.  
It was envisaged that the mutations obtained while evolving GUS-WT and GUS-TR3337 
for a high level of glucosidase activity could provide insight into the glycosylation reaction.  Of 
particular interest was the correlation between hydrolysis and glycosylation, i.e. would the 
evolved variants also possess higher glycosylation activity? It was hoped that this might be 
possible in the future after refinements had been made to the reaction protocols so that 
useful levels of product could be obtained.  
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Chapter 7 
Conclusion and Future Directions 
Chemists have known for many years that there are advantages to be gained by using 
enzymes.  However, there are not many enzymes for reactions of interest to chemists.  Part of 
the problem in finding a suitable enzyme for a given reaction is that enzymes are usually very 
specific – one of the features that make enzymes very useful in a biological context.  So, the 
question arises, can protein engineers alter the substrate specificity of an enzyme to make it a 
useful catalyst for some practical application, as would be encountered by a synthetic 
chemist? This is the question addressed in this thesis.  There is no general answer to this 
question, rather answers can be provided on a case-by-case basis.  So, it is important to 
choose an enzyme and reaction that are of some practical utility.   
One of the more common steps in many synthetic reactions is to fuse a sugar ring, 
such a glucose or glucuronic acid, to a variety of substrates.  It was a class of reactions that was 
the target of the present work.  The reaction catalysed by E. coli β-GUS was unusual in that it is 
only specific for glucuronic acid and not the aglycone.  A simple mutation converts this 
hydrolytic enzyme into glucuronylsynthase – one that will fuse a glucuronyl group onto a 
variety of substrates.  This is potentially a very useful enzyme, but the kinetic properties of this 
glucuronylsynthase cannot be described as spectacular.  Improving the properties of this 
enzyme through directed evolution is the project of another student in the laboratory.  My 
project was to identify β-GUS variants with altered substrate specificity and to convert the 
best of these to glycosynthases, via the same mutation that converted β-GUS into a 
glucuronylsynthase.  
The initial approach to altering the substrate specificity of β-GUS was to change 
selected residues surrounding the active site and to monitor the effects on a number of 
substrates.  These residues were subjected to site saturation mutagenesis to identify variants 
that had reasonable activity on non-physiological substrates.  Residues were selected by 
examination of the structure of β-GUS with bound glucaro-δ-lactam – a reasonably good 
model for bound substrate.  Two sets of residues were investigated, primary (glycosyl binding 
residues) and secondary (non-glycosyl binding residues).  It had been observed that most of 
the selected glycosyl binding residues are not suitable for our purposes as the activities of 
these variants toward pNP-glucuronide, pNP-glucoside, pNP-galactoside, pNP-mannoside and 
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pNP-xyloside substrates were quite low (< 80 % of the activity of the starting enzyme).  In 
contrast, different substitutions of non-glycosyl binding residues were observed to enhance 
the catalytic activity with particular substrates, i.e. T509A and T509S mutations demonstrating 
increased glucosidase and galactosidase activities while mutant S557P showed higher 
galactosidase activities.  Even though this approach met with a small amount of success, there 
was still considerable room for improvement in the hydrolytic activity with all of the tested 
substrates.  None of the variants seemed to be suitable starting points for the anticipated 
directed evolution studies.  
The variants produced in the above studies did give some insight into the structure 
function relationship of β-GUS.  Residues that contact the substrate seemed to have a vital 
importance for the enzyme and substitutions gave rise to variants with little activity.  These 
residues included those that made contact with the acid group of glucuronic acid that is not 
present in any of the other substrates that were tested.  The reasons underlying this 
observation were never entirely clear and considerable time and effort would have been 
required to address this issue.  It is likely that active site residues are important for binding 
substrate and maintaining the integrity of the active site.  The appropriate tool to test this 
hypothesis was X-ray crystallography, but unfortunately a procedure for producing suitable 
crystals could not be found; a published protocol (Wallace et al. 2010) for producing 
diffraction quality crystals gave only amorphous precipitates.  
Residues close to the active site, but which did not appear to make contact with the 
substrate, produce reasonable activity with non-physiological substrates and some of these 
same variants were later identified in the directed evolution studies described in Chapter 4.  
Some of the variants identified in Chapter 3 were also found in directed evolution studies 
carried out in other laboratories (Matsumura & Ellington 2001).  These later studies were 
directed towards finding variants that were more stable than the native enzyme.  The topic of 
stability often arises in directed evolution studies and not just for those studies that are aimed 
at improving stability.  Increased stability often occurs in studies where the aim is to improve 
activity; leading to the idea that stability enhances evolvability.  The word “evolvability” is 
usually used to describe the ability of an organism to adapt to changing conditions.  When 
applied to the evolution of an enzyme, the changing condition implies the selection condition 
– usually an increase in activity.  If evolvability is taken to mean a process that gives increased 
activity, then the link between evolvability and stability is really a link between activity and 
stability.  Chapter 4 of this thesis was intended to be a more systematic attempt to study the 
link between stability and activity.  In this case, the activity was not with the physiological 
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substrate of the enzyme as β-GUS had already evolved to the point that it was close to the 
diffusion limit.  In addition, the presence of OTG in crude extracts meant that the evolution 
had to overcome the presence of a weakly bound inhibitor.  This later aspect of the 
experiments was unintended and took some effort to identify, as outlined in Chapter 5.  
However, the presence of OTG meant that the laboratory evolution might mimic the way 
enzyme regulations evolve in nature.  Specifically, β-GUS evolved such that the final variants 
show much reduced activity in the absence of OTG; this reagent has become an activator of 
the variant enzymes.  
 Proteins from thermophilic organisms generally show not only greater thermal 
stability, but also stability towards chemical denaturants and proteolysis (Vieille & Zeikus 2001, 
Leuschner & Antranikian 1995, Jaenicke 1991).  Since not all enzymes are presently found in 
thermophiles and thermophilic proteins sometimes do not fold into the native conformation 
when expressed in E. coli, the overall stability of a target enzyme can be raised with directed 
evolution.  However, it had previously been observed that the emergence of a desirable trait in 
an enzyme is accompanied by an evolutionary cost in some other properties, such as stability, 
activity or specificity (Antikainen et al. 2003, Celenza et al. 2008, Valderrama et al. 2002).  Even 
though it is virtually impossible to predict these costs, it is widely believed that improvements 
in enzyme activity through protein engineering often come at the cost of reduced stability.  For 
this reason, a stable enzyme was thought to evolve a function more efficiently than a similar, 
but less stable enzyme.  This hypothesis has been demonstrated experimentally, by comparing 
the evolvability of marginally stable and thermostable variants of cytochrome P450 BM3 
(Bloom et al. 2006).  However, variants were only examined through one round of directed 
evolution.  In general, directed evolution uses multiple generations of mutation and selection 
to improve or alter biochemical functions of proteins.  In our study, we compare the 
evolvability of wild-type and thermostable variants of β-GUS for up to 5 rounds of directed 
evolution.  The laboratory evolved version of the GUS-WT, that is GUS-TR3337, not only 
exhibited higher thermostability (Xiong et al. 2007) but also showed better resistance to 
chemical denaturants and mutations than wild type β-GUS.  These comparative experiments 
show that, even though the stable GUS-TR3337 protein started with a lower glucosidase 
activity at room temperature relative to GUS-WT, the best variants obtained during each 
generation from GUS-TR3337 library achieved higher glucosidase activity and tolerance 
towards OTG than those from GUS-WT library.   
By measuring the stability of the evolved enzyme and their precursors, it was 
demonstrated that the effect of a mutation was depended on the stability of the parent, i.e. 
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the stability of GUS-WT was first raised by introducing the stabilizing T509A mutation in 
WT1P17G2 to allow for the subsequent discovery of the functionally beneficial but 
destabilizing mutation, K568Q, in WT3P24E11 (Figure 7.1).  Mutations that improve both 
properties simultaneously are rare, however, the mutation T509A was found not only to 
increase the stability of β-GUS, but also increase glucosidase activity.  Similar to the results 
obtained with GUS-WT, the highly thermostable THERMO2P23C4 could tolerate the 
destabilizing K568E mutation even though this was accompanied with a loss of 2 
thermostabilizing mutations (S550N and S566N) in THERMO3P24F7.   
(a) 
    
(b) 
 
Figure 7.1 Activity and stability changes during the directed evolution of GUS-WT and GUS-
TR3337 for activity on β-glucoside 
(a) The changes in glucosidase activity and protein thermostability (b) The changes in 
glucosidase activity and chemical stability at 2 M urea. 
The stabilities of evolved variants were measured before the effects of OTG were 
established.  Clearly, the stability of native and variant proteins needs to be measured in the 
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presence of OTG.  The time constraints of an Australian PhD did not allow these 
measurements to be repeated before this thesis was written.  It is intended that these 
measurements will be made after thesis submission so that a manuscript can be submitted for 
publication. 
 In most directed evolution experiments, cell lysis is an important step for releasing 
enzyme into the supernatant for the subsequent assays to determine protein content and 
enzyme activity.  Common cell disruption methods include mechanical (i.e. sonication, French 
press, bead milling), chemical (i.e. alkali, detergents), and enzymatic (i.e. lysozyme) methods 
(Chisti & Moo-Young 1986).  Physical methods are not suitable for high throughput 
experiments while enzymatic methods are expensive.  Since detergent treatment is a relatively 
inexpensive and effective method; and suited for high-throughput screening assays, lysis with 
the BugBuster TM reagent was applied in our study.  However, it had led to unexpected impacts 
on the output of the screening process due to the presence of molecules that are structurally 
similar to the native substrate of β-GUS.  One lesson that was learnt from the use of BugBuster 
TM reagent, was that reagents of unknown composition should not be used in experiments.  If 
they are to be used a test for negative effects of the reagent should be made.  In the 
experiments described in Chapter 4, a comparison of the activity obtained with BugBuster TM 
reagent and R-lysozyme would have revealed a drop in the activity due to BugBuster TM 
reagent.   
During screening process, OTG was added to assays unintentionally as part of the 
BugBusterTM reagent.  This eventually resulted in variants with glucosidase activity that was 
activated by OTG.  By examining the effects of mutations, the mutation at K568 residue in 
particular appears responsible for restoring the kinetic model from double Michaelis-Menten 
kinetics to single Michaelis-Menten kinetics (non-cooperativity) in the presence of excess OTG.  
To our knowledge, this is the first time such kinetic behavior was reported for a tetrameric 
enzyme with a single ligand-binding site one each subunit.  The sum of two Michaelis-Menten 
model often represents two independent enzymes operating in the range of assayed substrate 
concentrations and it therefore prompted us to launch an investigation into whether the 
variants contain two kinetic forms due to the existence of different oligomeric forms.   
Unfortunately, no direct link between the biphasic kinetics and different oligomeric 
forms of enzymes was observed.  However, future work should determine if OTG modulates 
the oligomeric stage and thus the activity of evolved enzymes.  Much effort has been directed 
towards investigating the reason for the loss of glucosidase activity of evolved variants in the 
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absence of OTG.  There was insufficient time available in this project to investigate various 
effects of OTG on evolved variants.  For example, it seems likely that evolution abolished the 
inhibitory effect of OTG, but it still has an effect on the later generation variants.  This 
observation suggests that OTG is bound to the later generation variants.  Binding of OTG to 
variants can be verified and quantitated the OTG with isothermal titration calorimetry.   
It is also worth considering whether variants can use OTG as a substrate.  This is not 
likely as OTG instead of OG as the latter reagent is subject to enzymatic hydrolysis while the 
former does not.  However, one way of dealing with the inhibitory effects of OTG might be to 
produce variants that can break the β-thioglucoside linkage.  This may explain the abolition of 
competitive binding by OTG.  That is, the cleavage of β-thioglucoside linkage by evolved 
variant would release D-glucose from the active site.  Again, these experiments should be done 
in the future.  
Despite the need to perform additional experiments, the results obtained to-date are 
generally positive regarding the alteration of the substrate specificity of β-GUS.  Furthermore, 
the evolution of the thermostable variant was proceeding more rapidly than the native β-GUS; 
as expected.  The evolution was particularly impressive given that it overcame the presence of 
OTG.  Although the presence and effects of OTG were not anticipated, it was of considerable 
interest.  The evolution introduced the capacity to regulate the β-GUS.  This is possible similar 
to the route by which enzyme regulation evolves in nature.  
 Lastly, the E504G mutation was introduced into evolved variants in order to test their 
synthetic capability.  As it turned out, steroidal glucosides were not detected after the 
enzymatic reaction.  This was a negative result and unfortunately there was insufficient time to 
optimize the experimental conditions, nor was there time to test other substrates.  The intent 
of this thesis was first to improve the glucosidase activity of the β-GUS followed by converting 
the hydrolysis activity into the glycosylation activity.  While the evolved glucosidase activity 
remained much lower than the native enzyme’s activity on its physiological substrate, the 
catalytic efficiency of GUS-WT for glucuronidase activity was 342 fold higher than 
THERMO4P11F2 for glucosidase activity, making it possible that the converted glycosylation 
activity was too low to be detected.  Further evolution of the glucosidase activity of the best 
variants could be carried out in the future. Alternatively, attempts could be made to apply 
directed evolution on the glucuronylsynthase directly.  These experiments may form the 
subject of other research projects.  
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Appendices 
A. Chapter 1 
A.1. Nomenclature 
A summary of the nomenclature used for the chemical compounds and the main reactions 
that will be encountered throughout this thesis is provided below for convenience of the 
reader.  The substrates used in this thesis are structurally complex and are related to a number 
of stereoisomers.  This thesis follows the nomenclature outlined in the International Union of 
Pure and Applied Chemistry (IUPAC) guidelines, though trivial names will be used where 
possible for brevity.   
A.1.1. Reactions 
Glycosides consist of a sugar residue (glycone) covalently bound to a different structure called 
the aglycone.  The sugar moiety can be joined to the aglycone via an oxygen atom (O-
glycoside), sulphur (S-glycoside), nitrogen (N-glycoside) or carbon (C-glycoside).  Specifically in 
this thesis, glycosides consist of a glycosyl and a general aglycone component, that are linked 
by an O-glycosidic bond.  In naming of glycosides, the “ose” suffix of the sugar name is 
replaced by “oside”.  For example, if the glycone group of a glycoside is glucose, then the 
molecule is a glucoside; if it is glucuronic acid, then the molecule is a glucuronide; etc.   
The hydrolysis of glycosides will generate a free sugar moiety and an aglycone moiety.  
The reverse process, conjugation or glycosylation, results in the synthesis of a glycosidic bond.  
Among various glycosylation reactions, the main focus in this thesis is on glucosylation and 
glucuronylation, which involve addition of a glucose or glucuronic acid to an aglycone.  The 
reactions are shown in Figure A.1 and the nomenclature for the two components in a glycoside 
is detailed in the next two sections.   
  
A Appendices 
 
136 
 
(a) 
 
(b) 
 
Figure A.1 Reactions that are discussed in this thesis are the hydrolysis and synthesis of 
glycosides 
A glycoside consists a glycosyl group (blue) and an aglycone component (red). (a) Glucosylation 
(b) Glucuronylation. 
A.1.2. Glycosyl groups 
Following the guidelines set out by McNaught (1997), the numbering for the monosaccharides 
begins at the aldehyde chain in the Fisher projection (Figure A.2).  The configuration 
descriptor, D or L, is determined by the stereochemistry at the “highest-numbered center of 
chirality” which exists at C5.  Therefore, with the hydroxyl group (red) positioned to the right, 
this is a “D” sugar; conversely, with the hydroxyl group (blue) positioned to the left this is an 
“L” sugar.  They are enantiomerically related but the “D” form is the more common of the two 
in nature.  It is the form that is applicable to this thesis.  Therefore, only “D” sugars were 
represented in Figure A.1. 
 
Figure A.2 The Fischer project of D-glucose and L-glucose 
 Monosaccharides usually occur in aqueous solution as cyclic structures, in which the 
C5 hydroxyl group forms an intramolecular bond with the C1 aldehyde.  The newly-produced 
center of chirality at C1 is designated as the anomeric carbon, as shown in Figure A.3.  The 
stereochemistry at the C1 is defined by prefixes “α” or “β” depending on its relative 
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stereochemistry to C5.  In the β-anomer, the ring oxygen at C5 (red) is formally trans to the C1 
oxygen (blue), while in the α-anomer the relationship is formally cis.   
 
 
Figure A.3 Glycosyl groups: The glucuronyl acid is essentially a glucose oxidized at the C6 
position 
The glycosyl groups on glycosides that relates to this study in a hydrolysis reaction, are 
β-D-glucuronic acid and β-D-glucose.  These are hydrolysis products that will be frequently 
presented throughout this thesis.  Most glycosynthases derived from β-retaining glycoside 
hydrolases, i.e. β-glucuronidase (β-GUS), prefer α-glycosyl-fluorides donors and proceed 
through a single-displacement mechanism (α → β) (Perugino et al. 2004).  Therefore, the 
glycosyl donors used for this work (Chapter 6) in a glycosylation reaction, are α-D-glucosyl 
fluoride and α-D-glucuronyl fluoride, and their glycone groups are α-D-glucose and α-D-
glucuronic acid, respectively (Figure A.4).  Their C1 carbon carries a fluorine atom instead of a 
hydroxyl group.  The reaction mechanisms of β-GUS and glucuronylsynthase will be discussed 
in detail in Chapter 1. 
(a)                                  (b) 
            
Figure A.4 β-D-glycosyl fluoride 
(a) β-D-glucosyl fluoride (b) β-D-glucuronyl fluoride. 
With regards to ring size, the term “pyran” refers to the six-membered cyclic sugars, 
collectively known as the pyranose.  The sugars discussed in this thesis will only cover such 
sugars and no other ring sizes will be examined.  For the purpose of this thesis, the trivial 
names for the common monosaccharides were used, i.e. glucose and glucuronic acid.   
β-D-glucose 
β-D-glucose D-glucose α-D-glucose 
 α-D-glucose 
A Appendices 
 
138 
 
A.1.3. Aglycone groups 
The other component in the β-D-glucuronide is the aglycone.  This is either the leaving group 
in the hydrolysis reaction or an acceptor substrate for the conjugation reaction.  Para-
nitrophenol is the leaving group in the substrate used to monitor hydrolysis in this thesis.  In 
glucuronylation, the two main acceptors used for this work are steroids where the center for 
the conjugation reaction happens at a hydroxyl group.  They are dehydroepiandrosterone O-
(carboxymethyl)oxime (CMO-DHEA) and testosterone (Figure A.5).  Since the systematic 
names are tedious to present, the common names and abbreviations will be used.   
(a)                    (b)                                                                     (c)                              
                      
Figure A.5 Aglycones discussed 
Acceptors of the leaving group in the hydrolysis reaction or glucuronyl donors in 
glucuronylation reactions. (a) Para-nitrophenol (b) CMO-DHEA (c) Testosterone. 
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A.2. 
Considering ePCR introduces point mutations at the DNA level, on average just 5.7 of the 
potential 19 alternative amino-acids are accessible by a single nucleotide change (Miyazaki & 
Arnold 1999).   Therefore, theoretical library size is calculated by equation below which was 
discussed by (Patrick et al. 2003): 
V = 5.7x N! / [x! (N-x) !] 
Where V is the total number of possible variants, N is the length of template sequence and x is 
the average mutation frequency. 
To achieve 95 % library coverage, the sampling factor is about three.  This is calculated by: 
F = 1 – e-L/V 
Where F is the fraction of completeness of the library, L is the library size and V is the total 
number of possible sequence variants.  To construct a library expected to contain 95 % of all 
possible sequence variants, then F = 0.95, therefore: 
0.95 = 1 – e-L/V 
L = - V In 0.05 
  ≈ 3 V 
Which means three fold excess of transformants needs to be screened. 
Table B.1 Library sizes and the oversampling size required to achieve 95 % library coverage of 
a 600 amino acid in directed evolution experiments.   
Average mutation frequency Theoretical library size 
(number of variants) 
95 % coverage 
(number of variants) 
1 3.42 x 103 1.02 x 104 
2 5.84 x 106 1.75 x 107 
3 6.63 x 109 1.98 x 1010 
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B. Chapter 2 
B.1. Recipes and Reagents 
The recipes and chemical preparations used throughout this project are described below. 
Buffer A 
Solution of 0.5 M NaCl, 20 mM imidazole and 20 mM phosphate buffer adjusted to pH 7.4. 
Buffer B 
Solution of 0.5 M NaCl, 500 mM imidazole and 20 mM phosphate buffer adjusted to pH 7.4. 
β-Glucuronidase (β-GUS) Activity Indicator Agar 
2 g of agar (Difco) is dissolved in 500 mL of water at 100 °C, this solution is then cooled to 70 °C 
before 2.75 g of disodium phosphate (Ajax) and 0.68 g of monosodium phosphate (Ajax) is 
added and dissolved to provide a buffer of 50 mM buffer at pH 7.4.  This is allowed to cool 
further, to 60 °C before adding 0.2 g of 5-bromo-4-chloro-3-indolyl-β-D-glucoside (X-glucoside) 
for 1 mM final concentration. 
Luria-Bertani (LB) 
For one litre of this media, dissolve 10 g of tryptone (Difco), 5 g of yeast extract (Difco) and 10 
g of NaCl in 0.9 L of water and adjust to pH 7 with 250 µL of 10 M NaOH make up to volume 
and sterilize by autoclaving. 
LB-Kanamycin (LBK) Media 
Prepare LB as above and add filter-sterilised ampicillin (Astral) at 50 mg/mL (stored in aliquots 
at -20 °C) for a final concentration of 50 µg/mL in the sterilized media. 
LB(K) Agar 
Prepare LB(K) as above, but include 15 g/L of agar (Difco) before autoclaving.  
Yeast Extract Nutrient Broth (YENB) 
Solution of 7.5 g/L bacto yeast extract (Difco) and 8 g/L bacto nutrient broth (Difco) sterilized 
by autoclaving. 
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C. Chapter 4 
C.1. 
(a) 
 
(b) 
 
Figure C.1 Temperature optima of GUS-WT and GUS-TR3337 variants 
(a) GUS-WT (b) GUS-TR3337.  
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C.2. 
(a)                                                                          (b) 
 
(c)                                                                                   (d) 
  
Figure C.2 Chemical induced unfolding is shown by changes in λmax 
(a) Urea induced unfolding in GUS-WT* (b) Urea induced unfolding in GUS-TR3337* (c) GdnHCl 
induced in GUS-WT* (d) GdnHCl induced in GUS-TR3337. 
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C.3. 
(a)                                                                                    (b) 
 
(c)                                                                                    (d) 
 
Figure C.3 Impact of the presence of different concentrations of urea and GdnHCl on the 
glucosidase activity of GUS variants 
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D. Chapter 5 
D.1. Spectra of octyl thioglucoside 
(a) 
 
  
D Appendices 
 
146 
 
(b) 
 
Figure D.1. Spectra of octyl thioglucoside in BugBusterTM reagent (methanol fraction) 
(a) NMR spectrum (b) MS spectrum. 
The BugBusterTM reagent was subjected to solild-phase purification.  A 3 mL Oasis WAX SPE 
cartridge was pre-conditioned with 1 mL methanol and 3 mL milliQ water.  The BugBusterTM 
reagent was loaded onto the cartridge and washed with 3 mL aqueous formic acid, 3 mL 
mQH2O, 3 mL methanol and finally with 9 mL saturated aqueous ammonium hydroxide in 
methanol. 
1H NMR ( 400 MHz, CD3OD): 4.34 (1H, d, J 9.7 Hz), 3.85 (1H, dd, J 12.1, 2.0 Hz). 3.65 (1H, dd, J 
11.9, 5.3 Hz), 3.36-3.32 (1H, m), 3.30-3.24 (2H, m), 3.18 (1H, m), 2.72 (2H. m). 2.72 (2H, m), 
1.63 (2H, m), 1.43-1.31 (10H, m), 0.90 (3H, m); LRMS (+ESI) m/z 640 ([2M+Na]+), 331 
([M+Na]+); HRMS (+ESI) m/z calculated. for C14H28O5NaS ([M+Na]
+) 331.1555, found 331.1548. 
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D.2. Michaelis-Menten plots for the hydrolysis of pNP-glucuronide by 
wild-type and evolved variants 
(a)                                                                         (b)  
    
(c)                                                                                  (d) 
    
(e)                                                                                 (f) 
    
  
GUS-WT 
WT1P17G2 
WT3P24E11 
WT4P26F8 
WT5P26A7 GUS-TR3337 
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(g)                                                                                 (h)  
    
(i)                                                                                   
    
Figure D.2 Michaelis-Menten plots for the hydrolysis of pNP-glucuronide by wild-type and 
evolved variants   
(a) GUS-WT (b) WT1P17G2 (c) WT3P24E11 (d) WT4P26F8 (e) WT5P26A7 (f) GUS-TR3337 (g) 
THERMO2P23C4 (h) THERMO3P24F7 (i) THERMO4P11F2. 
  
THERMO2P23C4 THERMO3P24F7 
THERMO4P11F2 
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D.3. Michaelis-Menten plots for the hydrolysis of pNP-glucoside by 
wild-type and evolved variants   
(a)                                                                                 (b)  
    
(c)                                                                                 (d) 
    
(e)                                                                                   (f) 
     
GUS-WT WT1P17G2 
WT3P24E11 
WT4P26F8 
WT5P26A7 
GUS-TR3337 
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(g)                                                                                   (h) 
    
(i)                                                                                       (j) 
    
Figure D.3 Michaelis-Menten plots for the hydrolysis of pNP-glucoside by wild-type and 
evolved variants   
Data were fitted to the Hill equation using Kaleidagraph version 4.1 (Synergy software).  
Parameters for the fitted curves are given (m1: Vmax; m2: n; m3: K0.5); R is the correlation 
coefficient.  (a) GUS-WT (b) WT1P17G2 (c) WT3P24E11 (d) WT4P26F8 (e) WT5P26A7 (f) GUS-
TR3337 (g) THERMO1P6B9 (h) THERMO2P23C4 (i) THERMO3P24F7 (j) THERMO4P11F2. 
  
THERMO2P23C4 
THERMO3P24F7 THERMO4P11F2 
THERMO1P6B9 
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D.4. Michaelis-Menten plots for the hydrolysis of pNP-glucoside by 
wild-type and evolved variants in the presence of 5 mM OTG   
(a)                                                                          (b) 
    
(c)                                                                                     (d)  
    
(e)                                                                                    (f) 
     
GUS-WT WT1P17G
2
WT3P24E11 WT4P26F8 
WT5P26A7 GUS-TR3337 
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(g)                                                                                      (h) 
       
(i)                                                                               (j)  
    
Figure D.4 Michaelis-Menten plots for the hydrolysis of pNP-glucoside by wild-type and 
evolved variants in the presence of 5 mM OTG   
Data were fitted to the Hill equation using Kaleidagraph version 4.1 (Synergy software). 
Parameters for the fitted curves are given (m1: Vmax; m2: n; m3: K0.5); R is the correlation 
coefficient.  (a) GUS-WT (b) WT1P17G2 (c) WT3P24E11 (d) WT4P26F8 (e) WT5P26A7 (f) GUS-
TR3337 (g) THERMO1P6B9 (h) THERMO2P23C4 (i) THERMO3P24F7 (j) THERMO4P11F2. 
  
THERMO1P6B9 THERMO2P23C
4 
THERMO3P24F7 THERMO4P11F2 
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D.5. Eadie-Hofstee plots of the pNP-glucuronide hydrolysis by wild-
type and evolved variants 
(a)                                                                                        (b) 
    
(c)                                                                                        (d) 
    
(e)                                                                                        (f)  
    
(g)                                                                                        (h) 
     
GUS-WT 
WT1P17G2 
WT3P24E11 WT4P26F8 
WT5P26A7 
GUS-TR3337 
THERMO2P23C4 
THERMO3P24F7 
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(i) 
 
Figure D.5 Eadie-Hofstee plots of the pNP-glucuronide hydrolysis by wild-type and evolved 
variants 
Each plot is the mean of triplicates 
(a) GUS-WT (b) WT1P17G2 (c) WT3P24E11 (d) WT4P26F8 (e) WT5P26A7 (f) GUS-TR3337 (g) 
THERMO2P23C4 (h) THERMO3P24F7 (i) THERMO4P11F2. 
  
THERMO4P11F2 
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D.6. Eadie-Hofstee plots of the pNP-glucoside hydrolysis by wild-type 
and evolved variants 
(a)                                                                                (b) 
    
(c)                                                                                         (d) 
    
(e)                                                                                         (f) 
    
(g)                                                                                        (h) 
    
GUS-WT WT1P17G2 
WT3P24E11 
WT4P26F8 
WT5P26A7 
GUS-TR3337 
THERMO1P6B9 THERMO2P23C4 
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(i)                                                                                   (j)  
    
Figure D.6 Eadie-Hofstee plots of the pNP-glucoside hydrolysis by wild-type and evolved 
variants 
Each plot is the mean of triplicates 
(a) GUS-WT (b) WT1P17G2 (c) WT3P24E11 (d) WT4P26F8 (e) WT5P26A7 (f) GUS-TR3337 (g) 
THERMO1P6B9 (h) THERMO2P23C4 (i) THERMO3P24F7 (j) THERMO4P11F2. 
  
THERMO3P24F7 THERMO4P11F2 
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D.7. Eadie-Hofstee plots of the pNP-glucoside hydrolysis by wild-type 
and evolved variants in the presence of 5 mM OTG 
(a)                                                                                        (b) 
    
(c)                                                                                         (d)  
    
(e)                                                                                         (f)  
    
(g)                                                                                        (h) 
    
GUS-WT WT1P17G2 
WT3P24E11 WT4P26F8 
WT5P26A7 GUS-TR3337 
THERMO1P6B9 THERMO2P23C4 
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(i)                                                                                (j) 
    
Figure D.7 Eadie-Hofstee plots of the pNP-glucoside hydrolysis by wild-type and evolved 
variants in the presence of 5 mM OTG 
Each plot is the mean of triplicates 
(a) GUS-WT (b) WT1P17G2 (c) WT3P24E11 (d) WT4P26F8 (e) WT5P26A7 (f) GUS-TR3337 (g) 
THERMO1P6B9 (h) THERMO2P23C4 (i) THERMO3P24F7 (j) THERMO4P11F2. 
  
THERMO3P24F7 THERMO4P11F2 
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D.8. Hydrolysis rate by evolved variants as a function of pNP-glucoside 
concentration, fitted to the double Michealis-Menten equation 
(a)                                                                        (b)  
    
(c)                                                                        (d) 
    
(e)                                                                           (f) 
    
Figure D.8 Hydrolysis rate by evolved variants as a function of pNP-glucoside concentration, 
fitted to the double Michealis-Menten equation 
Parameters for the fitted curves are given (m1: Vmax1; m2: Km1; m3: Vmax2; m4: Km2); R is the 
correlation coefficient.  (a) WT3P24E11 (b) WT4P26F8 (c) WT5P26A7 (d) THERMO2P23C4 (e) 
THERMO3P24F7 (f) THERMO4P11F2. 
WT3P24E11 
WT4P26F8 
WT5P26A7 THERMO2P23C4 
THERMO3P24F7 THERMO4P11F2 
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D.9. 
D.9.1. Determination of protein molecular weight 
The Superdex 200 size exclusion column (120 mL) used to estimate the size of GUS-WT* and 
GUS-TR3337* were pre-calibrated with five protein standards (ferritin, conalbumin, 
ovalbumin, thyroglobulin and aldolase) purchase from GE Healthcare Life Sciences (Section 
2.3.4.5.). 
The GUS-WT, WT1P17G2, WT3P24E11, WT5P26A7, GUS-TR3337, THERMO4P11F2 
were loaded on the size-exclusion chromatography column.  For all samples (20 mg of wild-
type and mutants), three peaks were observed corresponding to the potential tetrameric, 
dimeric and monomeric states, which had apparent molecular masses of 69, 139 and 279 kDa, 
respectively (Figure D.9).  Analysis by size exclusion chromatography demonstrated the 
presence of predominantly monomer species with smaller fractions of dimer and tetramer.  
This might be due to the sample dilution since diffusion occurs as sample passes through the 
column.  
(a)  
 
(b)  
 
Figure D.9 Oligomeric GUS-WT and GUS-TR3337 variants are observed during size exclusion 
chromatography 
Peak 1, tetramer (279 kDa); peak 2, dimer (139 kDa) and peak 3, monomer (69 kDa).  Protein 
samples were analysed on a Superdex 200 column equilibrated with 50 mM phosphate buffer 
(pH 7.4), 100 mM NaCl at a flow rate of 0.3 mL/min.  (a) GUS-WT* (b) GUS-TR3337*. 
1 
2 
3 
1 
2 
3 
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D.9.2. Discontinuous native protein gel electrophoresis analysis 
To further investigate the oligomerization state of GUS-WT* and GUS-TR3337*, discontinuous 
native protein gel electrophoresis analysis was used, which allows the separation of the 
protein complex in its native quaternary structure according to its size and shape (Niepmann & 
Zheng 2006).  As shown in Figure D.10, GUS-WT and GUS-TR3337 variants form dimeric and 
tetrameric bands with a molecular size of 139 and 279 kDa, respectively.  Judging from the 
intensities of the bands, the monomeric form is more abundant than the tetrameric form at a 
protein concentration of 1 mg/mL.  This observation was consistent with all tested mutants 
except THERMO4P11F2 migrated on the discontinuous native gel as a broad smear in addition 
to a weak 139 kDa band.   
                               1            2            3            4            5            6            7            8            9          10 
                        
Figure D.10 Discontinuous native gel electrophoresis of GUS-WT and GUS-TR3337 variants 
Lane 1: Bovine serum albumin (BSA), lane 2: GUS-WT, lane 3: WT1P17G2, lane 4: WT3P24E11, 
lane 5: WT4P26F8, lane 6: WT5P26A7, lane 7: THERMO1P6B9, lane 8: THERMO2P23C4, lane 9: 
THERMO3P24F7, lane 10: THERMO4P11F2. 
D.9.3. Assessment of biphasic kinetics in WT3P24E11 
Based on results obtained by using size exclusion chromatography and discontinuous native 
gel electrophoresis, GUS-WT and GUS-TR3337 mutants did not show significant differences in 
the oligomerization state.  Since GUS-WT and GUS-TR3337 mutants did not exhibit biphasic 
but standard Michaelis-Menten kinetics with pNP-glucuronide, a series of experiments was 
conducted with pNP-glucopyranoside in order to explore factors that might affect the negative 
cooperativity in the mutant enzymes.  WT3P24E11 was selected for further analysis as it 
carried fewest mutations (T509A, K568Q and P597Q) yet showed biphasic kinetics. 
D.9.3.1. Crosslinking 
The size-exclusion chromatography and discontinuous native gel experiments showed GUS-
WT* and GUS-TR3337* may exist as an equilibrium mixture of monomers, dimers and 
133 kDa 
66 kDa 
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tetramers, dependent on protein concentration.  In order to investigate further whether the 
biphasic curves were caused by differences in the enzymatic activity of different oligomers, 
GUS-WT and WT3P24E11 were incubated with bis(sulfosuccinimidyl)suberate (BS3) for various 
times to produce different ratios of covalent dimers to covalent tetramers and subsequently 
examined their glucosidase activity.  SDS-PAGE analysis of GUS-WT incubated with BS3 
indicated a fraction of the monomers were cross-linked into dimers, as evident from the 
decrease and increase in the intensity of the monomer and dimer bands, respectively (Figure 
D.11).  The cross-linking reaction also resulted in the formation of a band with a molecular 
weight higher than that of cross-linked dimers (~130 kDa).  It was presumably the result of 
intramolecular cross-links within un-cross-linked dimers preventing complete unfolding during 
SDS-PAGE.  The same cross-linking patterns were observed for WT3P24E11.  However, GUS-
WT displayed significantly more dimer formation compared to the WT3P24E11 protein.  Since 
the samples were not heat-treated before loading onto the gel, it was surprising to find that 
the GUS-WT dimer was more resistant to SDS than the WT3P24E11 dimer as one additional 
band with molecular weight estimates of 130 kDa indicated the GUS-WT dimer was observed 
before incubation with BS3.  The assessment of glucosidase activity was performed on GUS-WT 
and WT3P24E11 with the 20 min incubation period.  However, the cross-linking product of 
GUS-WT was inactive while the cross-linked sample of WT3P24E11 was less active than the 
uncross-linked WT3P24E11 (Figure D.12).   
GUS-WT  WT3P24E11 
              Minutes          0           1            5           20        M         0             1           5           20 
                                   
Figure D.11 Crosslinking of GUS-WT and WT3P24E11 with BS3, and subjected to SDS-PAGE 
 
Figure D.12 Glucuronidase activity of native and cross-linked GUS-WT and WT3P24E11 
66.2 kDa 
kDa 
116.3 kDa 
kDa 
200    kDa 
97.4 kDa 
kDa 
45 kDa 
kDa
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Untreated: Samples were prepared in the absence of BS3. Treated: Samples were prepared by 
incubating BS3 for 20 minutes. 
D.9.3.1. Effect of protein concentration on the biphasic kinetics 
If the biphasic kinetics result from two distinct forms of GUS-WT* and GUS-TR3337*, 
performing assays with pNP-glucopyranoside at different protein concentrations will give 
distinct kinetic patterns as the ratio of dimer/tetramer is depending on the protein 
concentration.  The glucosidase activity was measured using four different concentrations (0.1 
mg/mL, 0.05 mg/mL, 0.025 mg/mL and 0.01 mg/mL) of WT3P24E11.  Similar biphasic curve 
was observed under the range of 0.1-0.01 mg/mL protein, suggesting that the kinetic 
behaviour does not caused by different enzymatic species as the kinetic profile does not 
change with the protein concentration (Figure D.13).   
 
Figure D.13 The glucosidase activity is measured at different WT3P24E11 concentration 
D.9.3.2. End-product inhibition and activation 
Biphasic kinetics can also result from product activation, even without binding cooperativity.  
In order to investigate end-product inhibition, glucosidase activities of WT3P24E11 were 
obtained in the presence of different glucose concentrations (0.009 to 75 mM).  A control 
experiment was performed in the absence of glucose.  Figure D.14 exhibits substantially no 
activation nor inhibition of activity with the presence of high glucose concentration at 75 mM.  
The mutant retains its activity, both in the presence and absence of glucose.  This property has 
great biotechnological merit as most β-glucosidases are inhibited by low concentrations of 
glucose (Saha & Bothast 1996). 
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Figure D.14 Effects of glucose on the relative activity of WT3P27F8 
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